TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-1280215	Cytokine Signaling in Immune system	1.78112723963051e-27	-61.5925510662815	756	109	0.224279835390947	486	10287	2633,4939,1440,10125,3576,3394,8767,2537,1839,5971,23529,4312,6363,56300,2903,3455,4233,6352,6348,3601,3561,90865,8638,27189,1326,595,9235,91543,3429,115362,23586,3586,2920,3589,1844,10148,6288,8503,149233,29949,4314,3592,2919,4790,54739,3162,941,970,4982,4318,3553,27177,2635,2069,1847,26281,330,2668,11213,3659,3656,1848,1437,5699,4067,5698,3593,11009,3557,3669,5292,8995,6351,4938,3552,3559,1850,1435,3055,5743,3687,3575,3934,4791,3684,3569,9636,3604,6364,960,8809,2247,2634,6347,943,3383,3976,50604,4940,7133,3460,64127,4843,51561,146433,6708,3627,5721,115361	GBP1,OAS2,CSF3,RASGRP1,CXCL8,IRF8,RIPK2,IFI6,HBEGF,RELB,CLCF1,MMP1,CCL19,IL36G,GRIN2A,IFNAR2,MET,CCL5,CCL3,IL15RA,IL2RG,IL33,OASL,IL17C,MAP3K8,CCND1,IL32,RSAD2,IFI27,GBP5,DDX58,IL10,CXCL2,IL11,DUSP2,EBI3,SAA1,PIK3R3,IL23R,IL19,MMP3,IL12A,CXCL1,NFKB1,XAF1,HMOX1,CD80,CD70,TNFRSF11B,MMP9,IL1B,IL36B,GBP3,EREG,DUSP5,FGF20,BIRC3,GDNF,IRAK3,IRF1,IRAK2,DUSP6,CSF2,PSMB10,LYN,PSMB9,IL12B,IL24,IL1RN,ISG20,PIM1,TNFSF18,CCL4,OAS1,IL1A,IL2RA,DUSP8,CSF1,HCK,PTGS2,ITGAX,IL7R,LCN2,NFKB2,ITGAM,IL6,ISG15,TNFRSF9,CCL20,CD44,IL18R1,FGF2,GBP2,CCL2,TNFRSF8,ICAM1,LIF,IL20,OAS3,TNFRSF1B,IFNGR2,NOD2,NOS2,IL23A,IL34,SPTA1,CXCL10,PSME2,GBP4
R-HSA-449147	Signaling by Interleukins	3.62728770693115e-22	-49.3683868650497	525	81	0.166666666666667	486	10287	8809,3684,4791,6364,3569,3575,3687,5743,3055,3934,1435,6708,3627,5721,146433,51561,64127,4843,3383,7133,3976,50604,2247,6347,1437,5699,4067,3656,11213,1848,26281,1847,2668,27177,3553,2069,3559,3552,1850,6351,3557,5292,5698,11009,3593,2920,3589,1844,3586,4318,4790,3162,941,29949,2919,4314,3592,10148,6288,149233,8503,8767,23529,1839,10125,3576,1440,595,9235,90865,3601,3561,6348,1326,27189,6363,4312,4233,6352,56300,2903	IL18R1,ITGAM,NFKB2,CCL20,IL6,IL7R,ITGAX,PTGS2,HCK,LCN2,CSF1,SPTA1,CXCL10,PSME2,IL34,IL23A,NOD2,NOS2,ICAM1,TNFRSF1B,LIF,IL20,FGF2,CCL2,CSF2,PSMB10,LYN,IRAK2,IRAK3,DUSP6,FGF20,DUSP5,GDNF,IL36B,IL1B,EREG,IL2RA,IL1A,DUSP8,CCL4,IL1RN,PIM1,PSMB9,IL24,IL12B,CXCL2,IL11,DUSP2,IL10,MMP9,NFKB1,HMOX1,CD80,IL19,CXCL1,MMP3,IL12A,EBI3,SAA1,IL23R,PIK3R3,RIPK2,CLCF1,HBEGF,RASGRP1,CXCL8,CSF3,CCND1,IL32,IL33,IL15RA,IL2RG,CCL3,MAP3K8,IL17C,CCL19,MMP1,MET,CCL5,IL36G,GRIN2A
R-HSA-6783783	Interleukin-10 signaling	8.69033848134884e-21	-46.1920750636832	49	25	0.051440329218107	486	10287	3552,3627,6351,941,6348,3592,3976,6352,7133,2919,3557,3383,6363,3593,6347,2920,1437,3569,3586,6364,3576,5743,1435,1440,3553	IL1A,CXCL10,CCL4,CD80,CCL3,IL12A,LIF,CCL5,TNFRSF1B,CXCL1,IL1RN,ICAM1,CCL19,IL12B,CCL2,CXCL2,CSF2,IL6,IL10,CCL20,CXCL8,PTGS2,CSF1,CSF3,IL1B
R-HSA-168256	Immune System	1.88295815674564e-17	-38.5111025530609	2101	178	0.366255144032922	486	10287	2634,50604,3460,5068,2207,146433,3627,342510,55521,7128,115361,23327,23308,3575,5317,3055,4792,6317,9636,3710,8809,79930,960,11009,3593,3557,3669,629,4033,10584,6351,6616,2268,3559,4938,1540,2635,245973,27177,3553,2069,2668,3656,127544,1437,7498,6279,5806,4067,6288,8503,255488,29949,2919,4314,5005,4790,3162,54739,941,7295,2495,57823,4982,3429,23586,3586,2920,1844,3725,719,4312,718,6363,84676,114770,4233,3455,7130,90865,3561,6348,1326,50617,53831,595,3386,5004,2633,1440,6890,6278,92369,10071,3394,1118,2247,6347,3383,943,7133,3976,4940,54210,4843,64127,51561,6708,5721,5329,1435,5743,3687,4794,3934,3684,4791,3604,6364,3569,4688,117157,5698,4586,5292,8995,3552,644150,1850,1604,330,26281,1847,272,11213,3659,1848,5699,3937,10148,6280,149233,55008,8876,3592,10517,970,4318,7087,115362,29126,285852,64135,3589,7097,26253,6352,56300,2903,3601,27189,8638,221687,9235,91543,6891,4939,10125,11119,3576,5266,1520,154664,8767,2537,5971,23529,1839	GBP2,IL20,IFNGR2,REG3A,FCER1G,IL34,CXCL10,CD300E,TRIM36,TNFAIP3,GBP4,NEDD4L,ICOSLG,IL7R,PKP1,HCK,NFKBIA,SERPINB3,ISG15,ITPR3,IL18R1,DOK3,CD44,IL24,IL12B,IL1RN,ISG20,CFB,LRMP,COLEC10,CCL4,SNAP25,FGR,IL2RA,OAS1,CYLD,GBP3,ATP6V1C2,IL36B,IL1B,EREG,GDNF,IRAK2,RNF19B,CSF2,XDH,S100A8,PTX3,LYN,SAA1,PIK3R3,RNF144B,IL19,CXCL1,MMP3,ORM2,NFKB1,HMOX1,XAF1,CD80,TXN,FTH1,SLAMF7,TNFRSF11B,IFI27,DDX58,IL10,CXCL2,DUSP2,JUN,C3AR1,MMP1,C3,CCL19,TRIM63,PGLYRP2,MET,IFNAR2,TNFAIP6,IL33,IL2RG,CCL3,MAP3K8,ATP6V0A4,GPR84,CCND1,ICAM4,ORM1,GBP1,CSF3,TAP1,S100A7,SPSB4,MUC12,IRF8,CHIT1,FGF2,CCL2,ICAM1,TNFRSF8,TNFRSF1B,LIF,OAS3,TREM1,NOS2,NOD2,IL23A,SPTA1,PSME2,PLAUR,CSF1,PTGS2,ITGAX,NFKBIE,LCN2,ITGAM,NFKB2,TNFRSF9,CCL20,IL6,NCF2,SH2D1B,PSMB9,MUC5AC,PIM1,TNFSF18,IL1A,WIPF3,DUSP8,CD55,BIRC3,FGF20,DUSP5,AMPD3,IRAK3,IRF1,DUSP6,PSMB10,LCP2,EBI3,S100A9,IL23R,HERC6,VNN1,IL12A,FBXW10,CD70,MMP9,ICAM5,GBP5,CD274,TREML4,IFIH1,IL11,TLR2,CLEC4E,CCL5,IL36G,GRIN2A,IL15RA,IL17C,OASL,RNF182,IL32,RSAD2,TAP2,OAS2,RASGRP1,BTN3A1,CXCL8,PI3,CTSS,ABCA13,RIPK2,IFI6,RELB,CLCF1,HBEGF
R-HSA-380108	Chemokine receptors bind chemokines	1.48333537896676e-13	-29.5393130223348	48	19	0.0390946502057613	486	10287	6346,3627,57007,2921,6372,9034,2919,6352,6363,6373,6364,6376,4283,6374,7852,643,2920,1236,3576	CCL1,CXCL10,ACKR3,CXCL3,CXCL6,CCRL2,CXCL1,CCL5,CCL19,CXCL11,CCL20,CX3CL1,CXCL9,CXCL5,CXCR4,CXCR5,CXCL2,CCR7,CXCL8
R-HSA-6785807	Interleukin-4 and 13 signaling	9.56665145966693e-13	-27.6753229644082	111	27	0.0555555555555556	486	10287	3934,3576,5743,3687,3553,3569,3586,3684,3976,4314,3592,5292,7133,3383,4312,3593,6347,149233,2247,6288,4318,595,3552,4843,51561,3162,3561	LCN2,CXCL8,PTGS2,ITGAX,IL1B,IL6,IL10,ITGAM,LIF,MMP3,IL12A,PIM1,TNFRSF1B,ICAM1,MMP1,IL12B,CCL2,IL23R,FGF2,SAA1,MMP9,CCND1,IL1A,NOS2,IL23A,HMOX1,IL2RG
R-HSA-375276	Peptide ligand-binding receptors	3.66411216571977e-09	-19.4246797776883	188	30	0.0617283950617284	486	10287	3576,5021,10887,2151,6752,623,7852,643,2920,1236,6376,6364,6374,4283,1910,2847,2919,6352,6373,6363,718,9283,719,57007,2921,6288,6372,9034,6346,3627	CXCL8,OXTR,PROKR1,F2RL2,SSTR2,BDKRB1,CXCR4,CXCR5,CXCL2,CCR7,CX3CL1,CCL20,CXCL5,CXCL9,EDNRB,MCHR1,CXCL1,CCL5,CXCL11,CCL19,C3,GPR37L1,C3AR1,ACKR3,CXCL3,SAA1,CXCL6,CCRL2,CCL1,CXCL10
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	1.23638243071797e-06	-13.6033208368202	322	36	0.0740740740740741	486	10287	7852,643,2920,1236,150,6376,6364,6374,1910,10887,135,134864,2151,3627,2919,2847,6373,2863,6288,8111,6372,4283,3576,5021,6752,623,6346,6352,6363,718,9283,2921,57007,719,9034,147	CXCR4,CXCR5,CXCL2,CCR7,ADRA2A,CX3CL1,CCL20,CXCL5,EDNRB,PROKR1,ADORA2A,TAAR1,F2RL2,CXCL10,CXCL1,MCHR1,CXCL11,GPR39,SAA1,GPR68,CXCL6,CXCL9,CXCL8,OXTR,SSTR2,BDKRB1,CCL1,CCL5,CCL19,C3,GPR37L1,CXCL3,ACKR3,C3AR1,CCRL2,ADRA1B
R-HSA-909733	Interferon alpha/beta signaling	3.22608300108961e-06	-12.6442418497982	69	14	0.0288065843621399	486	10287	4939,2634,4940,3455,3429,3669,8638,3394,9636,54739,3659,91543,4938,2537	OAS2,GBP2,OAS3,IFNAR2,IFI27,ISG20,OASL,IRF8,ISG15,XAF1,IRF1,RSAD2,OAS1,IFI6
R-HSA-418594	G alpha (i) signalling events	3.48783496148697e-06	-12.5662293691244	242	29	0.0596707818930041	486	10287	1236,2920,643,7852,6374,4283,150,6364,3576,623,6752,2918,3627,2914,5996,718,6004,6363,6373,2919,2847,6352,5999,9628,6372,719,57007,2921,6288	CCR7,CXCL2,CXCR5,CXCR4,CXCL5,CXCL9,ADRA2A,CCL20,CXCL8,BDKRB1,SSTR2,GRM8,CXCL10,GRM4,RGS1,C3,RGS16,CCL19,CXCL11,CXCL1,MCHR1,CCL5,RGS4,RGS6,CXCL6,C3AR1,ACKR3,CXCL3,SAA1
R-HSA-500792	GPCR ligand binding	3.82994728983824e-06	-12.4726595173107	453	44	0.0905349794238683	486	10287	9340,3627,6372,8111,6288,2863,6373,2847,2919,1910,6374,150,6376,6364,1236,2920,643,90226,7852,11211,2151,134864,135,10887,2914,6346,147,9034,2921,57007,719,9283,2642,718,6363,7474,6352,4283,623,6752,2918,1604,5021,3576	GLP2R,CXCL10,CXCL6,GPR68,SAA1,GPR39,CXCL11,MCHR1,CXCL1,EDNRB,CXCL5,ADRA2A,CX3CL1,CCL20,CCR7,CXCL2,CXCR5,UCN2,CXCR4,FZD10,F2RL2,TAAR1,ADORA2A,PROKR1,GRM4,CCL1,ADRA1B,CCRL2,CXCL3,ACKR3,C3AR1,GPR37L1,GCGR,C3,CCL19,WNT5A,CCL5,CXCL9,BDKRB1,SSTR2,GRM8,CD55,OXTR,CXCL8
R-HSA-168249	Innate Immune System	1.2054543408336e-05	-11.3260689227568	1285	93	0.191358024691358	486	10287	54210,7133,2247,5721,7128,342510,6708,4843,64127,2207,5068,3934,4792,5317,3687,3055,5329,79930,960,4688,3710,9636,6317,4791,3684,4586,4033,629,5698,1850,1540,644150,3559,6616,2268,10584,272,2668,1847,330,26281,1604,2069,3553,245973,3937,4067,5806,6279,1437,5699,1848,3659,11213,3656,2919,8876,8503,6288,6280,4318,2495,7295,941,4790,5005,23586,3725,1844,64135,2903,7130,114770,4233,26253,718,7097,719,5004,53831,50617,1326,3561,5266,1520,6278,10125,1839,5971,154664,8767,10071,1118	TREM1,TNFRSF1B,FGF2,PSME2,TNFAIP3,CD300E,SPTA1,NOS2,NOD2,FCER1G,REG3A,LCN2,NFKBIA,PKP1,ITGAX,HCK,PLAUR,DOK3,CD44,NCF2,ITPR3,ISG15,SERPINB3,NFKB2,ITGAM,MUC5AC,LRMP,CFB,PSMB9,DUSP8,CYLD,WIPF3,IL2RA,SNAP25,FGR,COLEC10,AMPD3,GDNF,DUSP5,BIRC3,FGF20,CD55,EREG,IL1B,ATP6V1C2,LCP2,LYN,PTX3,S100A8,CSF2,PSMB10,DUSP6,IRF1,IRAK3,IRAK2,CXCL1,VNN1,PIK3R3,SAA1,S100A9,MMP9,FTH1,TXN,CD80,NFKB1,ORM2,DDX58,JUN,DUSP2,IFIH1,GRIN2A,TNFAIP6,PGLYRP2,MET,CLEC4E,C3,TLR2,C3AR1,ORM1,GPR84,ATP6V0A4,MAP3K8,IL2RG,PI3,CTSS,S100A7,RASGRP1,HBEGF,RELB,ABCA13,RIPK2,MUC12,CHIT1
R-HSA-109582	Hemostasis	2.82659657013684e-05	-10.4738521024427	632	53	0.109053497942387	486	10287	4602,9056,10125,6385,3053,6401,10938,3659,9732,3937,4067,1437,5152,4312,8140,3561,5055,11343,5004,2268,5880,7273,3559,2888,5329,23657,2151,490,5341,962,3687,150,3710,2886,3684,55619,5197,6547,960,8503,9162,23764,5270,857,5552,54210,2207,4843,5327,5005,83953,3779,2152	MYB,SLC7A7,RASGRP1,SDC4,SERPIND1,SELE,EHD1,IRF1,DOCK4,LCP2,LYN,CSF2,PDE9A,MMP1,SLC7A5,IL2RG,SERPINB2,MGLL,ORM1,FGR,RAC2,TTN,IL2RA,GRB14,PLAUR,SLC7A11,F2RL2,ATP2B1,PLEK,CD48,ITGAX,ADRA2A,ITPR3,GRB7,ITGAM,DOCK10,PF4V1,SLC8A3,CD44,PIK3R3,DGKI,MAFF,SERPINE2,CAV1,SRGN,TREM1,FCER1G,NOS2,PLAT,ORM2,FCAMR,KCNMB1,F3
R-HSA-6799990	Metal sequestration by antimicrobial proteins	6.84209053789416e-05	-9.58983214583733	6	4	0.00823045267489712	486	10287	6278,3934,6279,6280	S100A7,LCN2,S100A8,S100A9
R-HSA-202733	Cell surface interactions at the vascular wall	6.90039255475741e-05	-9.58134716299148	136	18	0.037037037037037	486	10287	960,5197,4067,3684,2886,6401,6385,3687,9056,962,23657,2888,83953,8140,2207,4312,54210,857	CD44,PF4V1,LYN,ITGAM,GRB7,SELE,SDC4,ITGAX,SLC7A7,CD48,SLC7A11,GRB14,FCAMR,SLC7A5,FCER1G,MMP1,TREM1,CAV1
R-HSA-877300	Interferon gamma signaling	0.000122951473421002	-9.00372080546983	94	14	0.0288065843621399	486	10287	3460,3659,3394,8638,960,4938,115361,2634,2633,2635,4939,115362,3383,4940	IFNGR2,IRF1,IRF8,OASL,CD44,OAS1,GBP4,GBP2,GBP1,GBP3,OAS2,GBP5,ICAM1,OAS3
R-HSA-1474244	Extracellular matrix organization	0.000153401175993303	-8.78245400287209	296	29	0.0596707818930041	486	10287	4316,3383,4312,1305,1294,4314,2247,375790,9507,650,7087,9378,3386,4318,63923,6385,3687,1520,27302,3918,4319,4322,169044,56999,960,3914,10516,3684,4321	MMP7,ICAM1,MMP1,COL13A1,COL7A1,MMP3,FGF2,AGRN,ADAMTS4,BMP2,ICAM5,NRXN1,ICAM4,MMP9,TNN,SDC4,ITGAX,CTSS,BMP10,LAMC2,MMP10,MMP13,COL22A1,ADAMTS9,CD44,LAMB3,FBLN5,ITGAM,MMP12
R-HSA-448706	Interleukin-1 processing	0.000153680703537658	-8.7806334615755	7	4	0.00823045267489712	486	10287	3552,3553,4791,4790	IL1A,IL1B,NFKB2,NFKB1
R-HSA-913531	Interferon Signaling	0.000202701899037757	-8.50377413583902	201	22	0.0452674897119342	486	10287	3383,3669,3455,4940,2634,4938,91543,115361,3460,8638,54739,3429,115362,23586,2633,2635,4939,960,2537,3659,3394,9636	ICAM1,ISG20,IFNAR2,OAS3,GBP2,OAS1,RSAD2,GBP4,IFNGR2,OASL,XAF1,IFI27,GBP5,DDX58,GBP1,GBP3,OAS2,CD44,IFI6,IRF1,IRF8,ISG15
R-HSA-71240	Tryptophan catabolism	0.000216351668255817	-8.43860538041108	13	5	0.0102880658436214	486	10287	8140,8564,3620,8942,6999	SLC7A5,KMO,IDO1,KYNU,TDO2
R-HSA-446652	Interleukin-1 signaling	0.00025100169735227	-8.29005085649571	46	9	0.0185185185185185	486	10287	3557,3553,8767,3552,1326,64127,3656,11213,4790	IL1RN,IL1B,RIPK2,IL1A,MAP3K8,NOD2,IRAK2,IRAK3,NFKB1
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.000316785614055782	-8.05728530923253	29	7	0.01440329218107	486	10287	4792,8767,64127,4791,4790,6288,3656	NFKBIA,RIPK2,NOD2,NFKB2,NFKB1,SAA1,IRAK2
R-HSA-1442490	Collagen degradation	0.000472799937157002	-7.65683822478906	40	8	0.0164609053497942	486	10287	4318,4321,4314,4316,4312,1305,4319,4322	MMP9,MMP12,MMP3,MMP7,MMP1,COL13A1,MMP10,MMP13
R-HSA-1474228	Degradation of the extracellular matrix	0.000711909014432928	-7.24756044343577	111	14	0.0288065843621399	486	10287	960,3914,4318,4321,1305,4316,4312,4314,1520,9507,3918,56999,4319,4322	CD44,LAMB3,MMP9,MMP12,COL13A1,MMP7,MMP1,MMP3,CTSS,ADAMTS4,LAMC2,ADAMTS9,MMP10,MMP13
R-HSA-168898	Toll-Like Receptors Cascades	0.000882508115593044	-7.03274257305968	153	17	0.0349794238683128	486	10287	6288,6280,7097,4790,1326,64127,330,4792,1520,3656,3684,4791,11213,1848,8767,6279,3725	SAA1,S100A9,TLR2,NFKB1,MAP3K8,NOD2,BIRC3,NFKBIA,CTSS,IRAK2,ITGAM,NFKB2,IRAK3,DUSP6,RIPK2,S100A8,JUN
R-HSA-933542	TRAF6 mediated NF-kB activation	0.000885179750782455	-7.02971982535127	25	6	0.0123456790123457	486	10287	6288,4791,4790,64135,4792,23586	SAA1,NFKB2,NFKB1,IFIH1,NFKBIA,DDX58
R-HSA-6783589	Interleukin-6 family signaling	0.0013653579093926	-6.59633868003163	27	6	0.0123456790123457	486	10287	3589,23529,3976,3592,10148,3569	IL11,CLCF1,LIF,IL12A,EBI3,IL6
R-HSA-5689896	Ovarian tumor domain proteases	0.00150633530794658	-6.49807552634793	37	7	0.01440329218107	486	10287	64135,64127,23586,10318,7128,79931,8767	IFIH1,NOD2,DDX58,TNIP1,TNFAIP3,TNIP3,RIPK2
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.00165672423303053	-6.40291297983725	95	12	0.0246913580246914	486	10287	4792,7097,6288,3725,8767,1326,1848,64127,3656,4791,11213,4790	NFKBIA,TLR2,SAA1,JUN,RIPK2,MAP3K8,DUSP6,NOD2,IRAK2,NFKB2,IRAK3,NFKB1
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.00165672423303053	-6.40291297983725	95	12	0.0246913580246914	486	10287	4792,6288,7097,8767,3725,3656,4791,4790,11213,1848,64127,1326	NFKBIA,SAA1,TLR2,RIPK2,JUN,IRAK2,NFKB2,NFKB1,IRAK3,DUSP6,NOD2,MAP3K8
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.00165672423303053	-6.40291297983725	95	12	0.0246913580246914	486	10287	4792,7097,6288,3725,8767,1326,1848,64127,4790,11213,4791,3656	NFKBIA,TLR2,SAA1,JUN,RIPK2,MAP3K8,DUSP6,NOD2,NFKB1,IRAK3,NFKB2,IRAK2
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.00165672423303053	-6.40291297983725	95	12	0.0246913580246914	486	10287	6288,7097,4792,3656,4791,4790,11213,64127,1326,1848,8767,3725	SAA1,TLR2,NFKBIA,IRAK2,NFKB2,NFKB1,IRAK3,NOD2,MAP3K8,DUSP6,RIPK2,JUN
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.00198002159552767	-6.22464752750302	20	5	0.0102880658436214	486	10287	3589,23529,3592,3976,10148	IL11,CLCF1,IL12A,LIF,EBI3
R-HSA-425407	SLC-mediated transmembrane transport	0.00231401313295674	-6.06877197479169	287	25	0.051440329218107	486	10287	64116,6513,28231,124935,6506,64849,8671,51458,3099,8140,23382,6534,9056,64078,84102,23657,6580,6523,115019,80736,6542,6547,51296,28232,11182	SLC39A8,SLC2A1,SLCO4A1,SLC43A2,SLC1A2,SLC13A3,SLC4A4,RHCG,HK2,SLC7A5,AHCYL2,SLC6A7,SLC7A7,SLC28A3,SLC41A2,SLC7A11,SLC22A1,SLC5A1,SLC26A9,SLC44A4,SLC7A2,SLC8A3,SLC15A3,SLCO3A1,SLC2A6
R-HSA-5669034	TNFs bind their physiological receptors	0.00242873477360022	-6.02038482652533	30	6	0.0123456790123457	486	10287	8995,3604,943,970,4982,7133	TNFSF18,TNFRSF9,TNFRSF8,CD70,TNFRSF11B,TNFRSF1B
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.00244866054691727	-6.01221411947291	126	14	0.0288065843621399	486	10287	7097,6288,4792,330,1326,1848,64127,4791,11213,4790,3684,3656,3725,8767	TLR2,SAA1,NFKBIA,BIRC3,MAP3K8,DUSP6,NOD2,NFKB2,IRAK3,NFKB1,ITGAM,IRAK2,JUN,RIPK2
R-HSA-75205	Dissolution of Fibrin Clot	0.00250118793551432	-5.99098948576177	13	4	0.00823045267489712	486	10287	5329,5055,5270,5327	PLAUR,SERPINB2,SERPINE2,PLAT
R-HSA-166054	Activated TLR4 signalling	0.00296456486950239	-5.82102501295055	115	13	0.0267489711934156	486	10287	6288,7097,330,4792,3656,11213,4790,4791,1848,64127,1326,8767,3725	SAA1,TLR2,BIRC3,NFKBIA,IRAK2,IRAK3,NFKB1,NFKB2,DUSP6,NOD2,MAP3K8,RIPK2,JUN
R-HSA-5603029	IkBA variant leads to EDA-ID	0.0031804035381962	-5.75074719143719	7	3	0.00617283950617284	486	10287	4792,4790,4791	NFKBIA,NFKB1,NFKB2
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.00342197616610882	-5.67753706843738	32	6	0.0123456790123457	486	10287	4319,4322,4316,4312,4318,4314	MMP10,MMP13,MMP7,MMP1,MMP9,MMP3
R-HSA-168638	NOD1/2 Signaling Pathway	0.00342197616610882	-5.67753706843738	32	6	0.0123456790123457	486	10287	7128,1540,8767,330,64127,3656	TNFAIP3,CYLD,RIPK2,BIRC3,NOD2,IRAK2
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.00351234630402429	-5.65147100214104	443	34	0.0699588477366255	486	10287	10887,2151,1844,3710,1910,4314,2847,8503,2247,8111,9162,6288,5721,6708,2668,5021,1847,10125,26281,2069,623,1839,5699,1437,1848,2903,4233,2642,147,5698,1850,11343,3559,3561	PROKR1,F2RL2,DUSP2,ITPR3,EDNRB,MMP3,MCHR1,PIK3R3,FGF2,GPR68,DGKI,SAA1,PSME2,SPTA1,GDNF,OXTR,DUSP5,RASGRP1,FGF20,EREG,BDKRB1,HBEGF,PSMB10,CSF2,DUSP6,GRIN2A,MET,GCGR,ADRA1B,PSMB9,DUSP8,MGLL,IL2RA,IL2RG
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.00357346917487042	-5.63421839737463	104	12	0.0246913580246914	486	10287	970,5699,5971,4982,5721,4791,8995,3604,943,330,7133,5698	CD70,PSMB10,RELB,TNFRSF11B,PSME2,NFKB2,TNFSF18,TNFRSF9,TNFRSF8,BIRC3,TNFRSF1B,PSMB9
R-HSA-114604	GPVI-mediated activation cascade	0.0035865089484099	-5.63057598737513	54	8	0.0164609053497942	486	10287	3561,2207,3559,1437,5880,3937,4067,8503	IL2RG,FCER1G,IL2RA,CSF2,RAC2,LCP2,LYN,PIK3R3
R-HSA-112409	RAF-independent MAPK1/3 activation	0.00382264831966967	-5.56681181916898	23	5	0.0102880658436214	486	10287	1848,3569,1847,1850,1844	DUSP6,IL6,DUSP5,DUSP8,DUSP2
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.00442884909114742	-5.41961552751671	15	4	0.00823045267489712	486	10287	9420,1581,1646,1645	CYP7B1,CYP7A1,AKR1C2,AKR1C1
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.0049111119200465	-5.31625490251937	8	3	0.00617283950617284	486	10287	4792,4790,4791	NFKBIA,NFKB1,NFKB2
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.00604151776552173	-5.10910001291997	84	10	0.0205761316872428	486	10287	6288,4792,1848,1326,64127,3656,4791,4790,3725,8767	SAA1,NFKBIA,DUSP6,MAP3K8,NOD2,IRAK2,NFKB2,NFKB1,JUN,RIPK2
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.00604151776552173	-5.10910001291997	84	10	0.0205761316872428	486	10287	8767,3725,3656,4790,4791,1326,64127,1848,4792,6288	RIPK2,JUN,IRAK2,NFKB1,NFKB2,MAP3K8,NOD2,DUSP6,NFKBIA,SAA1
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.00604151776552173	-5.10910001291997	84	10	0.0205761316872428	486	10287	4792,6288,3725,8767,1848,64127,1326,4790,4791,3656	NFKBIA,SAA1,JUN,RIPK2,DUSP6,NOD2,MAP3K8,NFKB1,NFKB2,IRAK2
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.00604151776552173	-5.10910001291997	84	10	0.0205761316872428	486	10287	4792,23586,6288,7128,1540,4791,3659,4790,9636,64135	NFKBIA,DDX58,SAA1,TNFAIP3,CYLD,NFKB2,IRF1,NFKB1,ISG15,IFIH1
R-HSA-351200	Interconversion of polyamines	0.00647322608578504	-5.04008067251674	3	2	0.00411522633744856	486	10287	54498,6303	SMOX,SAT1
R-HSA-210991	Basigin interactions	0.00665044066927764	-5.01307216045308	26	5	0.0102880658436214	486	10287	9056,4312,23657,857,8140	SLC7A7,MMP1,SLC7A11,CAV1,SLC7A5
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.00687731981118837	-4.97952626526327	99	11	0.0226337448559671	486	10287	6288,330,4792,3656,4790,4791,1848,1326,64127,8767,3725	SAA1,BIRC3,NFKBIA,IRAK2,NFKB1,NFKB2,DUSP6,MAP3K8,NOD2,RIPK2,JUN
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.00687731981118837	-4.97952626526327	99	11	0.0226337448559671	486	10287	64127,1848,1326,3656,4791,4790,3725,8767,6288,4792,330	NOD2,DUSP6,MAP3K8,IRAK2,NFKB2,NFKB1,JUN,RIPK2,SAA1,NFKBIA,BIRC3
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.00687731981118837	-4.97952626526327	99	11	0.0226337448559671	486	10287	6288,330,4792,3656,4791,4790,1848,1326,64127,8767,3725	SAA1,BIRC3,NFKBIA,IRAK2,NFKB2,NFKB1,DUSP6,MAP3K8,NOD2,RIPK2,JUN
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.00689194432436215	-4.97740203864825	48	7	0.01440329218107	486	10287	3656,7295,64127,8767,330,1540,7128	IRAK2,TXN,NOD2,RIPK2,BIRC3,CYLD,TNFAIP3
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.00689422196939038	-4.97707161393112	60	8	0.0164609053497942	486	10287	4322,3918,1294,4314,1520,4316,4318,3914	MMP13,LAMC2,COL7A1,MMP3,CTSS,MMP7,MMP9,LAMB3
R-HSA-8854691	Interleukin-19, 20, 22, 24	0.00711029073910281	-4.94621214442738	9	3	0.00617283950617284	486	10287	29949,50604,11009	IL19,IL20,IL24
R-HSA-2214320	Anchoring fibril formation	0.00711029073910281	-4.94621214442738	9	3	0.00617283950617284	486	10287	3914,1294,3918	LAMB3,COL7A1,LAMC2
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.00711029073910281	-4.94621214442738	9	3	0.00617283950617284	486	10287	5366,27113,637	PMAIP1,BBC3,BID
R-HSA-193639	p75NTR signals via NF-kB	0.00716419168676181	-4.93866003819554	17	4	0.00823045267489712	486	10287	4803,4790,4792,8767	NGF,NFKB1,NFKBIA,RIPK2
R-HSA-2871796	FCERI mediated MAPK activation	0.00724489732412955	-4.92745787527271	265	22	0.0452674897119342	486	10287	1844,4067,3725,1839,3937,1437,5699,1848,2668,26281,10125,1847,2069,5721,1850,3559,6708,3561,4233,2903,5698,2247	DUSP2,LYN,JUN,HBEGF,LCP2,CSF2,PSMB10,DUSP6,GDNF,FGF20,RASGRP1,DUSP5,EREG,PSME2,DUSP8,IL2RA,SPTA1,IL2RG,MET,GRIN2A,PSMB9,FGF2
R-HSA-382551	Transmembrane transport of small molecules	0.00772486005880154	-4.86331157172791	677	46	0.0946502057613169	486	10287	84102,245973,4645,9056,64078,8714,4363,6523,6542,115019,5699,80736,1080,6506,5698,64849,6513,8989,50617,8140,8671,6446,23657,23327,490,6534,3934,266675,51296,24,11182,28232,6580,6547,26154,124935,6338,64116,28231,3099,3162,23382,5721,366,2495,51458	SLC41A2,ATP6V1C2,MYO5B,SLC7A7,SLC28A3,ABCC3,ABCC1,SLC5A1,SLC7A2,SLC26A9,PSMB10,SLC44A4,CFTR,SLC1A2,PSMB9,SLC13A3,SLC2A1,TRPA1,ATP6V0A4,SLC7A5,SLC4A4,SGK1,SLC7A11,NEDD4L,ATP2B1,SLC6A7,LCN2,BEST4,SLC15A3,ABCA4,SLC2A6,SLCO3A1,SLC22A1,SLC8A3,ABCA12,SLC43A2,SCNN1B,SLC39A8,SLCO4A1,HK2,HMOX1,AHCYL2,PSME2,AQP9,FTH1,RHCG
R-HSA-5621481	C-type lectin receptors (CLRs)	0.00809875205380079	-4.81604529660535	144	14	0.0288065843621399	486	10287	5698,3553,4792,26253,4586,2207,10071,3710,4791,4790,5721,5971,4067,5699	PSMB9,IL1B,NFKBIA,CLEC4E,MUC5AC,FCER1G,MUC12,ITPR3,NFKB2,NFKB1,PSME2,RELB,LYN,PSMB10
R-HSA-5621480	Dectin-2 family	0.00919554280242357	-4.68903639032196	28	5	0.0102880658436214	486	10287	4067,4586,26253,10071,2207	LYN,MUC5AC,CLEC4E,MUC12,FCER1G
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.00931772500667054	-4.67583677807812	271	22	0.0452674897119342	486	10287	2668,10125,26281,3055,1847,2069,1844,4067,1839,1437,5699,1848,4233,2903,8503,5698,2247,5721,1850,6708,3559,3561	GDNF,RASGRP1,FGF20,HCK,DUSP5,EREG,DUSP2,LYN,HBEGF,CSF2,PSMB10,DUSP6,MET,GRIN2A,PIK3R3,PSMB9,FGF2,PSME2,DUSP8,SPTA1,IL2RA,IL2RG
R-HSA-372790	Signaling by GPCR	0.00988691101325694	-4.61654351648623	1299	79	0.162551440329218	486	10287	8503,6372,64108,2863,9162,6288,283365,4314,2919,6004,9340,11211,135,6374,90226,643,1844,2920,9283,9034,9628,719,57007,2921,7474,2903,6352,4233,5996,6363,718,3561,11343,53831,2918,5021,3576,10125,4283,1839,2247,8111,2847,6373,5142,5721,3627,6708,2151,134864,10887,3710,6376,150,6364,1910,26230,7852,1236,26575,2642,147,5698,5999,2914,1850,6346,3559,5880,1604,2069,623,6752,2668,1847,26281,1848,5699,1437	PIK3R3,CXCL6,RTP4,GPR39,DGKI,SAA1,OR6C6,MMP3,CXCL1,RGS16,GLP2R,FZD10,ADORA2A,CXCL5,UCN2,CXCR5,DUSP2,CXCL2,GPR37L1,CCRL2,RGS6,C3AR1,ACKR3,CXCL3,WNT5A,GRIN2A,CCL5,MET,RGS1,CCL19,C3,IL2RG,MGLL,GPR84,GRM8,OXTR,CXCL8,RASGRP1,CXCL9,HBEGF,FGF2,GPR68,MCHR1,CXCL11,PDE4B,PSME2,CXCL10,SPTA1,F2RL2,TAAR1,PROKR1,ITPR3,CX3CL1,ADRA2A,CCL20,EDNRB,TIAM2,CXCR4,CCR7,RGS17,GCGR,ADRA1B,PSMB9,RGS4,GRM4,DUSP8,CCL1,IL2RA,RAC2,CD55,EREG,BDKRB1,SSTR2,GDNF,DUSP5,FGF20,DUSP6,PSMB10,CSF2
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.00992983032234536	-4.61221188844815	372	28	0.0576131687242798	486	10287	3710,1848,3725,1839,3937,4067,1844,5699,1437,2069,2668,4792,1847,26281,10125,2207,941,3561,4790,1850,5721,6708,3559,8503,2247,5698,2903,4233	ITPR3,DUSP6,JUN,HBEGF,LCP2,LYN,DUSP2,PSMB10,CSF2,EREG,GDNF,NFKBIA,DUSP5,FGF20,RASGRP1,FCER1G,CD80,IL2RG,NFKB1,DUSP8,PSME2,SPTA1,IL2RA,PIK3R3,FGF2,PSMB9,GRIN2A,MET
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.0105023829644077	-4.55615309857648	91	10	0.0205761316872428	486	10287	1326,64127,1848,4791,4790,3656,3725,8767,6288,4792	MAP3K8,NOD2,DUSP6,NFKB2,NFKB1,IRAK2,JUN,RIPK2,SAA1,NFKBIA
R-HSA-913709	O-linked glycosylation of mucins	0.0110857422843825	-4.5020954751984	65	8	0.0164609053497942	486	10287	6484,4586,50614,79623,10071,10164,51301,6482	ST3GAL4,MUC5AC,GALNT9,GALNT14,MUC12,CHST4,GCNT4,ST3GAL1
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.0120843137207095	-4.41584705413388	107	11	0.0226337448559671	486	10287	51296,23382,8140,6547,8671,6542,115019,124935,23657,6506,9056	SLC15A3,AHCYL2,SLC7A5,SLC8A3,SLC4A4,SLC7A2,SLC26A9,SLC43A2,SLC7A11,SLC1A2,SLC7A7
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.012148765903485	-4.41052768608397	93	10	0.0205761316872428	486	10287	1848,1326,64127,3656,4790,4791,3725,8767,6288,4792	DUSP6,MAP3K8,NOD2,IRAK2,NFKB1,NFKB2,JUN,RIPK2,SAA1,NFKBIA
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.012148765903485	-4.41052768608397	93	10	0.0205761316872428	486	10287	4792,6288,8767,3725,4790,4791,3656,1326,1848,64127	NFKBIA,SAA1,RIPK2,JUN,NFKB1,NFKB2,IRAK2,MAP3K8,DUSP6,NOD2
R-HSA-1474290	Collagen formation	0.012148765903485	-4.41052768608397	93	10	0.0205761316872428	486	10287	3918,4322,169044,1305,4316,1294,1520,4314,4318,3914	LAMC2,MMP13,COL22A1,COL13A1,MMP7,COL7A1,CTSS,MMP3,MMP9,LAMB3
R-HSA-162582	Signal Transduction	0.0124537234624021	-4.38573562749961	2548	142	0.292181069958848	486	10287	7128,3627,6373,54567,83478,26230,1236,26575,2886,10252,3710,150,1910,4792,134864,195814,10887,23327,1540,6346,3559,4803,2914,51176,23286,4067,4629,1437,113878,2668,2069,623,245973,1030,9340,941,4790,4314,2919,27121,8503,857,283365,6288,3725,1844,2920,116984,24,3624,135,83595,11343,650,595,53831,50617,3561,7474,4233,91010,718,6363,9628,57007,719,3914,9938,4283,4023,7185,6484,3918,5957,5142,5721,6708,2847,2247,8111,375790,7852,4688,3569,6364,6376,64321,2151,284654,1850,84870,644150,5880,6658,5999,1645,23002,23767,1080,2642,147,5698,5699,1848,1847,330,26281,64220,1604,6752,4318,5327,6004,6372,64108,723790,10046,9162,2863,90226,643,6374,8828,11211,658,8313,2986,92737,2903,6352,5996,9283,9034,2921,1839,8767,6461,5021,3576,6385,10125,2918	TNFAIP3,CXCL10,CXCL11,DLL4,ARHGAP24,TIAM2,CCR7,RGS17,GRB7,SPRY1,ITPR3,ADRA2A,EDNRB,NFKBIA,TAAR1,SDR16C5,PROKR1,NEDD4L,CYLD,CCL1,IL2RA,NGF,GRM4,LEF1,WWC1,LYN,MYH11,CSF2,DTX2,GDNF,EREG,BDKRB1,ATP6V1C2,CDKN2B,GLP2R,CD80,NFKB1,MMP3,CXCL1,DKK4,PIK3R3,CAV1,OR6C6,SAA1,JUN,DUSP2,CXCL2,ARAP2,ABCA4,INHBA,ADORA2A,SOX7,MGLL,BMP2,CCND1,GPR84,ATP6V0A4,IL2RG,WNT5A,MET,FMNL3,C3,CCL19,RGS6,ACKR3,C3AR1,LAMB3,ARHGAP25,CXCL9,LPL,TRAF1,ST3GAL4,LAMC2,RCVRN,PDE4B,PSME2,SPTA1,MCHR1,FGF2,GPR68,AGRN,CXCR4,NCF2,IL6,CCL20,CX3CL1,SOX17,F2RL2,RSPO1,DUSP8,RSPO3,WIPF3,RAC2,SOX3,RGS4,AKR1C1,DAAM1,FLRT3,CFTR,GCGR,ADRA1B,PSMB9,PSMB10,DUSP6,DUSP5,BIRC3,FGF20,STRA6,CD55,SSTR2,MMP9,PLAT,RGS16,CXCL6,RTP4,HIST2H2AA4,MAMLD1,DGKI,GPR39,UCN2,CXCR5,CXCL5,NRP2,FZD10,BMPR1B,AXIN2,GUCY2F,DNER,GRIN2A,CCL5,RGS1,GPR37L1,CCRL2,CXCL3,HBEGF,RIPK2,SHB,OXTR,CXCL8,SDC4,RASGRP1,GRM8
R-HSA-173736	Alternative complement activation	0.0125419042105116	-4.37867990438755	4	2	0.00411522633744856	486	10287	718,629	C3,CFB
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.0125419042105116	-4.37867990438755	4	2	0.00411522633744856	486	10287	9353,6092	SLIT2,ROBO2
R-HSA-447115	Interleukin-12 signaling	0.0125419042105116	-4.37867990438755	4	2	0.00411522633744856	486	10287	3593,3592	IL12B,IL12A
R-HSA-352230	Amino acid transport across the plasma membrane	0.0141592497580411	-4.25738717530941	31	5	0.0102880658436214	486	10287	124935,23657,8140,9056,6542	SLC43A2,SLC7A11,SLC7A5,SLC7A7,SLC7A2
R-HSA-6798695	Neutrophil degranulation	0.0142367335189436	-4.25192978702633	487	34	0.0699588477366255	486	10287	8876,7133,2919,6280,2495,4318,4790,5005,2207,3687,5317,3934,5329,960,79930,3684,6317,4033,718,7130,719,7097,2268,6616,53831,5004,6278,272,1520,1604,154664,5806,6279,1118	VNN1,TNFRSF1B,CXCL1,S100A9,FTH1,MMP9,NFKB1,ORM2,FCER1G,ITGAX,PKP1,LCN2,PLAUR,CD44,DOK3,ITGAM,SERPINB3,LRMP,C3,TNFAIP6,C3AR1,TLR2,FGR,SNAP25,GPR84,ORM1,S100A7,AMPD3,CTSS,CD55,ABCA13,PTX3,S100A8,CHIT1
R-HSA-170984	ARMS-mediated activation	0.0142587215995514	-4.25038651741506	249	20	0.0411522633744856	486	10287	1848,1437,5699,1844,1839,2069,10125,26281,1847,2668,3561,4803,3559,6708,5721,1850,5698,2247,4233,2903	DUSP6,CSF2,PSMB10,DUSP2,HBEGF,EREG,RASGRP1,FGF20,DUSP5,GDNF,IL2RG,NGF,IL2RA,SPTA1,PSME2,DUSP8,PSMB9,FGF2,MET,GRIN2A
R-HSA-187706	Signalling to p38 via RIT and RIN	0.0142587215995514	-4.25038651741506	249	20	0.0411522633744856	486	10287	2069,2668,26281,10125,1847,1848,1844,1839,5699,1437,5698,2247,4233,2903,4803,3561,5721,1850,3559,6708	EREG,GDNF,FGF20,RASGRP1,DUSP5,DUSP6,DUSP2,HBEGF,PSMB10,CSF2,PSMB9,FGF2,MET,GRIN2A,NGF,IL2RG,PSME2,DUSP8,IL2RA,SPTA1
R-HSA-216083	Integrin cell surface interactions	0.0143666130940253	-4.24284829950165	68	8	0.0164609053497942	486	10287	375790,3383,1305,3687,3684,960,3386,7087	AGRN,ICAM1,COL13A1,ITGAX,ITGAM,CD44,ICAM4,ICAM5
R-HSA-170968	Frs2-mediated activation	0.0148422013469503	-4.21028071350073	250	20	0.0411522633744856	486	10287	2247,5698,2903,4233,4803,3561,1850,5721,6708,3559,2069,2668,1847,26281,10125,1848,1839,1844,1437,5699	FGF2,PSMB9,GRIN2A,MET,NGF,IL2RG,DUSP8,PSME2,SPTA1,IL2RA,EREG,GDNF,DUSP5,FGF20,RASGRP1,DUSP6,HBEGF,DUSP2,CSF2,PSMB10
R-HSA-194068	Bile acid and bile salt metabolism	0.0148789236957528	-4.20780958446797	43	6	0.0123456790123457	486	10287	1645,9023,9420,8714,1581,1646	AKR1C1,CH25H,CYP7B1,ABCC3,CYP7A1,AKR1C2
R-HSA-5684996	MAPK1/MAPK3 signaling	0.0154443548359517	-4.17051172519323	251	20	0.0411522633744856	486	10287	3561,1850,5721,3559,6708,2247,5698,2903,4233,3569,1848,1839,1844,5699,1437,2069,2668,1847,10125,26281	IL2RG,DUSP8,PSME2,IL2RA,SPTA1,FGF2,PSMB9,GRIN2A,MET,IL6,DUSP6,HBEGF,DUSP2,PSMB10,CSF2,EREG,GDNF,DUSP5,RASGRP1,FGF20
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.015519170717818	-4.16567919878495	21	4	0.00823045267489712	486	10287	5069,3484,4312,60676	PAPPA,IGFBP1,MMP1,PAPPA2
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	0.015519170717818	-4.16567919878495	21	4	0.00823045267489712	486	10287	637,8626,27113,5366	BID,TP63,BBC3,PMAIP1
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.015519170717818	-4.16567919878495	21	4	0.00823045267489712	486	10287	6288,4790,4791,4792	SAA1,NFKB1,NFKB2,NFKBIA
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.016016481063949	-4.13413702040001	97	10	0.0205761316872428	486	10287	3656,4791,4790,1326,64127,1848,8767,3725,6288,4792	IRAK2,NFKB2,NFKB1,MAP3K8,NOD2,DUSP6,RIPK2,JUN,SAA1,NFKBIA
R-HSA-169893	Prolonged ERK activation events	0.0160655731187903	-4.13107661205593	252	20	0.0411522633744856	486	10287	1437,5699,1839,1844,1848,1847,26281,10125,2668,2069,6708,3559,1850,5721,3561,4803,2903,4233,2247,5698	CSF2,PSMB10,HBEGF,DUSP2,DUSP6,DUSP5,FGF20,RASGRP1,GDNF,EREG,SPTA1,IL2RA,DUSP8,PSME2,IL2RG,NGF,GRIN2A,MET,FGF2,PSMB9
R-HSA-196071	Metabolism of steroid hormones	0.016147633757017	-4.12598175664145	32	5	0.0102880658436214	486	10287	1586,6716,441282,3290,231	CYP17A1,SRD5A2,AKR1B15,HSD11B1,AKR1B1
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.0165623017008938	-4.10062614808359	44	6	0.0123456790123457	486	10287	8942,259307,6999,8564,3620,8140	KYNU,IL4I1,TDO2,KMO,IDO1,SLC7A5
R-HSA-8853659	RET signaling	0.0170301990310382	-4.07276709729197	270	21	0.0432098765432099	486	10287	1850,5721,6708,3559,3561,2903,4233,8503,2247,5698,1839,1844,5699,1437,2886,1848,2668,1847,26281,10125,2069	DUSP8,PSME2,SPTA1,IL2RA,IL2RG,GRIN2A,MET,PIK3R3,FGF2,PSMB9,HBEGF,DUSP2,PSMB10,CSF2,GRB7,DUSP6,GDNF,DUSP5,FGF20,RASGRP1,EREG
R-HSA-196854	Metabolism of vitamins and cofactors	0.0177328496478738	-4.03233644717047	174	15	0.0308641975308642	486	10287	4023,8875,4363,952,10135,375790,8876,1591,54625,6385,5743,441024,1645,6513,1594	LPL,VNN2,ABCC1,CD38,NAMPT,AGRN,VNN1,CYP24A1,PARP14,SDC4,PTGS2,MTHFD2L,AKR1C1,SLC2A1,CYP27B1
R-HSA-912526	Interleukin receptor SHC signaling	0.0180475445089402	-4.01474564174316	255	20	0.0411522633744856	486	10287	1847,26281,10125,2668,2069,5699,1437,1839,1844,1848,2903,4233,2247,5698,8503,6708,3559,1850,5721,3561	DUSP5,FGF20,RASGRP1,GDNF,EREG,PSMB10,CSF2,HBEGF,DUSP2,DUSP6,GRIN2A,MET,FGF2,PSMB9,PIK3R3,SPTA1,IL2RA,DUSP8,PSME2,IL2RG
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.018372498674373	-3.99690036971403	45	6	0.0123456790123457	486	10287	9378,3914,6385,2247,3918,375790	NRXN1,LAMB3,SDC4,FGF2,LAMC2,AGRN
R-HSA-167044	Signalling to RAS	0.0187489539488483	-3.97661731751676	256	20	0.0411522633744856	486	10287	5698,2247,4233,2903,4803,3561,5721,1850,6708,3559,2069,2668,10125,26281,1847,1848,1844,1839,1437,5699	PSMB9,FGF2,MET,GRIN2A,NGF,IL2RG,PSME2,DUSP8,SPTA1,IL2RA,EREG,GDNF,RASGRP1,FGF20,DUSP5,DUSP6,DUSP2,HBEGF,CSF2,PSMB10
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.0202152705419917	-3.9013169927491	258	20	0.0411522633744856	486	10287	3561,5721,1850,3559,6708,5698,2247,4233,2903,1848,3710,1844,1839,1437,5699,2069,2668,10125,26281,1847	IL2RG,PSME2,DUSP8,IL2RA,SPTA1,PSMB9,FGF2,MET,GRIN2A,DUSP6,ITPR3,DUSP2,HBEGF,CSF2,PSMB10,EREG,GDNF,RASGRP1,FGF20,DUSP5
R-HSA-2142850	Hyaluronan biosynthesis and export	0.0202526211794299	-3.89947105284685	5	2	0.00411522633744856	486	10287	3038,3036	HAS3,HAS1
R-HSA-192105	Synthesis of bile acids and bile salts	0.0206624667152614	-3.87943642671293	34	5	0.0102880658436214	486	10287	9023,1645,9420,1581,1646	CH25H,AKR1C1,CYP7B1,CYP7A1,AKR1C2
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.0210296489946843	-3.86182198010181	13	3	0.00617283950617284	486	10287	6288,4791,4790	SAA1,NFKB2,NFKB1
R-HSA-2029481	FCGR activation	0.0210296489946843	-3.86182198010181	13	3	0.00617283950617284	486	10287	3055,2268,4067	HCK,FGR,LYN
R-HSA-179812	GRB2 events in EGFR signaling	0.023127678318236	-3.76672518312321	245	19	0.0390946502057613	486	10287	5698,2247,4233,2903,3561,6708,3559,5721,1850,2069,26281,10125,1847,2668,1848,5699,1437,1844,1839	PSMB9,FGF2,MET,GRIN2A,IL2RG,SPTA1,IL2RA,PSME2,DUSP8,EREG,FGF20,RASGRP1,DUSP5,GDNF,DUSP6,PSMB10,CSF2,DUSP2,HBEGF
R-HSA-112412	SOS-mediated signalling	0.023127678318236	-3.76672518312321	245	19	0.0390946502057613	486	10287	2903,4233,2247,5698,3559,6708,1850,5721,3561,1847,26281,10125,2668,2069,5699,1437,1839,1844,1848	GRIN2A,MET,FGF2,PSMB9,IL2RA,SPTA1,DUSP8,PSME2,IL2RG,DUSP5,FGF20,RASGRP1,GDNF,EREG,PSMB10,CSF2,HBEGF,DUSP2,DUSP6
R-HSA-5673001	RAF/MAP kinase cascade	0.023127678318236	-3.76672518312321	245	19	0.0390946502057613	486	10287	1847,26281,10125,2668,2069,5699,1437,1839,1844,1848,2903,4233,2247,5698,6708,3559,1850,5721,3561	DUSP5,FGF20,RASGRP1,GDNF,EREG,PSMB10,CSF2,HBEGF,DUSP2,DUSP6,GRIN2A,MET,FGF2,PSMB9,SPTA1,IL2RA,DUSP8,PSME2,IL2RG
R-HSA-180336	SHC1 events in EGFR signaling	0.023127678318236	-3.76672518312321	245	19	0.0390946502057613	486	10287	2069,2668,26281,10125,1847,1848,1844,1839,5699,1437,5698,2247,4233,2903,3561,5721,1850,3559,6708	EREG,GDNF,FGF20,RASGRP1,DUSP5,DUSP6,DUSP2,HBEGF,PSMB10,CSF2,PSMB9,FGF2,MET,GRIN2A,IL2RG,PSME2,DUSP8,IL2RA,SPTA1
R-HSA-451927	Interleukin-2 signaling	0.0234129484542074	-3.75446605691775	262	20	0.0411522633744856	486	10287	8503,2247,5698,2903,4233,3561,1850,5721,6708,3559,2069,2668,1847,26281,10125,1848,1839,1844,5699,1437	PIK3R3,FGF2,PSMB9,GRIN2A,MET,IL2RG,DUSP8,PSME2,SPTA1,IL2RA,EREG,GDNF,DUSP5,FGF20,RASGRP1,DUSP6,HBEGF,DUSP2,PSMB10,CSF2
R-HSA-187687	Signalling to ERKs	0.0242698818663858	-3.71851912673031	263	20	0.0411522633744856	486	10287	4803,3561,1850,5721,6708,3559,2247,5698,2903,4233,1848,1839,1844,5699,1437,2069,2668,1847,26281,10125	NGF,IL2RG,DUSP8,PSME2,SPTA1,IL2RA,FGF2,PSMB9,GRIN2A,MET,DUSP6,HBEGF,DUSP2,PSMB10,CSF2,EREG,GDNF,DUSP5,FGF20,RASGRP1
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.0246546559856163	-3.70278951253192	24	4	0.00823045267489712	486	10287	7097,4790,4791,4792	TLR2,NFKB1,NFKB2,NFKBIA
R-HSA-5260271	Diseases of Immune System	0.0246546559856163	-3.70278951253192	24	4	0.00823045267489712	486	10287	4791,4790,7097,4792	NFKB2,NFKB1,TLR2,NFKBIA
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.0246546559856163	-3.70278951253192	24	4	0.00823045267489712	486	10287	1645,1581,1646,9420	AKR1C1,CYP7A1,AKR1C2,CYP7B1
R-HSA-209560	NF-kB is activated and signals survival	0.0258453044593583	-3.65562634020006	14	3	0.00617283950617284	486	10287	4792,4803,4790	NFKBIA,NGF,NFKB1
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.0259300281890206	-3.6523535923122	36	5	0.0102880658436214	486	10287	64135,9636,23586,1540,7128	IFIH1,ISG15,DDX58,CYLD,TNFAIP3
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.0279562355838729	-3.57711500645066	106	10	0.0205761316872428	486	10287	64849,84102,6534,6513,64116,11182,80736,51458,6523,6580	SLC13A3,SLC41A2,SLC6A7,SLC2A1,SLC39A8,SLC2A6,SLC44A4,RHCG,SLC5A1,SLC22A1
R-HSA-422475	Axon guidance	0.028148607722887	-3.57025738484207	549	36	0.0740740740740741	486	10287	1844,2886,2048,8828,137970,286,8503,375790,2247,4318,5721,6708,2668,10125,26281,1847,2069,6092,4629,9353,27289,1839,4067,5699,1437,6461,1848,4233,80031,2903,5698,1850,3559,5880,214,3561	DUSP2,GRB7,EPHB2,NRP2,UNC5D,ANK1,PIK3R3,AGRN,FGF2,MMP9,PSME2,SPTA1,GDNF,RASGRP1,FGF20,DUSP5,EREG,ROBO2,MYH11,SLIT2,RND1,HBEGF,LYN,PSMB10,CSF2,SHB,DUSP6,MET,SEMA6D,GRIN2A,PSMB9,DUSP8,IL2RA,RAC2,ALCAM,IL2RG
R-HSA-977068	Termination of O-glycan biosynthesis	0.0282871443874058	-3.56534783947028	25	4	0.00823045267489712	486	10287	6482,4586,10071,6484	ST3GAL1,MUC5AC,MUC12,ST3GAL4
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.0282871443874058	-3.56534783947028	25	4	0.00823045267489712	486	10287	4792,6288,4790,4791	NFKBIA,SAA1,NFKB1,NFKB2
R-HSA-1433557	Signaling by SCF-KIT	0.0292597997285086	-3.53154072796216	337	24	0.0493827160493827	486	10287	1839,4067,1844,5699,1437,1848,2886,2668,1847,26281,10125,2069,1850,5721,4318,3559,6708,941,3561,2903,4233,8503,2247,5698	HBEGF,LYN,DUSP2,PSMB10,CSF2,DUSP6,GRB7,GDNF,DUSP5,FGF20,RASGRP1,EREG,DUSP8,PSME2,MMP9,IL2RA,SPTA1,CD80,IL2RG,GRIN2A,MET,PIK3R3,FGF2,PSMB9
R-HSA-211916	Vitamins	0.0294373134650317	-3.52549224386994	6	2	0.00411522633744856	486	10287	1594,1591	CYP27B1,CYP24A1
R-HSA-5336415	Uptake and function of diphtheria toxin	0.0294373134650317	-3.52549224386994	6	2	0.00411522633744856	486	10287	1839,7296	HBEGF,TXNRD1
R-HSA-5660668	CLEC7A/inflammasome pathway	0.0294373134650317	-3.52549224386994	6	2	0.00411522633744856	486	10287	4790,3553	NFKB1,IL1B
R-HSA-187015	Activation of TRKA receptors	0.0294373134650317	-3.52549224386994	6	2	0.00411522633744856	486	10287	135,4803	ADORA2A,NGF
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.0294373134650317	-3.52549224386994	6	2	0.00411522633744856	486	10287	5743,247	PTGS2,ALOX15B
R-HSA-194138	Signaling by VEGF	0.0301580162971522	-3.50130451064634	338	24	0.0493827160493827	486	10287	3561,3559,6708,5721,1850,5698,2247,857,4233,2903,8828,6461,3710,1848,5699,1437,4688,1844,1839,2069,26281,10125,1847,2668	IL2RG,IL2RA,SPTA1,PSME2,DUSP8,PSMB9,FGF2,CAV1,MET,GRIN2A,NRP2,SHB,ITPR3,DUSP6,PSMB10,CSF2,NCF2,DUSP2,HBEGF,EREG,FGF20,RASGRP1,DUSP5,GDNF
R-HSA-450294	MAP kinase activation in TLR cascade	0.0306007211881089	-3.48673170206268	64	7	0.01440329218107	486	10287	3725,8767,1848,1326,64127,3656,4790	JUN,RIPK2,DUSP6,MAP3K8,NOD2,IRAK2,NFKB1
R-HSA-2586552	Signaling by Leptin	0.0308983587327491	-3.47705221193413	253	19	0.0390946502057613	486	10287	5721,1850,3559,6708,3561,4233,2903,5698,2247,1844,1839,1437,5699,1848,2668,26281,10125,1847,2069	PSME2,DUSP8,IL2RA,SPTA1,IL2RG,MET,GRIN2A,PSMB9,FGF2,DUSP2,HBEGF,CSF2,PSMB10,DUSP6,GDNF,FGF20,RASGRP1,DUSP5,EREG
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.0322210905177807	-3.4351340558166	26	4	0.00823045267489712	486	10287	330,1540,7128,7185	BIRC3,CYLD,TNFAIP3,TRAF1
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0329559772629302	-3.41258263045104	65	7	0.01440329218107	486	10287	1839,4233,26281,8503,2069,941,2247	HBEGF,MET,FGF20,PIK3R3,EREG,CD80,FGF2
R-HSA-5683057	MAPK family signaling cascades	0.0340359359578679	-3.38033837259643	290	21	0.0432098765432099	486	10287	1848,3569,1437,5699,1844,3725,1839,2069,26281,10125,1847,2668,3561,6708,3559,5721,1850,5698,2247,4233,2903	DUSP6,IL6,CSF2,PSMB10,DUSP2,JUN,HBEGF,EREG,FGF20,RASGRP1,DUSP5,GDNF,IL2RG,SPTA1,IL2RA,PSME2,DUSP8,PSMB9,FGF2,MET,GRIN2A
R-HSA-114508	Effects of PIP2 hydrolysis	0.0364592635054986	-3.31155971000425	27	4	0.00823045267489712	486	10287	9162,3710,10125,11343	DGKI,ITPR3,RASGRP1,MGLL
R-HSA-977606	Regulation of Complement cascade	0.0364592635054986	-3.31155971000425	27	4	0.00823045267489712	486	10287	719,1604,629,718	C3AR1,CD55,CFB,C3
R-HSA-380994	ATF4 activates genes	0.0364592635054986	-3.31155971000425	27	4	0.00823045267489712	486	10287	6347,467,3576,3484	CCL2,ATF3,CXCL8,IGFBP1
R-HSA-400685	Sema4D in semaphorin signaling	0.0364592635054986	-3.31155971000425	27	4	0.00823045267489712	486	10287	4629,4233,27289,5880	MYH11,MET,RND1,RAC2
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.0370867543452467	-3.2944953988522	16	3	0.00617283950617284	486	10287	8091,3008,3159	HMGA2,HIST1H1E,HMGA1
R-HSA-5686938	Regulation of TLR by endogenous ligand	0.0370867543452467	-3.2944953988522	16	3	0.00617283950617284	486	10287	6279,6280,7097	S100A8,S100A9,TLR2
R-HSA-375165	NCAM signaling for neurite out-growth	0.0377140436080265	-3.27772274439589	276	20	0.0411522633744856	486	10287	2668,1847,26281,10125,2069,1839,1844,1437,5699,1848,2903,4233,2247,5698,375790,1850,5721,3559,6708,3561	GDNF,DUSP5,FGF20,RASGRP1,EREG,HBEGF,DUSP2,CSF2,PSMB10,DUSP6,GRIN2A,MET,FGF2,PSMB9,AGRN,DUSP8,PSME2,IL2RA,SPTA1,IL2RG
R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0378545359076634	-3.27400446723882	53	6	0.0123456790123457	486	10287	4023,375790,6385,1591,1594,1645	LPL,AGRN,SDC4,CYP24A1,CYP27B1,AKR1C1
R-HSA-416476	G alpha (q) signalling events	0.038374395149331	-3.26036483477994	192	15	0.0308641975308642	486	10287	11343,3710,1910,2847,5021,10887,10125,2151,8503,2642,8111,9162,6288,147,623	MGLL,ITPR3,EDNRB,MCHR1,OXTR,PROKR1,RASGRP1,F2RL2,PIK3R3,GCGR,GPR68,DGKI,SAA1,ADRA1B,BDKRB1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0398817694319765	-3.22183596596664	330	23	0.0473251028806584	486	10287	3559,6708,1850,5721,3561,2903,4233,2247,857,5698,5699,4688,1437,1839,1844,3710,1848,6461,1847,10125,26281,2668,2069	IL2RA,SPTA1,DUSP8,PSME2,IL2RG,GRIN2A,MET,FGF2,CAV1,PSMB9,PSMB10,NCF2,CSF2,HBEGF,DUSP2,ITPR3,DUSP6,SHB,DUSP5,RASGRP1,FGF20,GDNF,EREG
R-HSA-174577	Activation of C3 and C5	0.0399400774364676	-3.22037501217643	7	2	0.00411522633744856	486	10287	629,718	CFB,C3
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.0399400774364676	-3.22037501217643	7	2	0.00411522633744856	486	10287	8313,51176	AXIN2,LEF1
R-HSA-447038	NrCAM interactions	0.0399400774364676	-3.22037501217643	7	2	0.00411522633744856	486	10287	8828,286	NRP2,ANK1
R-HSA-196791	Vitamin D (calciferol) metabolism	0.0399400774364676	-3.22037501217643	7	2	0.00411522633744856	486	10287	1594,1591	CYP27B1,CYP24A1
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.040736739618788	-3.20062490037988	68	7	0.01440329218107	486	10287	1594,1591,1551,1577,1581,1586,9420	CYP27B1,CYP24A1,CYP3A7,CYP3A5,CYP7A1,CYP17A1,CYP7B1
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.0410032169559027	-3.19410475301675	28	4	0.00823045267489712	486	10287	51703,2182,79993,2181	ACSL5,ACSL4,ELOVL7,ACSL3
R-HSA-5173105	O-linked glycosylation	0.0429797206847511	-3.14702688651502	114	10	0.0205761316872428	486	10287	9507,6484,56999,4586,50614,10071,79623,10164,6482,51301	ADAMTS4,ST3GAL4,ADAMTS9,MUC5AC,GALNT9,MUC12,GALNT14,CHST4,ST3GAL1,GCNT4
R-HSA-2142845	Hyaluronan metabolism	0.043498732059321	-3.1350234893739	17	3	0.00617283950617284	486	10287	3036,3038,960	HAS1,HAS3,CD44
R-HSA-196807	Nicotinate metabolism	0.0458533369304852	-3.0823073036371	29	4	0.00823045267489712	486	10287	54625,5743,10135,952	PARP14,PTGS2,NAMPT,CD38
R-HSA-2172127	DAP12 interactions	0.0464946062013602	-3.06841896878652	371	25	0.051440329218107	486	10287	4233,2903,54210,8503,5698,2247,5721,1850,6708,3559,342510,941,3561,2668,26281,10125,1847,2069,1844,3937,1839,1437,5699,1848,3710	MET,GRIN2A,TREM1,PIK3R3,PSMB9,FGF2,PSME2,DUSP8,SPTA1,IL2RA,CD300E,CD80,IL2RG,GDNF,FGF20,RASGRP1,DUSP5,EREG,DUSP2,LCP2,HBEGF,CSF2,PSMB10,DUSP6,ITPR3
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	0.0472440944880199	-3.05242761723412	1	1	0.00205761316872428	486	10287	7296	TXNRD1
R-HSA-5688426	Deubiquitination	0.0476179999123277	-3.04454443980658	301	21	0.0432098765432099	486	10287	4792,23586,330,8313,8767,5699,84101,64135,8900,8975,219333,79931,1080,5698,723790,7128,1540,10318,5721,64127,90865	NFKBIA,DDX58,BIRC3,AXIN2,RIPK2,PSMB10,USP44,IFIH1,CCNA1,USP13,USP12,TNIP3,CFTR,PSMB9,HIST2H2AA4,TNFAIP3,CYLD,TNIP1,PSME2,NOD2,IL33
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.0489608716349433	-3.01673383793524	101	9	0.0185185185185185	486	10287	5699,5971,5721,4790,4791,3710,4792,3553,5698	PSMB10,RELB,PSME2,NFKB1,NFKB2,ITPR3,NFKBIA,IL1B,PSMB9
R-HSA-197264	Nicotinamide salvaging	0.0504238761021405	-2.98729048389515	18	3	0.00617283950617284	486	10287	10135,54625,5743	NAMPT,PARP14,PTGS2
R-HSA-912631	Regulation of signaling by CBL	0.0504238761021405	-2.98729048389515	18	3	0.00617283950617284	486	10287	3055,4067,8503	HCK,LYN,PIK3R3
R-HSA-381042	PERK regulates gene expression	0.051008894369924	-2.97575526205335	30	4	0.00823045267489712	486	10287	467,6347,3484,3576	ATF3,CCL2,IGFBP1,CXCL8
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.0516163992734625	-2.96391584161005	8	2	0.00411522633744856	486	10287	27289,4233	RND1,MET
R-HSA-917937	Iron uptake and transport	0.055110841408872	-2.89840882339603	44	5	0.0102880658436214	486	10287	2495,3934,245973,3162,50617	FTH1,LCN2,ATP6V1C2,HMOX1,ATP6V0A4
R-HSA-114452	Activation of BH3-only proteins	0.0564681009803229	-2.8740793846866	31	4	0.00823045267489712	486	10287	5366,27113,637,8626	PMAIP1,BBC3,BID,TP63
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.0578482253136654	-2.84993250319131	19	3	0.00617283950617284	486	10287	64127,3656,8767	NOD2,IRAK2,RIPK2
R-HSA-166658	Complement cascade	0.0597031342504179	-2.81837075995466	45	5	0.0102880658436214	486	10287	718,629,1604,10584,719	C3,CFB,CD55,COLEC10,C3AR1
R-HSA-5689880	Ub-specific processing proteases	0.0630137733943659	-2.76440195117824	223	16	0.0329218106995885	486	10287	5698,723790,1080,219333,8975,90865,5721,1540,8313,330,4792,23586,8900,64135,84101,5699	PSMB9,HIST2H2AA4,CFTR,USP12,USP13,IL33,PSME2,CYLD,AXIN2,BIRC3,NFKBIA,DDX58,CCNA1,IFIH1,USP44,PSMB10
R-HSA-2179392	EGFR Transactivation by Gastrin	0.0643324302850725	-2.74369141586348	9	2	0.00411522633744856	486	10287	1839,4314	HBEGF,MMP3
R-HSA-1296052	Ca2+ activated K+ channels	0.0643324302850725	-2.74369141586348	9	2	0.00411522633744856	486	10287	3783,3779	KCNN4,KCNMB1
R-HSA-194002	Glucocorticoid biosynthesis	0.0643324302850725	-2.74369141586348	9	2	0.00411522633744856	486	10287	3290,1586	HSD11B1,CYP17A1
R-HSA-390696	Adrenoceptors	0.0643324302850725	-2.74369141586348	9	2	0.00411522633744856	486	10287	147,150	ADRA1B,ADRA2A
R-HSA-8874081	MET activates PTK2 signaling	0.0657557041954288	-2.72180885586332	20	3	0.00617283950617284	486	10287	3918,3914,4233	LAMC2,LAMB3,MET
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.0657557041954288	-2.72180885586332	20	3	0.00617283950617284	486	10287	3656,64127,8767	IRAK2,NOD2,RIPK2
R-HSA-389356	CD28 co-stimulation	0.0682853651716288	-2.68405980810843	33	4	0.00823045267489712	486	10287	4067,1326,8503,941	LYN,MAP3K8,PIK3R3,CD80
R-HSA-5357905	Regulation of TNFR1 signaling	0.0682853651716288	-2.68405980810843	33	4	0.00823045267489712	486	10287	7128,1540,7185,330	TNFAIP3,CYLD,TRAF1,BIRC3
R-HSA-1222556	ROS, RNS production in phagocytes	0.0682853651716288	-2.68405980810843	33	4	0.00823045267489712	486	10287	4688,245973,50617,4843	NCF2,ATP6V1C2,ATP6V0A4,NOS2
R-HSA-186763	Downstream signal transduction	0.0716198948958508	-2.63638238193805	352	23	0.0473251028806584	486	10287	8503,2247,5698,2903,4233,941,3561,1850,5721,3559,6708,2069,2668,1847,10125,26281,2886,3710,1848,1839,1844,1437,5699	PIK3R3,FGF2,PSMB9,GRIN2A,MET,CD80,IL2RG,DUSP8,PSME2,IL2RA,SPTA1,EREG,GDNF,DUSP5,RASGRP1,FGF20,GRB7,ITPR3,DUSP6,HBEGF,DUSP2,CSF2,PSMB10
R-HSA-211945	Phase 1 - Functionalization of compounds	0.0723289349404705	-2.62653102323323	109	9	0.0185185185185185	486	10287	1551,1577,54498,9420,1594,1591,1581,1586,874	CYP3A7,CYP3A5,SMOX,CYP7B1,CYP27B1,CYP24A1,CYP7A1,CYP17A1,CBR3
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	0.0741284597755923	-2.60195574787197	21	3	0.00617283950617284	486	10287	1263,7832,10769	PLK3,BTG2,PLK2
R-HSA-76002	Platelet activation, signaling and aggregation	0.0755654320742189	-2.58275634806177	282	19	0.0390946502057613	486	10287	1437,4067,3937,150,3710,10125,5341,2151,7273,5880,3559,11343,5004,5005,3561,2207,9162,5552,8503	CSF2,LYN,LCP2,ADRA2A,ITPR3,RASGRP1,PLEK,F2RL2,TTN,RAC2,IL2RA,MGLL,ORM1,ORM2,IL2RG,FCER1G,DGKI,SRGN,PIK3R3
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.0759275324269617	-2.57797591428373	229	16	0.0329218106995885	486	10287	4233,5698,2247,8503,5721,4790,941,10125,26281,4792,4794,2069,5699,4067,1839,3710	MET,PSMB9,FGF2,PIK3R3,PSME2,NFKB1,CD80,RASGRP1,FGF20,NFKBIA,NFKBIE,EREG,PSMB10,LYN,HBEGF,ITPR3
R-HSA-1250342	PI3K events in ERBB4 signaling	0.0779643050336052	-2.55150418481038	10	2	0.00411522633744856	486	10287	2069,1839	EREG,HBEGF
R-HSA-425381	Bicarbonate transporters	0.0779643050336052	-2.55150418481038	10	2	0.00411522633744856	486	10287	23382,8671	AHCYL2,SLC4A4
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.0779643050336052	-2.55150418481038	10	2	0.00411522633744856	486	10287	27113,8626	BBC3,TP63
R-HSA-2424491	DAP12 signaling	0.0788621782056773	-2.54005352974144	356	23	0.0473251028806584	486	10287	8503,5698,2247,4233,2903,941,3561,5721,1850,3559,6708,2069,2668,10125,26281,1847,1848,3710,1844,3937,1839,5699,1437	PIK3R3,PSMB9,FGF2,MET,GRIN2A,CD80,IL2RG,PSME2,DUSP8,IL2RA,SPTA1,EREG,GDNF,RASGRP1,FGF20,DUSP5,DUSP6,ITPR3,DUSP2,LCP2,HBEGF,PSMB10,CSF2
R-HSA-2871837	FCERI mediated NF-kB activation	0.0789528969128587	-2.53890384594721	79	7	0.01440329218107	486	10287	4067,5721,4792,5699,10125,4790,5698	LYN,PSME2,NFKBIA,PSMB10,RASGRP1,NFKB1,PSMB9
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	0.0801738517754962	-2.52355785498354	49	5	0.0102880658436214	486	10287	7832,10769,1263,25946,8900	BTG2,PLK2,PLK3,ZNF385A,CCNA1
R-HSA-186797	Signaling by PDGF	0.0820102621880112	-2.50091089091404	376	24	0.0493827160493827	486	10287	2069,2668,10125,26281,1847,1848,3710,2886,1844,1839,1437,5699,8503,5698,2247,4233,2903,941,5327,3561,5721,1850,3559,6708	EREG,GDNF,RASGRP1,FGF20,DUSP5,DUSP6,ITPR3,GRB7,DUSP2,HBEGF,CSF2,PSMB10,PIK3R3,PSMB9,FGF2,MET,GRIN2A,CD80,PLAT,IL2RG,PSME2,DUSP8,IL2RA,SPTA1
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.0829471665159104	-2.48955142186931	22	3	0.00617283950617284	486	10287	8503,941,1326	PIK3R3,CD80,MAP3K8
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.0829471665159104	-2.48955142186931	22	3	0.00617283950617284	486	10287	5197,3053,5270	PF4V1,SERPIND1,SERPINE2
R-HSA-166663	Initial triggering of complement	0.0829471665159104	-2.48955142186931	22	3	0.00617283950617284	486	10287	629,718,10584	CFB,C3,COLEC10
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.0829471665159104	-2.48955142186931	22	3	0.00617283950617284	486	10287	4790,5971,4067	NFKB1,RELB,LYN
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.0832440312803356	-2.48597884902419	197	14	0.0288065843621399	486	10287	4233,4794,4792,26281,10125,2069,8503,2247,5698,1839,5721,5699,941,4790	MET,NFKBIE,NFKBIA,FGF20,RASGRP1,EREG,PIK3R3,FGF2,PSMB9,HBEGF,PSME2,PSMB10,CD80,NFKB1
R-HSA-74752	Signaling by Insulin receptor	0.0836415955293529	-2.48121432845166	322	21	0.0432098765432099	486	10287	5699,1437,1839,1844,1848,1847,26281,10125,2668,245973,2069,3559,6708,1850,5721,3561,50617,2903,4233,2247,5698	PSMB10,CSF2,HBEGF,DUSP2,DUSP6,DUSP5,FGF20,RASGRP1,GDNF,ATP6V1C2,EREG,IL2RA,SPTA1,DUSP8,PSME2,IL2RG,ATP6V0A4,GRIN2A,MET,FGF2,PSMB9
R-HSA-6803157	Antimicrobial peptides	0.0875107804030554	-2.43599328860128	97	8	0.0164609053497942	486	10287	6279,5068,5266,3934,114770,6278,7097,6280	S100A8,REG3A,PI3,LCN2,PGLYRP2,S100A7,TLR2,S100A9
R-HSA-6804754	Regulation of TP53 Expression	0.0922605605630446	-2.38313852496539	2	1	0.00205761316872428	486	10287	639	PRDM1
R-HSA-111452	Activation and oligomerization of BAK protein	0.0922605605630446	-2.38313852496539	2	1	0.00205761316872428	486	10287	637	BID
R-HSA-187042	TRKA activation by NGF	0.0922605605630446	-2.38313852496539	2	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-205017	NFG and proNGF binds to p75NTR	0.0922605605630446	-2.38313852496539	2	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-141334	PAOs oxidise polyamines to amines	0.0922605605630446	-2.38313852496539	2	1	0.00205761316872428	486	10287	54498	SMOX
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.0922605605630446	-2.38313852496539	2	1	0.00205761316872428	486	10287	366	AQP9
R-HSA-5652227	Fructose biosynthesis	0.0922605605630446	-2.38313852496539	2	1	0.00205761316872428	486	10287	231	AKR1B1
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.0922605605630446	-2.38313852496539	2	1	0.00205761316872428	486	10287	637	BID
R-HSA-190872	Transport of connexons to the plasma membrane	0.0922605605630446	-2.38313852496539	2	1	0.00205761316872428	486	10287	2706	GJB2
R-HSA-193048	Androgen biosynthesis	0.0923974999168283	-2.38165535787773	11	2	0.00411522633744856	486	10287	1586,6716	CYP17A1,SRD5A2
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.0923974999168283	-2.38165535787773	11	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-446107	Type I hemidesmosome assembly	0.0923974999168283	-2.38165535787773	11	2	0.00411522633744856	486	10287	3918,3914	LAMC2,LAMB3
R-HSA-177929	Signaling by EGFR	0.0947938948367973	-2.35605027225068	364	23	0.0473251028806584	486	10287	3561,941,6708,3559,5721,1850,5698,2247,8503,4233,2903,3710,1848,10252,1437,5699,1844,1839,2069,26281,10125,1847,2668	IL2RG,CD80,SPTA1,IL2RA,PSME2,DUSP8,PSMB9,FGF2,PIK3R3,MET,GRIN2A,ITPR3,DUSP6,SPRY1,CSF2,PSMB10,DUSP2,HBEGF,EREG,FGF20,RASGRP1,DUSP5,GDNF
R-HSA-1169091	Activation of NF-kappaB in B cells	0.101150557711478	-2.29114520167644	68	6	0.0123456790123457	486	10287	5699,5721,4794,4792,5698,4790	PSMB10,PSME2,NFKBIE,NFKBIA,PSMB9,NFKB1
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.101839394011867	-2.28435827514477	24	3	0.00617283950617284	486	10287	3779,5152,4843	KCNMB1,PDE9A,NOS2
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.101839394011867	-2.28435827514477	24	3	0.00617283950617284	486	10287	5880,4629,27289	RAC2,MYH11,RND1
R-HSA-112399	IRS-mediated signalling	0.102805097073497	-2.27492034476323	294	19	0.0390946502057613	486	10287	1848,1844,1839,5699,1437,2069,2668,10125,26281,1847,3561,5721,1850,6708,3559,5698,2247,4233,2903	DUSP6,DUSP2,HBEGF,PSMB10,CSF2,EREG,GDNF,RASGRP1,FGF20,DUSP5,IL2RG,PSME2,DUSP8,SPTA1,IL2RA,PSMB9,FGF2,MET,GRIN2A
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.102839732829277	-2.27458349451395	38	4	0.00823045267489712	486	10287	4688,7296,7295,6648	NCF2,TXNRD1,TXN,SOD2
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.104361754814823	-2.25989200384135	387	24	0.0493827160493827	486	10287	5698,2247,8503,4233,2903,3561,941,4803,3559,6708,5721,1850,2069,10125,135,26281,1847,2668,3710,1848,1437,5699,1844,1839	PSMB9,FGF2,PIK3R3,MET,GRIN2A,IL2RG,CD80,NGF,IL2RA,SPTA1,PSME2,DUSP8,EREG,RASGRP1,ADORA2A,FGF20,DUSP5,GDNF,ITPR3,DUSP6,CSF2,PSMB10,DUSP2,HBEGF
R-HSA-2187338	Visual phototransduction	0.10445081584382	-2.25903898015492	101	8	0.0164609053497942	486	10287	64220,5957,375790,1645,6385,2986,24,4023	STRA6,RCVRN,AGRN,AKR1C1,SDC4,GUCY2F,ABCA4,LPL
R-HSA-1236975	Antigen processing-Cross presentation	0.10445081584382	-2.25903898015492	101	8	0.0164609053497942	486	10287	4688,5699,5721,1520,5698,6891,7097,6890	NCF2,PSMB10,PSME2,CTSS,PSMB9,TAP2,TLR2,TAP1
R-HSA-388841	Costimulation by the CD28 family	0.10663399588309	-2.23835290736844	69	6	0.0123456790123457	486	10287	29126,941,8503,1326,23308,4067	CD274,CD80,PIK3R3,MAP3K8,ICOSLG,LYN
R-HSA-73621	Pyrimidine catabolism	0.107526229843224	-2.23002046263561	12	2	0.00411522633744856	486	10287	51733,1890	UPB1,TYMP
R-HSA-8851680	Butyrophilin (BTN) family interactions	0.107526229843224	-2.23002046263561	12	2	0.00411522633744856	486	10287	7498,11119	XDH,BTN3A1
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.107526229843224	-2.23002046263561	12	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-2033514	FGFR3 mutant receptor activation	0.107526229843224	-2.23002046263561	12	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.107526229843224	-2.23002046263561	12	2	0.00411522633744856	486	10287	6385,375790	SDC4,AGRN
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.107526229843224	-2.23002046263561	12	2	0.00411522633744856	486	10287	6385,375790	SDC4,AGRN
R-HSA-190373	FGFR1c ligand binding and activation	0.107526229843224	-2.23002046263561	12	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-879518	Transport of organic anions	0.107526229843224	-2.23002046263561	12	2	0.00411522633744856	486	10287	28231,28232	SLCO4A1,SLCO3A1
R-HSA-1280218	Adaptive Immune System	0.107963733115805	-2.22595991273615	810	46	0.0946502057613169	486	10287	1326,221687,3386,5698,7097,718,84676,4233,127544,5699,8767,7498,3937,1839,4067,6891,2069,6890,92369,26281,11119,10125,1520,4790,941,10517,342510,55521,57823,5721,7087,2247,255488,8503,55008,3383,54210,29126,285852,3710,4688,117157,23308,23327,4792,4794	MAP3K8,RNF182,ICAM4,PSMB9,TLR2,C3,TRIM63,MET,RNF19B,PSMB10,RIPK2,XDH,LCP2,HBEGF,LYN,TAP2,EREG,TAP1,SPSB4,FGF20,BTN3A1,RASGRP1,CTSS,NFKB1,CD80,FBXW10,CD300E,TRIM36,SLAMF7,PSME2,ICAM5,FGF2,RNF144B,PIK3R3,HERC6,ICAM1,TREM1,CD274,TREML4,ITPR3,NCF2,SH2D1B,ICOSLG,NEDD4L,NFKBIA,NFKBIE
R-HSA-74751	Insulin receptor signalling cascade	0.110471911754855	-2.20299398260042	297	19	0.0390946502057613	486	10287	2069,2668,1847,10125,26281,1848,1839,1844,5699,1437,2247,5698,2903,4233,3561,1850,5721,6708,3559	EREG,GDNF,DUSP5,RASGRP1,FGF20,DUSP6,HBEGF,DUSP2,PSMB10,CSF2,FGF2,PSMB9,GRIN2A,MET,IL2RG,DUSP8,PSME2,SPTA1,IL2RA
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.110556513352103	-2.20222845571093	39	4	0.00823045267489712	486	10287	3053,2152,5197,5270	SERPIND1,F3,PF4V1,SERPINE2
R-HSA-2428924	IGF1R signaling cascade	0.113104067581049	-2.17944693204126	298	19	0.0390946502057613	486	10287	1844,1839,1437,5699,1848,2668,26281,10125,1847,2069,5721,1850,3559,6708,3561,4233,2903,5698,2247	DUSP2,HBEGF,CSF2,PSMB10,DUSP6,GDNF,FGF20,RASGRP1,DUSP5,EREG,PSME2,DUSP8,IL2RA,SPTA1,IL2RG,MET,GRIN2A,PSMB9,FGF2
R-HSA-2428928	IRS-related events triggered by IGF1R	0.113104067581049	-2.17944693204126	298	19	0.0390946502057613	486	10287	1437,5699,1839,1844,1848,1847,26281,10125,2668,2069,3559,6708,1850,5721,3561,2903,4233,2247,5698	CSF2,PSMB10,HBEGF,DUSP2,DUSP6,DUSP5,FGF20,RASGRP1,GDNF,EREG,IL2RA,SPTA1,DUSP8,PSME2,IL2RG,GRIN2A,MET,FGF2,PSMB9
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.115774465574565	-2.15611124269538	299	19	0.0390946502057613	486	10287	4233,2903,5698,2247,3559,6708,5721,1850,3561,26281,10125,1847,2668,2069,5699,1437,1844,1839,1848	MET,GRIN2A,PSMB9,FGF2,IL2RA,SPTA1,PSME2,DUSP8,IL2RG,FGF20,RASGRP1,DUSP5,GDNF,EREG,PSMB10,CSF2,DUSP2,HBEGF,DUSP6
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.116505892923458	-2.14981342422169	87	7	0.01440329218107	486	10287	941,2069,8503,2247,1839,4233,26281	CD80,EREG,PIK3R3,FGF2,HBEGF,MET,FGF20
R-HSA-351202	Metabolism of polyamines	0.116505892923458	-2.14981342422169	87	7	0.01440329218107	486	10287	5698,54498,6303,5721,6534,6611,5699	PSMB9,SMOX,SAT1,PSME2,SLC6A7,SMS,PSMB10
R-HSA-5675221	Negative regulation of MAPK pathway	0.118523165562294	-2.13264684753546	40	4	0.00823045267489712	486	10287	1847,1850,1844,1848	DUSP5,DUSP8,DUSP2,DUSP6
R-HSA-388396	GPCR downstream signaling	0.118771825704378	-2.13055105755041	974	54	0.111111111111111	486	10287	9340,5142,3627,8503,6372,64108,8111,6288,283365,9162,2919,2847,6004,6373,6374,3710,6364,150,1910,643,7852,26230,1236,2920,26575,2151,134864,10887,135,2914,3561,11343,53831,5880,3559,2642,147,9628,719,2921,57007,5999,6352,5996,6363,718,4283,1437,2918,623,6752,5021,3576,10125	GLP2R,PDE4B,CXCL10,PIK3R3,CXCL6,RTP4,GPR68,SAA1,OR6C6,DGKI,CXCL1,MCHR1,RGS16,CXCL11,CXCL5,ITPR3,CCL20,ADRA2A,EDNRB,CXCR5,CXCR4,TIAM2,CCR7,CXCL2,RGS17,F2RL2,TAAR1,PROKR1,ADORA2A,GRM4,IL2RG,MGLL,GPR84,RAC2,IL2RA,GCGR,ADRA1B,RGS6,C3AR1,CXCL3,ACKR3,RGS4,CCL5,RGS1,CCL19,C3,CXCL9,CSF2,GRM8,BDKRB1,SSTR2,OXTR,CXCL8,RASGRP1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.122897826108012	-2.09640195086592	122	9	0.0185185185185185	486	10287	4363,952,8875,10135,6513,441024,54625,5743,8876	ABCC1,CD38,VNN2,NAMPT,SLC2A1,MTHFD2L,PARP14,PTGS2,VNN1
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	8900,25946	CCNA1,ZNF385A
R-HSA-190372	FGFR3c ligand binding and activation	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	4688,5880	NCF2,RAC2
R-HSA-190375	FGFR2c ligand binding and activation	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-190239	FGFR3 ligand binding and activation	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	2069,1839	EREG,HBEGF
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	163732,4435	CITED4,CITED1
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	64135,23586	IFIH1,DDX58
R-HSA-75892	Platelet Adhesion to exposed collagen	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	4067,2207	LYN,FCER1G
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.12325288090413	-2.09351709185682	13	2	0.00411522633744856	486	10287	7128,1540	TNFAIP3,CYLD
R-HSA-1630316	Glycosaminoglycan metabolism	0.132038481161494	-2.0246618749299	124	9	0.0185185185185185	486	10287	9435,960,6482,6385,3038,6484,50515,3036,375790	CHST2,CD44,ST3GAL1,SDC4,HAS3,ST3GAL4,CHST11,HAS1,AGRN
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.132038481161494	-2.0246618749299	124	9	0.0185185185185185	486	10287	718,3383,54210,342510,57823,3386,117157,7087,285852	C3,ICAM1,TREM1,CD300E,SLAMF7,ICAM4,SH2D1B,ICAM5,TREML4
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.132624525846663	-2.02023325719736	90	7	0.01440329218107	486	10287	26281,4233,1839,2247,8503,2069,941	FGF20,MET,HBEGF,FGF2,PIK3R3,EREG,CD80
R-HSA-382556	ABC-family proteins mediated transport	0.133008563506271	-2.01734176556796	107	8	0.0164609053497942	486	10287	5721,5699,8714,4363,24,1080,26154,5698	PSME2,PSMB10,ABCC3,ABCC1,ABCA4,CFTR,ABCA12,PSMB9
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	1080	CFTR
R-HSA-198745	Signalling to STAT3	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	6616	SNAP25
R-HSA-5653890	Lactose synthesis	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	6513	SLC2A1
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	51458	RHCG
R-HSA-177539	Autointegration results in viral DNA circles	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	3159	HMGA1
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	4121	MAN1A1
R-HSA-190704	Oligomerization of connexins into connexons	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	2706	GJB2
R-HSA-193681	Ceramide signalling	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	8900	CCNA1
R-HSA-190827	Transport of connexins along the secretory pathway	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	2706	GJB2
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	150	ADRA2A
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	3159	HMGA1
R-HSA-8875791	MET activates STAT3	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	4233	MET
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.13515422780234	-2.0013387244527	3	1	0.00205761316872428	486	10287	6616	SNAP25
R-HSA-2559583	Cellular Senescence	0.136556452077577	-1.99101718151904	196	13	0.0267489711934156	486	10287	3552,23135,3725,8900,4790,1030,3569,7295,3008,8091,3576,723790,3159	IL1A,KDM6B,JUN,CCNA1,NFKB1,CDKN2B,IL6,TXN,HIST1H1E,HMGA2,CXCL8,HIST2H2AA4,HMGA1
R-HSA-166520	Signalling by NGF	0.137207856857515	-1.98625829960465	477	28	0.0576131687242798	486	10287	5721,1850,3559,6708,941,4803,3561,4790,4233,2903,8503,5698,2247,26230,1844,1839,8767,1437,5699,1848,3710,4792,2668,26281,10125,135,1847,2069	PSME2,DUSP8,IL2RA,SPTA1,CD80,NGF,IL2RG,NFKB1,MET,GRIN2A,PIK3R3,PSMB9,FGF2,TIAM2,DUSP2,HBEGF,RIPK2,CSF2,PSMB10,DUSP6,ITPR3,NFKBIA,GDNF,FGF20,RASGRP1,ADORA2A,DUSP5,EREG
R-HSA-418346	Platelet homeostasis	0.138231674944536	-1.97882419749517	91	7	0.01440329218107	486	10287	3779,5152,2268,6547,4843,3710,490	KCNMB1,PDE9A,FGR,SLC8A3,NOS2,ITPR3,ATP2B1
R-HSA-209543	p75NTR recruits signalling complexes	0.139487476976961	-1.96978045252483	14	2	0.00411522633744856	486	10287	8767,4803	RIPK2,NGF
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.139487476976961	-1.96978045252483	14	2	0.00411522633744856	486	10287	11182,6513	SLC2A6,SLC2A1
R-HSA-190322	FGFR4 ligand binding and activation	0.139487476976961	-1.96978045252483	14	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	0.139487476976961	-1.96978045252483	14	2	0.00411522633744856	486	10287	25946,8626	ZNF385A,TP63
R-HSA-162594	Early Phase of HIV Life Cycle	0.139487476976961	-1.96978045252483	14	2	0.00411522633744856	486	10287	7852,3159	CXCR4,HMGA1
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.139487476976961	-1.96978045252483	14	2	0.00411522633744856	486	10287	1645,1646	AKR1C1,AKR1C2
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.139487476976961	-1.96978045252483	14	2	0.00411522633744856	486	10287	490,6547	ATP2B1,SLC8A3
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.139487476976961	-1.96978045252483	14	2	0.00411522633744856	486	10287	1839,2069	HBEGF,EREG
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.143829920206085	-1.93912378714585	43	4	0.00823045267489712	486	10287	51176,6658,64321,83595	LEF1,SOX3,SOX17,SOX7
R-HSA-75893	TNF signaling	0.143829920206085	-1.93912378714585	43	4	0.00823045267489712	486	10287	330,7185,7128,1540	BIRC3,TRAF1,TNFAIP3,CYLD
R-HSA-2022854	Keratan sulfate biosynthesis	0.144020568572503	-1.93779915229736	28	3	0.00617283950617284	486	10287	6484,9435,6482	ST3GAL4,CHST2,ST3GAL1
R-HSA-1266695	Interleukin-7 signaling	0.144020568572503	-1.93779915229736	28	3	0.00617283950617284	486	10287	3575,3561,8503	IL7R,IL2RG,PIK3R3
R-HSA-211976	Endogenous sterols	0.144020568572503	-1.93779915229736	28	3	0.00617283950617284	486	10287	1586,1581,9420	CYP17A1,CYP7A1,CYP7B1
R-HSA-2142753	Arachidonic acid metabolism	0.145182849134233	-1.92976130247827	59	5	0.0102880658436214	486	10287	9536,5743,4363,247,242	PTGES,PTGS2,ABCC1,ALOX15B,ALOX12B
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.148641089917635	-1.90622067134368	110	8	0.0164609053497942	486	10287	3552,3725,8900,4790,3569,1030,3576,723790	IL1A,JUN,CCNA1,NFKB1,IL6,CDKN2B,CXCL8,HIST2H2AA4
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.152661817361529	-1.879530148048	60	5	0.0102880658436214	486	10287	5699,5971,5721,4791,5698	PSMB10,RELB,PSME2,NFKB2,PSMB9
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.152701828085974	-1.87926809508086	44	4	0.00823045267489712	486	10287	8626,637,27113,5366	TP63,BID,BBC3,PMAIP1
R-HSA-975634	Retinoid metabolism and transport	0.152701828085974	-1.87926809508086	44	4	0.00823045267489712	486	10287	375790,4023,6385,1645	AGRN,LPL,SDC4,AKR1C1
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.155726939973047	-1.8596511902342	94	7	0.01440329218107	486	10287	26281,1839,4233,2247,941,8503,2069	FGF20,HBEGF,MET,FGF2,CD80,PIK3R3,EREG
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.15614717831382	-1.8569562657729	15	2	0.00411522633744856	486	10287	27121,7474	DKK4,WNT5A
R-HSA-6785631	ERBB2 Regulates Cell Motility	0.15614717831382	-1.8569562657729	15	2	0.00411522633744856	486	10287	1839,2069	HBEGF,EREG
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.15614717831382	-1.8569562657729	15	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.15614717831382	-1.8569562657729	15	2	0.00411522633744856	486	10287	9536,5743	PTGES,PTGS2
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.160298118788832	-1.83071995500111	61	5	0.0102880658436214	486	10287	5698,4791,5721,5971,5699	PSMB9,NFKB2,PSME2,RELB,PSMB10
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.160298118788832	-1.83071995500111	61	5	0.0102880658436214	486	10287	5698,8900,5721,5699,595	PSMB9,CCNA1,PSME2,PSMB10,CCND1
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	0.161774871385413	-1.82154959306053	45	4	0.00823045267489712	486	10287	5366,27113,637,8626	PMAIP1,BBC3,BID,TP63
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.166940741557153	-1.79011637051147	30	3	0.00617283950617284	486	10287	113878,54567,92737	DTX2,DLL4,DNER
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.166940741557153	-1.79011637051147	30	3	0.00617283950617284	486	10287	595,3725,10046	CCND1,JUN,MAMLD1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.166940741557153	-1.79011637051147	30	3	0.00617283950617284	486	10287	3710,4067,3937	ITPR3,LYN,LCP2
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.173155810308687	-1.7535634521926	16	2	0.00411522633744856	486	10287	23586,64135	DDX58,IFIH1
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.173155810308687	-1.7535634521926	16	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-1963642	PI3K events in ERBB2 signaling	0.173155810308687	-1.7535634521926	16	2	0.00411522633744856	486	10287	1839,2069	HBEGF,EREG
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.173155810308687	-1.7535634521926	16	2	0.00411522633744856	486	10287	1839,2069	HBEGF,EREG
R-HSA-190242	FGFR1 ligand binding and activation	0.173155810308687	-1.7535634521926	16	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.173155810308687	-1.7535634521926	16	2	0.00411522633744856	486	10287	4790,1326	NFKB1,MAP3K8
R-HSA-15869	Metabolism of nucleotides	0.174183333456426	-1.74764689390305	97	7	0.01440329218107	486	10287	7296,7295,57089,51733,7498,272,1890	TXNRD1,TXN,ENTPD7,UPB1,XDH,AMPD3,TYMP
R-HSA-417973	Adenosine P1 receptors	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	135	ADORA2A
R-HSA-140179	Amine Oxidase reactions	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	54498	SMOX
R-HSA-209905	Catecholamine biosynthesis	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	1644	DDC
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	6616	SNAP25
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	25946	ZNF385A
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	6506	SLC1A2
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	7296	TXNRD1
R-HSA-209563	Axonal growth stimulation	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	8828	NRP2
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	25946	ZNF385A
R-HSA-167060	NGF processing	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	6506	SLC1A2
R-HSA-2473224	Antagonism of Activin by Follistatin	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	3624	INHBA
R-HSA-427975	Proton/oligopeptide cotransporters	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	51296	SLC15A3
R-HSA-173107	Binding and entry of HIV virion	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	7852	CXCR4
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.176025002333868	-1.73712923531821	4	1	0.00205761316872428	486	10287	637	BID
R-HSA-5339562	Uptake and actions of bacterial toxins	0.178777095903433	-1.72161552342218	31	3	0.00617283950617284	486	10287	6616,1839,7296	SNAP25,HBEGF,TXNRD1
R-HSA-418360	Platelet calcium homeostasis	0.178777095903433	-1.72161552342218	31	3	0.00617283950617284	486	10287	6547,490,3710	SLC8A3,ATP2B1,ITPR3
R-HSA-5654687	Downstream signaling of activated FGFR1	0.178777095903433	-1.72161552342218	31	3	0.00617283950617284	486	10287	2247,23767,26281	FGF2,FLRT3,FGF20
R-HSA-2129379	Molecules associated with elastic fibres	0.178777095903433	-1.72161552342218	31	3	0.00617283950617284	486	10287	10516,27302,650	FBLN5,BMP10,BMP2
R-HSA-8875878	MET promotes cell motility	0.178777095903433	-1.72161552342218	31	3	0.00617283950617284	486	10287	3914,4233,3918	LAMB3,MET,LAMC2
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.180482015475574	-1.71212414342776	47	4	0.00823045267489712	486	10287	10046,6484,595,3725	MAMLD1,ST3GAL4,CCND1,JUN
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.190094587783658	-1.66023350025781	48	4	0.00823045267489712	486	10287	3559,1437,8503,3561	IL2RA,CSF2,PIK3R3,IL2RG
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	0.190443420746946	-1.65840013248283	17	2	0.00411522633744856	486	10287	10071,4586	MUC12,MUC5AC
R-HSA-192456	Digestion of dietary lipid	0.190443420746946	-1.65840013248283	17	2	0.00411522633744856	486	10287	9388,119548	LIPG,PNLIPRP3
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	0.190443420746946	-1.65840013248283	17	2	0.00411522633744856	486	10287	4586,10071	MUC5AC,MUC12
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.190443420746946	-1.65840013248283	17	2	0.00411522633744856	486	10287	8876,8875	VNN1,VNN2
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	0.190443420746946	-1.65840013248283	17	2	0.00411522633744856	486	10287	4586,10071	MUC5AC,MUC12
R-HSA-2033519	Activated point mutants of FGFR2	0.190443420746946	-1.65840013248283	17	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-75109	Triglyceride Biosynthesis	0.190592228211182	-1.65761906398067	82	6	0.0123456790123457	486	10287	2181,2710,80168,2182,51703,79993	ACSL3,GK,MOGAT2,ACSL4,ACSL5,ELOVL7
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.192297349310646	-1.64871241061841	65	5	0.0102880658436214	486	10287	25946,5698,8900,5721,5699	ZNF385A,PSMB9,CCNA1,PSME2,PSMB10
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.192297349310646	-1.64871241061841	65	5	0.0102880658436214	486	10287	25946,5698,8900,5721,5699	ZNF385A,PSMB9,CCNA1,PSME2,PSMB10
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.203088733222276	-1.59411228597552	33	3	0.00617283950617284	486	10287	6484,6482,9435	ST3GAL4,ST3GAL1,CHST2
R-HSA-5357801	Programmed Cell Death	0.205424228098409	-1.58267803275545	175	11	0.0226337448559671	486	10287	637,5317,8626,330,27113,5366,5698,660,5699,5721,3008	BID,PKP1,TP63,BIRC3,BBC3,PMAIP1,PSMB9,BMX,PSMB10,PSME2,HIST1H1E
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.207945863825897	-1.57047750322475	18	2	0.00411522633744856	486	10287	6580,6616	SLC22A1,SNAP25
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.207945863825897	-1.57047750322475	18	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-5654710	PI-3K cascade:FGFR3	0.207945863825897	-1.57047750322475	18	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-418457	cGMP effects	0.207945863825897	-1.57047750322475	18	2	0.00411522633744856	486	10287	5152,3779	PDE9A,KCNMB1
R-HSA-210993	Tie2 Signaling	0.207945863825897	-1.57047750322475	18	2	0.00411522633744856	486	10287	2886,2888	GRB7,GRB14
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.207945863825897	-1.57047750322475	18	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-69615	G1/S DNA Damage Checkpoints	0.209081982631413	-1.56502884253739	67	5	0.0102880658436214	486	10287	8900,25946,5698,5721,5699	CCNA1,ZNF385A,PSMB9,PSME2,PSMB10
R-HSA-73887	Death Receptor Signalling	0.209783272281346	-1.56168031793679	50	4	0.00823045267489712	486	10287	1540,7128,7185,330	CYLD,TNFAIP3,TRAF1,BIRC3
R-HSA-1236974	ER-Phagosome pathway	0.212840724466164	-1.54721116545332	85	6	0.0123456790123457	486	10287	7097,6890,5698,6891,5721,5699	TLR2,TAP1,PSMB9,TAP2,PSME2,PSMB10
R-HSA-3781865	Diseases of glycosylation	0.212840724466164	-1.54721116545332	85	6	0.0123456790123457	486	10287	6385,4586,375790,9507,10071,56999	SDC4,MUC5AC,AGRN,ADAMTS4,MUC12,ADAMTS9
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	5366	PMAIP1
R-HSA-426048	Arachidonate production from DAG	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	11343	MGLL
R-HSA-3000471	Scavenging by Class B Receptors	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	6288	SAA1
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	2886	GRB7
R-HSA-2161517	Abacavir transmembrane transport	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	6580	SLC22A1
R-HSA-112307	Transmission across Electrical Synapses	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	56666	PANX2
R-HSA-68911	G2 Phase	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	8900	CCNA1
R-HSA-187024	NGF-independant TRKA activation	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	135	ADORA2A
R-HSA-112303	Electric Transmission Across Gap Junctions	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	56666	PANX2
R-HSA-8875513	MET interacts with TNS proteins	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	4233	MET
R-HSA-8865999	MET activates PTPN11	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	4233	MET
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	857	CAV1
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	64849	SLC13A3
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	3159	HMGA1
R-HSA-1614517	Sulfide oxidation to sulfate	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	58472	SQOR
R-HSA-209931	Serotonin and melatonin biosynthesis	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	1644	DDC
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	4121	MAN1A1
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	2152	F3
R-HSA-1169092	Activation of RAS in B cells	0.214968097626321	-1.53726564499773	5	1	0.00205761316872428	486	10287	10125	RASGRP1
R-HSA-3928663	EPHA-mediated growth cone collapse	0.215519731439652	-1.53470281242493	34	3	0.00617283950617284	486	10287	4629,4067,6461	MYH11,LYN,SHB
R-HSA-373755	Semaphorin interactions	0.2176479687412	-1.52487634371197	68	5	0.0102880658436214	486	10287	27289,80031,4233,4629,5880	RND1,SEMA6D,MET,MYH11,RAC2
R-HSA-397795	G-protein beta:gamma signalling	0.219837500452583	-1.51486663986094	51	4	0.00823045267489712	486	10287	3561,8503,1437,3559	IL2RG,PIK3R3,CSF2,IL2RA
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.225604409525447	-1.48897221378043	19	2	0.00411522633744856	486	10287	6385,375790	SDC4,AGRN
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.225604409525447	-1.48897221378043	19	2	0.00411522633744856	486	10287	375790,6385	AGRN,SDC4
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.225604409525447	-1.48897221378043	19	2	0.00411522633744856	486	10287	6385,375790	SDC4,AGRN
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.225604409525447	-1.48897221378043	19	2	0.00411522633744856	486	10287	6580,6534	SLC22A1,SLC6A7
R-HSA-933541	TRAF6 mediated IRF7 activation	0.22810546545875	-1.47794718917767	35	3	0.00617283950617284	486	10287	23586,64135,3659	DDX58,IFIH1,IRF1
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.230017087242753	-1.46960168045869	52	4	0.00823045267489712	486	10287	595,5699,5721,5698	CCND1,PSMB10,PSME2,PSMB9
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.230017087242753	-1.46960168045869	52	4	0.00823045267489712	486	10287	5721,595,5699,5698	PSME2,CCND1,PSMB10,PSMB9
R-HSA-201681	TCF dependent signaling in response to WNT	0.235557154210858	-1.44580170193112	238	14	0.0288065843621399	486	10287	6658,5721,84870,5699,51176,83595,8313,64321,284654,723790,857,5698,7474,27121	SOX3,PSME2,RSPO3,PSMB10,LEF1,SOX7,AXIN2,SOX17,RSPO1,HIST2H2AA4,CAV1,PSMB9,WNT5A,DKK4
R-HSA-6806003	Regulation of TP53 Expression and Degradation	0.240825086305614	-1.4236843919637	36	3	0.00617283950617284	486	10287	639,6446,8900	PRDM1,SGK1,CCNA1
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.243365376792325	-1.41319135672967	20	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.243365376792325	-1.41319135672967	20	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.243365376792325	-1.41319135672967	20	2	0.00411522633744856	486	10287	857,11343	CAV1,MGLL
R-HSA-190241	FGFR2 ligand binding and activation	0.243365376792325	-1.41319135672967	20	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-5654720	PI-3K cascade:FGFR4	0.243365376792325	-1.41319135672967	20	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-3000170	Syndecan interactions	0.243365376792325	-1.41319135672967	20	2	0.00411522633744856	486	10287	2247,6385	FGF2,SDC4
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.243961173161468	-1.41074619273831	71	5	0.0102880658436214	486	10287	5698,8900,5699,595,5721	PSMB9,CCNA1,PSMB10,CCND1,PSME2
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	27121	DKK4
R-HSA-205025	NADE modulates death signalling	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-8849470	PTK6 Regulates Cell Cycle	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	595	CCND1
R-HSA-193144	Estrogen biosynthesis	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	441282	AKR1B15
R-HSA-5676934	Protein repair	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	7295	TXN
R-HSA-189483	Heme degradation	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	3162	HMOX1
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	242	ALOX12B
R-HSA-388479	Vasopressin-like receptors	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	5021	OXTR
R-HSA-428808	Na+-dependent glucose transporters	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	6523	SLC5A1
R-HSA-8851907	MET activates PI3K/AKT signaling	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	4233	MET
R-HSA-5690714	CD22 mediated BCR regulation	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	4067	LYN
R-HSA-190370	FGFR1b ligand binding and activation	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	2247	FGF2
R-HSA-8857538	PTK6 promotes HIF1A stabilization	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	1839	HBEGF
R-HSA-3000484	Scavenging by Class F Receptors	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	8578	SCARF1
R-HSA-6806942	MET Receptor Activation	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	4233	MET
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.252074254459363	-1.37803157432158	6	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-69202	Cyclin E associated events during G1/S transition	0.252915080071732	-1.37470149848871	72	5	0.0102880658436214	486	10287	8900,5698,5721,595,5699	CCNA1,PSMB9,PSME2,CCND1,PSMB10
R-HSA-198203	PI3K/AKT activation	0.258397483929896	-1.3532562442345	128	8	0.0164609053497942	486	10287	1839,4803,941,26281,4233,2247,2069,8503	HBEGF,NGF,CD80,FGF20,MET,FGF2,EREG,PIK3R3
R-HSA-2024096	HS-GAG degradation	0.261179789110854	-1.34254626163773	21	2	0.00411522633744856	486	10287	6385,375790	SDC4,AGRN
R-HSA-5654689	PI-3K cascade:FGFR1	0.261179789110854	-1.34254626163773	21	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.261179789110854	-1.34254626163773	21	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.261199859344847	-1.342469420076	55	4	0.00823045267489712	486	10287	2181,2182,51703,79993	ACSL3,ACSL4,ACSL5,ELOVL7
R-HSA-373080	Class B/2 (Secretin family receptors)	0.26783300702683	-1.31739160079266	92	6	0.0123456790123457	486	10287	2642,11211,1604,9340,90226,7474	GCGR,FZD10,CD55,GLP2R,UCN2,WNT5A
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.26783300702683	-1.31739160079266	92	6	0.0123456790123457	486	10287	5329,154064,8875,5277,27076,8876	PLAUR,RAET1L,VNN2,PIGA,LYPD3,VNN1
R-HSA-4641257	Degradation of AXIN	0.27177327077811	-1.30278712360899	56	4	0.00823045267489712	486	10287	5721,5699,8313,5698	PSME2,PSMB10,AXIN2,PSMB9
R-HSA-157118	Signaling by NOTCH	0.278189472245746	-1.27945284260371	112	7	0.01440329218107	486	10287	92737,3725,595,113878,54567,6484,10046	DNER,JUN,CCND1,DTX2,DLL4,ST3GAL4,MAMLD1
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.278782230466873	-1.2773243378986	131	8	0.0164609053497942	486	10287	4233,26281,2069,8503,2247,4067,1839,941	MET,FGF20,EREG,PIK3R3,FGF2,LYN,HBEGF,CD80
R-HSA-5655332	Signaling by FGFR3 in disease	0.279003051364015	-1.27653256043199	22	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-389513	CTLA4 inhibitory signaling	0.279003051364015	-1.27653256043199	22	2	0.00411522633744856	486	10287	4067,941	LYN,CD80
R-HSA-4641263	Regulation of FZD by ubiquitination	0.279003051364015	-1.27653256043199	22	2	0.00411522633744856	486	10287	284654,84870	RSPO1,RSPO3
R-HSA-202131	Metabolism of nitric oxide	0.279003051364015	-1.27653256043199	22	2	0.00411522633744856	486	10287	2643,857	GCH1,CAV1
R-HSA-203765	eNOS activation and regulation	0.279003051364015	-1.27653256043199	22	2	0.00411522633744856	486	10287	2643,857	GCH1,CAV1
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.279003051364015	-1.27653256043199	22	2	0.00411522633744856	486	10287	3053,5270	SERPIND1,SERPINE2
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.279003051364015	-1.27653256043199	22	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.279003051364015	-1.27653256043199	22	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.279003051364015	-1.27653256043199	22	2	0.00411522633744856	486	10287	1839,2069	HBEGF,EREG
R-HSA-164843	2-LTR circle formation	0.287429950632434	-1.24677609840635	7	1	0.00205761316872428	486	10287	3159	HMGA1
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	0.287429950632434	-1.24677609840635	7	1	0.00205761316872428	486	10287	64078	SLC28A3
R-HSA-162791	Attachment of GPI anchor to uPAR	0.287429950632434	-1.24677609840635	7	1	0.00205761316872428	486	10287	5329	PLAUR
R-HSA-447043	Neurofascin interactions	0.287429950632434	-1.24677609840635	7	1	0.00205761316872428	486	10287	286	ANK1
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.287429950632434	-1.24677609840635	7	1	0.00205761316872428	486	10287	54567	DLL4
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.287429950632434	-1.24677609840635	7	1	0.00205761316872428	486	10287	54567	DLL4
R-HSA-5652084	Fructose metabolism	0.287429950632434	-1.24677609840635	7	1	0.00205761316872428	486	10287	231	AKR1B1
R-HSA-190371	FGFR3b ligand binding and activation	0.287429950632434	-1.24677609840635	7	1	0.00205761316872428	486	10287	26281	FGF20
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.287429950632434	-1.24677609840635	7	1	0.00205761316872428	486	10287	5818	NECTIN1
R-HSA-429593	Inositol transporters	0.287429950632434	-1.24677609840635	7	1	0.00205761316872428	486	10287	6523	SLC5A1
R-HSA-556833	Metabolism of lipids and lipoproteins	0.291863550108165	-1.23146888007991	813	42	0.0864197530864197	486	10287	26230,441282,9420,2182,231,25816,5743,2181,79993,9388,2710,130367,119548,9536,1646,242,50486,3638,1586,8503,29923,84879,51365,857,9023,80736,660,8714,4023,6716,85441,80168,4363,247,27242,3290,11343,9108,7296,1645,1581,51703	TIAM2,AKR1B15,CYP7B1,ACSL4,AKR1B1,TNFAIP8,PTGS2,ACSL3,ELOVL7,LIPG,GK,SGPP2,PNLIPRP3,PTGES,AKR1C2,ALOX12B,G0S2,INSIG1,CYP17A1,PIK3R3,HILPDA,MFSD2A,PLA1A,CAV1,CH25H,SLC44A4,BMX,ABCC3,LPL,SRD5A2,HELZ2,MOGAT2,ABCC1,ALOX15B,TNFRSF21,HSD11B1,MGLL,MTMR7,TXNRD1,AKR1C1,CYP7A1,ACSL5
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.292647408882148	-1.22878677726617	40	3	0.00617283950617284	486	10287	64078,28231,28232	SLC28A3,SLCO4A1,SLCO3A1
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	0.293126403090635	-1.2271513531299	58	4	0.00823045267489712	486	10287	2903,9378,9369,9456	GRIN2A,NRXN1,NRXN3,HOMER1
R-HSA-109581	Apoptosis	0.295400946262068	-1.21942170556545	172	10	0.0205761316872428	486	10287	5366,27113,5698,5317,637,8626,3008,660,5699,5721	PMAIP1,BBC3,PSMB9,PKP1,BID,TP63,HIST1H1E,BMX,PSMB10,PSME2
R-HSA-5654695	PI-3K cascade:FGFR2	0.296794646568575	-1.21471480501946	23	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.296794646568575	-1.21471480501946	23	2	0.00411522633744856	486	10287	24,64220	ABCA4,STRA6
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.296794646568575	-1.21471480501946	23	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.296794646568575	-1.21471480501946	23	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-8863678	Neurodegenerative Diseases	0.296794646568575	-1.21471480501946	23	2	0.00411522633744856	486	10287	3725,6648	JUN,SOD2
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	0.296794646568575	-1.21471480501946	23	2	0.00411522633744856	486	10287	3725,6648	JUN,SOD2
R-HSA-4086400	PCP/CE pathway	0.300724143998497	-1.20156189956545	96	6	0.0123456790123457	486	10287	5698,23002,5880,5699,7474,5721	PSMB9,DAAM1,RAC2,PSMB10,WNT5A,PSME2
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.303885934283174	-1.19110286416089	59	4	0.00823045267489712	486	10287	4586,9507,10071,56999	MUC5AC,ADAMTS4,MUC12,ADAMTS9
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.314517851343331	-1.15671444342441	24	2	0.00411522633744856	486	10287	6616,6506	SNAP25,SLC1A2
R-HSA-201451	Signaling by BMP	0.314517851343331	-1.15671444342441	24	2	0.00411522633744856	486	10287	650,658	BMP2,BMPR1B
R-HSA-202424	Downstream TCR signaling	0.317449914254943	-1.14743522347142	98	6	0.0123456790123457	486	10287	8767,5699,4792,5721,4790,5698	RIPK2,PSMB10,NFKBIA,PSME2,NFKB1,PSMB9
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.317470014499039	-1.14737190763208	79	5	0.0102880658436214	486	10287	3159,3008,8900,723790,8091	HMGA1,HIST1H1E,CCNA1,HIST2H2AA4,HMGA2
R-HSA-1566948	Elastic fibre formation	0.318867378573454	-1.14298000379065	42	3	0.00617283950617284	486	10287	10516,650,27302	FBLN5,BMP2,BMP10
R-HSA-448424	Interleukin-17 signaling	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	27189	IL17C
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	57089	ENTPD7
R-HSA-174430	Telomere C-strand synthesis initiation	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-68952	DNA replication initiation	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-5576890	Phase 3 - rapid repolarisation	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	23630	KCNE5
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	4688	NCF2
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	6513	SLC2A1
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	11343	MGLL
R-HSA-164944	Nef and signal transduction	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	3055	HCK
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	6288	SAA1
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.321117600815767	-1.13594786526319	8	1	0.00205761316872428	486	10287	9945	GFPT2
R-HSA-422356	Regulation of insulin secretion	0.326882170303564	-1.11815550848441	80	5	0.0102880658436214	486	10287	3710,150,6513,4082,6616	ITPR3,ADRA2A,SLC2A1,MARCKS,SNAP25
R-HSA-202403	TCR signaling	0.331331496316452	-1.10463590532559	119	7	0.01440329218107	486	10287	4790,5698,3937,4792,5721,5699,8767	NFKB1,PSMB9,LCP2,NFKBIA,PSME2,PSMB10,RIPK2
R-HSA-375280	Amine ligand-binding receptors	0.331995187948482	-1.10263480430177	43	3	0.00617283950617284	486	10287	147,150,134864	ADRA1B,ADRA2A,TAAR1
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.331995187948482	-1.10263480430177	43	3	0.00617283950617284	486	10287	2495,6288,8578	FTH1,SAA1,SCARF1
R-HSA-211981	Xenobiotics	0.332139469182679	-1.10220031037823	25	2	0.00411522633744856	486	10287	1577,1551	CYP3A5,CYP3A7
R-HSA-425410	Metal ion SLC transporters	0.332139469182679	-1.10220031037823	25	2	0.00411522633744856	486	10287	84102,64116	SLC41A2,SLC39A8
R-HSA-5654708	Downstream signaling of activated FGFR3	0.332139469182679	-1.10220031037823	25	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.332139469182679	-1.10220031037823	25	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-3000157	Laminin interactions	0.332139469182679	-1.10220031037823	25	2	0.00411522633744856	486	10287	3918,3914	LAMC2,LAMB3
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.332139469182679	-1.10220031037823	25	2	0.00411522633744856	486	10287	6891,6890	TAP2,TAP1
R-HSA-1614635	Sulfur amino acid metabolism	0.332139469182679	-1.10220031037823	25	2	0.00411522633744856	486	10287	58472,2730	SQOR,GCLM
R-HSA-1251985	Nuclear signaling by ERBB4	0.332139469182679	-1.10220031037823	25	2	0.00411522633744856	486	10287	2069,1839	EREG,HBEGF
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.332139469182679	-1.10220031037823	25	2	0.00411522633744856	486	10287	7296,7295	TXNRD1,TXN
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.336379672832291	-1.08951477829676	62	4	0.00823045267489712	486	10287	5698,1080,5699,5721	PSMB9,CFTR,PSMB10,PSME2
R-HSA-69239	Synthesis of DNA	0.342786541827182	-1.0706473525765	101	6	0.0123456790123457	486	10287	5699,5721,8900,23649,64785,5698	PSMB10,PSME2,CCNA1,POLA2,GINS3,PSMB9
R-HSA-73848	Pyrimidine metabolism	0.349629580273548	-1.05088102701369	26	2	0.00411522633744856	486	10287	1890,51733	TYMP,UPB1
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.349629580273548	-1.05088102701369	26	2	0.00411522633744856	486	10287	6385,375790	SDC4,AGRN
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.349629580273548	-1.05088102701369	26	2	0.00411522633744856	486	10287	375790,6385	AGRN,SDC4
R-HSA-428543	Inactivation of Cdc42 and Rac	0.3532157471384	-1.04067622704912	9	1	0.00205761316872428	486	10287	9353	SLIT2
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.3532157471384	-1.04067622704912	9	1	0.00205761316872428	486	10287	9353	SLIT2
R-HSA-1614558	Degradation of cysteine and homocysteine	0.3532157471384	-1.04067622704912	9	1	0.00205761316872428	486	10287	58472	SQOR
R-HSA-193697	p75NTR regulates axonogenesis	0.3532157471384	-1.04067622704912	9	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-447041	CHL1 interactions	0.3532157471384	-1.04067622704912	9	1	0.00205761316872428	486	10287	286	ANK1
R-HSA-112411	MAPK1 (ERK2) activation	0.3532157471384	-1.04067622704912	9	1	0.00205761316872428	486	10287	3569	IL6
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.3532157471384	-1.04067622704912	9	1	0.00205761316872428	486	10287	81894	SLC25A28
R-HSA-2474795	Diseases associated with visual transduction	0.3532157471384	-1.04067622704912	9	1	0.00205761316872428	486	10287	64220	STRA6
R-HSA-162592	Integration of provirus	0.3532157471384	-1.04067622704912	9	1	0.00205761316872428	486	10287	3159	HMGA1
R-HSA-2453864	Retinoid cycle disease events	0.3532157471384	-1.04067622704912	9	1	0.00205761316872428	486	10287	64220	STRA6
R-HSA-77387	Insulin receptor recycling	0.366961307079777	-1.00249886678607	27	2	0.00411522633744856	486	10287	50617,245973	ATP6V0A4,ATP6V1C2
R-HSA-5654716	Downstream signaling of activated FGFR4	0.366961307079777	-1.00249886678607	27	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-1257604	PIP3 activates AKT signaling	0.377975991849794	-0.972924599004508	125	7	0.01440329218107	486	10287	4233,1839,26281,2069,8503,941,2247	MET,HBEGF,FGF20,EREG,PIK3R3,CD80,FGF2
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.383743575009164	-0.95778072286802	86	5	0.0102880658436214	486	10287	3710,4067,2268,3055,644150	ITPR3,LYN,FGR,HCK,WIPF3
R-HSA-2161522	Abacavir transport and metabolism	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	6580	SLC22A1
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	9108	MTMR7
R-HSA-168799	Neurotoxicity of clostridium toxins	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	6616	SNAP25
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	6580	SLC22A1
R-HSA-427601	Multifunctional anion exchangers	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	115019	SLC26A9
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	117283	IP6K3
R-HSA-193692	Regulated proteolysis of p75NTR	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	4790	NFKB1
R-HSA-1300644	Interaction With The Zona Pellucida	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	7784	ZP3
R-HSA-196108	Pregnenolone biosynthesis	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	231	AKR1B1
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	3725	JUN
R-HSA-74259	Purine catabolism	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	7498	XDH
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	64116	SLC39A8
R-HSA-110056	MAPK3 (ERK1) activation	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	3569	IL6
R-HSA-8875656	MET receptor recycling	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	4233	MET
R-HSA-399997	Acetylcholine regulates insulin secretion	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	4082	MARCKS
R-HSA-418886	Netrin mediated repulsion signals	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	137970	UNC5D
R-HSA-190377	FGFR2b ligand binding and activation	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	2247	FGF2
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.383799240709128	-0.957635673760864	10	1	0.00205761316872428	486	10287	3656	IRAK2
R-HSA-1483191	Synthesis of PC	0.384110594652799	-0.956824760952108	28	2	0.00411522633744856	486	10287	80736,84879	SLC44A4,MFSD2A
R-HSA-8948216	Collagen chain trimerization	0.384276509106367	-0.956392909726768	47	3	0.00617283950617284	486	10287	169044,1305,1294	COL22A1,COL13A1,COL7A1
R-HSA-4608870	Asymmetric localization of PCP proteins	0.39070932286397	-0.939791415255536	67	4	0.00823045267489712	486	10287	5698,7474,5721,5699	PSMB9,WNT5A,PSME2,PSMB10
R-HSA-1266738	Developmental Biology	0.39088966028335	-0.939329957586146	1075	53	0.109053497942387	486	10287	5266,2668,3854,1847,10125,26281,6092,2069,3849,4067,27289,1839,9353,4629,688,5699,1437,1000,1848,6461,4211,85441,4023,2903,80031,4233,5698,1850,55203,214,3559,5880,3561,5317,3725,1844,2886,8828,2048,137970,286,3855,8503,723790,2247,375790,9119,4318,5721,3868,2312,6708,4790	PI3,GDNF,KRT6B,DUSP5,RASGRP1,FGF20,ROBO2,EREG,KRT2,LYN,RND1,HBEGF,SLIT2,MYH11,KLF5,PSMB10,CSF2,CDH2,DUSP6,SHB,MEIS1,HELZ2,LPL,GRIN2A,SEMA6D,MET,PSMB9,DUSP8,LGI2,ALCAM,IL2RA,RAC2,IL2RG,PKP1,JUN,DUSP2,GRB7,NRP2,EPHB2,UNC5D,ANK1,KRT7,PIK3R3,HIST2H2AA4,FGF2,AGRN,KRT75,MMP9,PSME2,KRT16,FLG,SPTA1,NFKB1
R-HSA-418597	G alpha (z) signalling events	0.397221970532287	-0.923260034815462	48	3	0.00617283950617284	486	10287	5999,26575,150	RGS4,RGS17,ADRA2A
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.397221970532287	-0.923260034815462	48	3	0.00617283950617284	486	10287	56938,85441,10135	ARNTL2,HELZ2,NAMPT
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.397221970532287	-0.923260034815462	48	3	0.00617283950617284	486	10287	2048,4067,4318	EPHB2,LYN,MMP9
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.401056004860415	-0.913654198433983	29	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-180292	GAB1 signalosome	0.40143804373083	-0.912702069505557	128	7	0.01440329218107	486	10287	8503,941,2069,2247,4233,1839,26281	PIK3R3,CD80,EREG,FGF2,MET,HBEGF,FGF20
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.401525657506153	-0.912483843512187	68	4	0.00823045267489712	486	10287	4790,4791,6288,4792	NFKB1,NFKB2,SAA1,NFKBIA
R-HSA-3858494	Beta-catenin independent WNT signaling	0.40725571173603	-0.898314006463822	149	8	0.0164609053497942	486	10287	5698,51176,23002,7474,3710,5699,5880,5721	PSMB9,LEF1,DAAM1,WNT5A,ITPR3,PSMB10,RAC2,PSME2
R-HSA-69306	DNA Replication	0.410975998365037	-0.889220464329737	109	6	0.0123456790123457	486	10287	5721,5699,5698,64785,8900,23649	PSME2,PSMB10,PSMB9,GINS3,CCNA1,POLA2
R-HSA-5619084	ABC transporter disorders	0.412307486552753	-0.885985881411453	69	4	0.00823045267489712	486	10287	5698,1080,5699,5721	PSMB9,CFTR,PSMB10,PSME2
R-HSA-71288	Creatine metabolism	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	6534	SLC6A7
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	7097	TLR2
R-HSA-73614	Pyrimidine salvage reactions	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	1890	TYMP
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	7097	TLR2
R-HSA-5660526	Response to metal ions	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	4504	MT3
R-HSA-1980148	Signaling by NOTCH3	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	54567	DLL4
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	5317	PKP1
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	259307	IL4I1
R-HSA-1980150	Signaling by NOTCH4	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	54567	DLL4
R-HSA-8851805	MET activates RAS signaling	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	4233	MET
R-HSA-8875555	MET activates RAP1 and RAC1	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	4233	MET
R-HSA-1059683	Interleukin-6 signaling	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	3569	IL6
R-HSA-5661231	Metallothioneins bind metals	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	4504	MT3
R-HSA-549127	Organic cation transport	0.412939414789146	-0.884454392207726	11	1	0.00205761316872428	486	10287	6580	SLC22A1
R-HSA-69242	S Phase	0.417073309499343	-0.874493270478026	130	7	0.01440329218107	486	10287	23649,8900,64785,5698,595,5699,5721	POLA2,CCNA1,GINS3,PSMB9,CCND1,PSMB10,PSME2
R-HSA-5654696	Downstream signaling of activated FGFR2	0.417778523665041	-0.872803834567561	30	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-917977	Transferrin endocytosis and recycling	0.417778523665041	-0.872803834567561	30	2	0.00411522633744856	486	10287	245973,50617	ATP6V1C2,ATP6V0A4
R-HSA-5683826	Surfactant metabolism	0.417778523665041	-0.872803834567561	30	2	0.00411522633744856	486	10287	150,135	ADRA2A,ADORA2A
R-HSA-420092	Glucagon-type ligand receptors	0.417778523665041	-0.872803834567561	30	2	0.00411522633744856	486	10287	9340,2642	GLP2R,GCGR
R-HSA-8863795	Downregulation of ERBB2 signaling	0.417778523665041	-0.872803834567561	30	2	0.00411522633744856	486	10287	2069,1839	EREG,HBEGF
R-HSA-445095	Interaction between L1 and Ankyrins	0.417778523665041	-0.872803834567561	30	2	0.00411522633744856	486	10287	6708,286	SPTA1,ANK1
R-HSA-195721	Signaling by Wnt	0.420911169625232	-0.865333466077963	336	17	0.0349794238683128	486	10287	5699,3710,64321,8313,83595,284654,84870,5721,5880,6658,7474,27121,23002,51176,857,723790,5698	PSMB10,ITPR3,SOX17,AXIN2,SOX7,RSPO1,RSPO3,PSME2,RAC2,SOX3,WNT5A,DKK4,DAAM1,LEF1,CAV1,HIST2H2AA4,PSMB9
R-HSA-5654736	Signaling by FGFR1	0.422878787341732	-0.860669695748195	50	3	0.00617283950617284	486	10287	23767,2247,26281	FLRT3,FGF2,FGF20
R-HSA-71387	Metabolism of carbohydrates	0.42772500977775	-0.849274790411526	296	15	0.0308641975308642	486	10287	3036,375790,6484,50515,3038,6385,231,6513,1118,3099,6482,669,960,9435,6523	HAS1,AGRN,ST3GAL4,CHST11,HAS3,SDC4,AKR1B1,SLC2A1,CHIT1,HK2,ST3GAL1,BPGM,CD44,CHST2,SLC5A1
R-HSA-163685	Integration of energy metabolism	0.427987317686335	-0.848661715413347	111	6	0.0123456790123457	486	10287	6513,4082,6616,3710,2642,150	SLC2A1,MARCKS,SNAP25,ITPR3,GCGR,ADRA2A
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.434261380752739	-0.834108666368443	31	2	0.00411522633744856	486	10287	1848,3725	DUSP6,JUN
R-HSA-1839124	FGFR1 mutant receptor activation	0.434261380752739	-0.834108666368443	31	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-2022928	HS-GAG biosynthesis	0.434261380752739	-0.834108666368443	31	2	0.00411522633744856	486	10287	6385,375790	SDC4,AGRN
R-HSA-418990	Adherens junctions interactions	0.434261380752739	-0.834108666368443	31	2	0.00411522633744856	486	10287	5818,1000	NECTIN1,CDH2
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.434261380752739	-0.834108666368443	31	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-112310	Neurotransmitter Release Cycle	0.435568867774333	-0.831102360233308	51	3	0.00617283950617284	486	10287	6506,6616,6580	SLC1A2,SNAP25,SLC22A1
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.435568867774333	-0.831102360233308	51	3	0.00617283950617284	486	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-1227986	Signaling by ERBB2	0.435568867774333	-0.831102360233308	51	3	0.00617283950617284	486	10287	1839,2069,2886	HBEGF,EREG,GRB7
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.435568867774333	-0.831102360233308	51	3	0.00617283950617284	486	10287	50515,375790,6385	CHST11,AGRN,SDC4
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.435568867774333	-0.831102360233308	51	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	8626	TP63
R-HSA-1236977	Endosomal/Vacuolar pathway	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	1520	CTSS
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	8626	TP63
R-HSA-389359	CD28 dependent Vav1 pathway	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	941	CD80
R-HSA-4641265	Repression of WNT target genes	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	51176	LEF1
R-HSA-210990	PECAM1 interactions	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	4067	LYN
R-HSA-209822	Glycoprotein hormones	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	3624	INHBA
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	2643	GCH1
R-HSA-844456	The NLRP3 inflammasome	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	7295	TXN
R-HSA-1475029	Reversible hydration of carbon dioxide	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	771	CA12
R-HSA-176974	Unwinding of DNA	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	64785	GINS3
R-HSA-2160916	Hyaluronan uptake and degradation	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	960	CD44
R-HSA-203615	eNOS activation	0.440704249784939	-0.819381263920109	12	1	0.00205761316872428	486	10287	857	CAV1
R-HSA-68949	Orc1 removal from chromatin	0.444376141591056	-0.811083909446652	72	4	0.00823045267489712	486	10287	5699,5721,5698,8900	PSMB10,PSME2,PSMB9,CCNA1
R-HSA-6794362	Protein-protein interactions at synapses	0.444376141591056	-0.811083909446652	72	4	0.00823045267489712	486	10287	9369,2903,9378,9456	NRXN3,GRIN2A,NRXN1,HOMER1
R-HSA-69052	Switching of origins to a post-replicative state	0.444376141591056	-0.811083909446652	72	4	0.00823045267489712	486	10287	5721,5699,5698,8900	PSME2,PSMB10,PSMB9,CCNA1
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.448153670661962	-0.802619090512853	52	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.448153670661962	-0.802619090512853	52	3	0.00617283950617284	486	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-69190	DNA strand elongation	0.450489880701415	-0.797419664558026	32	2	0.00411522633744856	486	10287	23649,64785	POLA2,GINS3
R-HSA-376176	Signaling by Robo receptor	0.450489880701415	-0.797419664558026	32	2	0.00411522633744856	486	10287	9353,6092	SLIT2,ROBO2
R-HSA-1980143	Signaling by NOTCH1	0.454951612511042	-0.787564211815915	73	4	0.00823045267489712	486	10287	10046,113878,54567,92737	MAMLD1,DTX2,DLL4,DNER
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.454951612511042	-0.787564211815915	73	4	0.00823045267489712	486	10287	5698,8900,5721,5699	PSMB9,CCNA1,PSME2,PSMB10
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.460624220511321	-0.775172708281334	53	3	0.00617283950617284	486	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-180534	Vpu mediated degradation of CD4	0.460624220511321	-0.775172708281334	53	3	0.00617283950617284	486	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-75153	Apoptotic execution  phase	0.460624220511321	-0.775172708281334	53	3	0.00617283950617284	486	10287	3008,660,5317	HIST1H1E,BMX,PKP1
R-HSA-73923	Lipid digestion, mobilization, and transport	0.461755221756924	-0.772720351343179	115	6	0.0123456790123457	486	10287	4023,857,29923,119548,9388,11343	LPL,CAV1,HILPDA,PNLIPRP3,LIPG,MGLL
R-HSA-69300	Removal of licensing factors from origins	0.46545987184894	-0.764729390386973	74	4	0.00823045267489712	486	10287	5721,5699,5698,8900	PSME2,PSMB10,PSMB9,CCNA1
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.46545987184894	-0.764729390386973	74	4	0.00823045267489712	486	10287	5699,5721,5698,8900	PSMB10,PSME2,PSMB9,CCNA1
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.466451245070504	-0.762601776331213	33	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-4085001	Sialic acid metabolism	0.466451245070504	-0.762601776331213	33	2	0.00411522633744856	486	10287	6484,6482	ST3GAL4,ST3GAL1
R-HSA-1839126	FGFR2 mutant receptor activation	0.466451245070504	-0.762601776331213	33	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-1980145	Signaling by NOTCH2	0.466451245070504	-0.762601776331213	33	2	0.00411522633744856	486	10287	10046,54567	MAMLD1,DLL4
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	6288	SAA1
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	10046	MAMLD1
R-HSA-425561	Sodium/Calcium exchangers	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	6547	SLC8A3
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	51700	CYB5R2
R-HSA-350054	Notch-HLH transcription pathway	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	10046	MAMLD1
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	3710	ITPR3
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	7474	WNT5A
R-HSA-202670	ERKs are inactivated	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	1848	DUSP6
R-HSA-140342	Apoptosis induced DNA fragmentation	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	3008	HIST1H1E
R-HSA-74217	Purine salvage	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	272	AMPD3
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	2247	FGF2
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	51700	CYB5R2
R-HSA-432047	Passive transport by Aquaporins	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	366	AQP9
R-HSA-1502540	Signaling by Activin	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	3624	INHBA
R-HSA-211227	Activation of DNA fragmentation factor	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	3008	HIST1H1E
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	0.467158530512784	-0.761086613152573	13	1	0.00205761316872428	486	10287	2247	FGF2
R-HSA-2682334	EPH-Ephrin signaling	0.468288775016398	-0.758670132722458	95	5	0.0102880658436214	486	10287	6461,2048,4067,4318,4629	SHB,EPHB2,LYN,MMP9,MYH11
R-HSA-1430728	Metabolism	0.471134094855638	-0.752612523032189	2158	103	0.211934156378601	486	10287	27233,1890,272,874,27242,771,4504,5699,80736,7498,6716,4363,80168,1577,8714,3038,1645,6513,5698,51703,3036,2642,81894,6616,1551,3290,7296,8140,952,25816,231,5743,6534,960,669,6580,26230,9420,1644,150,3710,1591,6611,375790,84879,51365,1586,29923,119548,9536,5721,9435,130367,1646,54625,6385,58472,247,6484,660,51733,6523,6303,9023,4023,85441,117283,1118,8942,1581,50515,6999,6482,259307,11343,10135,3620,54498,9108,2181,441024,57089,79993,51700,441282,2182,8876,4082,3638,1594,8564,857,8503,2730,2643,9388,2710,8875,3099,3162,7295,242,50486	SULT1C4,TYMP,AMPD3,CBR3,TNFRSF21,CA12,MT3,PSMB10,SLC44A4,XDH,SRD5A2,ABCC1,MOGAT2,CYP3A5,ABCC3,HAS3,AKR1C1,SLC2A1,PSMB9,ACSL5,HAS1,GCGR,SLC25A28,SNAP25,CYP3A7,HSD11B1,TXNRD1,SLC7A5,CD38,TNFAIP8,AKR1B1,PTGS2,SLC6A7,CD44,BPGM,SLC22A1,TIAM2,CYP7B1,DDC,ADRA2A,ITPR3,CYP24A1,SMS,AGRN,MFSD2A,PLA1A,CYP17A1,HILPDA,PNLIPRP3,PTGES,PSME2,CHST2,SGPP2,AKR1C2,PARP14,SDC4,SQOR,ALOX15B,ST3GAL4,BMX,UPB1,SLC5A1,SAT1,CH25H,LPL,HELZ2,IP6K3,CHIT1,KYNU,CYP7A1,CHST11,TDO2,ST3GAL1,IL4I1,MGLL,NAMPT,IDO1,SMOX,MTMR7,ACSL3,MTHFD2L,ENTPD7,ELOVL7,CYB5R2,AKR1B15,ACSL4,VNN1,MARCKS,INSIG1,CYP27B1,KMO,CAV1,PIK3R3,GCLM,GCH1,LIPG,GK,VNN2,HK2,HMOX1,TXN,ALOX12B,G0S2
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.472972175564637	-0.748718717665231	54	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-69610	p53-Independent DNA Damage Response	0.472972175564637	-0.748718717665231	54	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.472972175564637	-0.748718717665231	54	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-169911	Regulation of Apoptosis	0.472972175564637	-0.748718717665231	54	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-189200	Hexose transport	0.472972175564637	-0.748718717665231	54	3	0.00617283950617284	486	10287	6523,6513,3099	SLC5A1,SLC2A1,HK2
R-HSA-211859	Biological oxidations	0.479865362094999	-0.734249710061877	222	11	0.0226337448559671	486	10287	1551,54498,9420,1577,1591,1594,27233,874,2730,1581,1586	CYP3A7,SMOX,CYP7B1,CYP3A5,CYP24A1,CYP27B1,SULT1C4,CBR3,GCLM,CYP7A1,CYP17A1
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.482134464659504	-0.729532231514456	34	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-5694530	Cargo concentration in the ER	0.482134464659504	-0.729532231514456	34	2	0.00411522633744856	486	10287	374,1294	AREG,COL7A1
R-HSA-113510	E2F mediated regulation of DNA replication	0.482134464659504	-0.729532231514456	34	2	0.00411522633744856	486	10287	23649,8900	POLA2,CCNA1
R-HSA-73847	Purine metabolism	0.482134464659504	-0.729532231514456	34	2	0.00411522633744856	486	10287	272,7498	AMPD3,XDH
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.485189809199516	-0.72321510543142	55	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.48625237454619	-0.721027500675924	76	4	0.00823045267489712	486	10287	5698,8900,5699,5721	PSMB9,CCNA1,PSMB10,PSME2
R-HSA-5619115	Disorders of transmembrane transporters	0.48625237454619	-0.721027500675924	76	4	0.00823045267489712	486	10287	1080,5698,5721,5699	CFTR,PSMB9,PSME2,PSMB10
R-HSA-193704	p75 NTR receptor-mediated signalling	0.486649325515294	-0.720211486085537	97	5	0.0102880658436214	486	10287	8767,26230,4792,4790,4803	RIPK2,TIAM2,NFKBIA,NFKB1,NGF
R-HSA-177504	Retrograde neurotrophin signalling	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-5675482	Regulation of necroptotic cell death	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	330	BIRC3
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	1520	CTSS
R-HSA-209952	Peptide hormone biosynthesis	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	3624	INHBA
R-HSA-69091	Polymerase switching	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-69166	Removal of the Flap Intermediate	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-69109	Leading Strand Synthesis	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-428540	Activation of Rac	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	9353	SLIT2
R-HSA-877312	Regulation of IFNG signaling	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	3460	IFNGR2
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	8626	TP63
R-HSA-174403	Glutathione synthesis and recycling	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	2730	GCLM
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.49236399617221	-0.708537006410542	14	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-69206	G1/S Transition	0.495003684886741	-0.703190072225517	119	6	0.0123456790123457	486	10287	595,5699,5721,23649,8900,5698	CCND1,PSMB10,PSME2,POLA2,CCNA1,PSMB9
R-HSA-69304	Regulation of DNA replication	0.496526142540353	-0.700119143226765	77	4	0.00823045267489712	486	10287	5698,8900,5721,5699	PSMB9,CCNA1,PSME2,PSMB10
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.496526142540353	-0.700119143226765	77	4	0.00823045267489712	486	10287	5699,5721,8900,5698	PSMB10,PSME2,CCNA1,PSMB9
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.497269990613524	-0.69862215971623	56	3	0.00617283950617284	486	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	0.497269990613524	-0.69862215971623	56	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-5578775	Ion homeostasis	0.497269990613524	-0.69862215971623	56	3	0.00617283950617284	486	10287	6547,490,3710	SLC8A3,ATP2B1,ITPR3
R-HSA-69541	Stabilization of p53	0.497269990613524	-0.69862215971623	56	3	0.00617283950617284	486	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-6804757	Regulation of TP53 Degradation	0.497530161585587	-0.698099097918502	35	2	0.00411522633744856	486	10287	6446,8900	SGK1,CCNA1
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.497530161585587	-0.698099097918502	35	2	0.00411522633744856	486	10287	2986,5957	GUCY2F,RCVRN
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.509206165121092	-0.67490230490735	57	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-3000178	ECM proteoglycans	0.509206165121092	-0.67490230490735	57	3	0.00617283950617284	486	10287	375790,63923,3687	AGRN,TNN,ITGAX
R-HSA-2514856	The phototransduction cascade	0.51263046012726	-0.66820004401767	36	2	0.00411522633744856	486	10287	5957,2986	RCVRN,GUCY2F
R-HSA-167021	PLC-gamma1 signalling	0.51263046012726	-0.66820004401767	36	2	0.00411522633744856	486	10287	3710,4803	ITPR3,NGF
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.516379483171494	-0.660913351295647	15	1	0.00205761316872428	486	10287	637	BID
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	0.516379483171494	-0.660913351295647	15	1	0.00205761316872428	486	10287	4233	MET
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.516379483171494	-0.660913351295647	15	1	0.00205761316872428	486	10287	7474	WNT5A
R-HSA-975577	N-Glycan antennae elongation	0.516379483171494	-0.660913351295647	15	1	0.00205761316872428	486	10287	6484	ST3GAL4
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.516379483171494	-0.660913351295647	15	1	0.00205761316872428	486	10287	54567	DLL4
R-HSA-5682910	LGI-ADAM interactions	0.516379483171494	-0.660913351295647	15	1	0.00205761316872428	486	10287	55203	LGI2
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.516379483171494	-0.660913351295647	15	1	0.00205761316872428	486	10287	27289	RND1
R-HSA-69183	Processive synthesis on the lagging strand	0.516379483171494	-0.660913351295647	15	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.516379483171494	-0.660913351295647	15	1	0.00205761316872428	486	10287	54567	DLL4
R-HSA-205043	NRIF signals cell death from the nucleus	0.516379483171494	-0.660913351295647	15	1	0.00205761316872428	486	10287	4803	NGF
R-HSA-1483255	PI Metabolism	0.516804633790738	-0.660090360240594	79	4	0.00823045267489712	486	10287	8503,9108,25816,660	PIK3R3,MTMR7,TNFAIP8,BMX
R-HSA-453279	Mitotic G1-G1/S phases	0.516919914518671	-0.65986732069181	143	7	0.01440329218107	486	10287	1030,5698,23649,8900,5721,5699,595	CDKN2B,PSMB9,POLA2,CCNA1,PSME2,PSMB10,CCND1
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.520992333961717	-0.65201995142202	58	3	0.00617283950617284	486	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-373760	L1CAM interactions	0.522658776707538	-0.648826462438901	101	5	0.0102880658436214	486	10287	8828,2048,214,6708,286	NRP2,EPHB2,ALCAM,SPTA1,ANK1
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	0.527428866333248	-0.639741273278153	37	2	0.00411522633744856	486	10287	9507,56999	ADAMTS4,ADAMTS9
R-HSA-419037	NCAM1 interactions	0.527428866333248	-0.639741273278153	37	2	0.00411522633744856	486	10287	2668,375790	GDNF,AGRN
R-HSA-4641258	Degradation of DVL	0.532623033938107	-0.62994135843739	59	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-1989781	PPARA activates gene expression	0.535540857761272	-0.624478093664527	124	6	0.0123456790123457	486	10287	26230,27242,7296,85441,50486,1581	TIAM2,TNFRSF21,TXNRD1,HELZ2,G0S2,CYP7A1
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.536695500331495	-0.622324383789233	81	4	0.00823045267489712	486	10287	5699,5721,5698,8900	PSMB10,PSME2,PSMB9,CCNA1
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.536972819021201	-0.62180780210218	253	12	0.0246913580246914	486	10287	2181,1581,79993,27242,51703,2710,26230,50486,80168,2182,7296,85441	ACSL3,CYP7A1,ELOVL7,TNFRSF21,ACSL5,GK,TIAM2,G0S2,MOGAT2,ACSL4,TXNRD1,HELZ2
R-HSA-5218859	Regulated Necrosis	0.539261061356476	-0.617555481440216	16	1	0.00205761316872428	486	10287	330	BIRC3
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.539261061356476	-0.617555481440216	16	1	0.00205761316872428	486	10287	5277	PIGA
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.539261061356476	-0.617555481440216	16	1	0.00205761316872428	486	10287	330	BIRC3
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.539261061356476	-0.617555481440216	16	1	0.00205761316872428	486	10287	135	ADORA2A
R-HSA-549132	Organic cation/anion/zwitterion transport	0.539261061356476	-0.617555481440216	16	1	0.00205761316872428	486	10287	6580	SLC22A1
R-HSA-392517	Rap1 signalling	0.539261061356476	-0.617555481440216	16	1	0.00205761316872428	486	10287	10125	RASGRP1
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.539261061356476	-0.617555481440216	16	1	0.00205761316872428	486	10287	3656	IRAK2
R-HSA-1433559	Regulation of KIT signaling	0.539261061356476	-0.617555481440216	16	1	0.00205761316872428	486	10287	4067	LYN
R-HSA-159418	Recycling of bile acids and salts	0.539261061356476	-0.617555481440216	16	1	0.00205761316872428	486	10287	8714	ABCC3
R-HSA-71291	Metabolism of amino acids and derivatives	0.541795297651409	-0.612867028491344	361	17	0.0349794238683128	486	10287	6534,58472,5699,6303,1644,6611,8942,8564,5698,2730,259307,6999,5721,54498,3620,8140,7296	SLC6A7,SQOR,PSMB10,SAT1,DDC,SMS,KYNU,KMO,PSMB9,GCLM,IL4I1,TDO2,PSME2,SMOX,IDO1,SLC7A5,TXNRD1
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.541920155502436	-0.612636602965498	38	2	0.00411522633744856	486	10287	10125,150	RASGRP1,ADRA2A
R-HSA-5655302	Signaling by FGFR1 in disease	0.541920155502436	-0.612636602965498	38	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.544093316935116	-0.608634508353569	60	3	0.00617283950617284	486	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.544093316935116	-0.608634508353569	60	3	0.00617283950617284	486	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.546485739307097	-0.604247066295041	82	4	0.00823045267489712	486	10287	7295,7296,54541,8626	TXN,TXNRD1,DDIT4,TP63
R-HSA-2672351	Stimuli-sensing channels	0.548936755329631	-0.599772043872486	104	5	0.0102880658436214	486	10287	266675,8989,6446,6338,23327	BEST4,TRPA1,SGK1,SCNN1B,NEDD4L
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.555398729345272	-0.588068991931155	61	3	0.00617283950617284	486	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	0.555398729345272	-0.588068991931155	61	3	0.00617283950617284	486	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-4086398	Ca2+ pathway	0.555398729345272	-0.588068991931155	61	3	0.00617283950617284	486	10287	7474,3710,51176	WNT5A,ITPR3,LEF1
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.555398729345272	-0.588068991931155	61	3	0.00617283950617284	486	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.555398729345272	-0.588068991931155	61	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.556100267107164	-0.586806664466555	39	2	0.00411522633744856	486	10287	56999,9507	ADAMTS9,ADAMTS4
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.556100267107164	-0.586806664466555	39	2	0.00411522633744856	486	10287	2918,2914	GRM8,GRM4
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.556100267107164	-0.586806664466555	39	2	0.00411522633744856	486	10287	660,5317	BMX,PKP1
R-HSA-69231	Cyclin D associated events in G1	0.556100267107164	-0.586806664466555	39	2	0.00411522633744856	486	10287	1030,595	CDKN2B,CCND1
R-HSA-69236	G1 Phase	0.556100267107164	-0.586806664466555	39	2	0.00411522633744856	486	10287	1030,595	CDKN2B,CCND1
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.556100267107164	-0.586806664466555	39	2	0.00411522633744856	486	10287	3710,4067	ITPR3,LYN
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.556167789538875	-0.586685250511726	83	4	0.00823045267489712	486	10287	51176,5698,5721,5699	LEF1,PSMB9,PSME2,PSMB10
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.559192411100767	-0.581261659147529	127	6	0.0123456790123457	486	10287	26230,7296,85441,27242,1581,50486	TIAM2,TXNRD1,HELZ2,TNFRSF21,CYP7A1,G0S2
R-HSA-622312	Inflammasomes	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	7295	TXN
R-HSA-5627117	RHO GTPases Activate ROCKs	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	4629	MYH11
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	2903	GRIN2A
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	80852	GRIP2
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	3656	IRAK2
R-HSA-435354	Zinc transporters	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	64116	SLC39A8
R-HSA-5625900	RHO GTPases activate CIT	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	4629	MYH11
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	2903	GRIN2A
R-HSA-189445	Metabolism of porphyrins	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	3162	HMOX1
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	6616	SNAP25
R-HSA-432142	Platelet sensitization by LDL	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	2268	FGR
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.561062163910576	-0.577923570488556	17	1	0.00205761316872428	486	10287	3710	ITPR3
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	0.569966207019542	-0.56217820584165	40	2	0.00411522633744856	486	10287	163732,4435	CITED4,CITED1
R-HSA-5654741	Signaling by FGFR3	0.569966207019542	-0.56217820584165	40	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.577499477543069	-0.549047741273924	63	3	0.00617283950617284	486	10287	6482,6484,9945	ST3GAL1,ST3GAL4,GFPT2
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.581833710957369	-0.541570592080956	18	1	0.00205761316872428	486	10287	6616	SNAP25
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.581833710957369	-0.541570592080956	18	1	0.00205761316872428	486	10287	6484	ST3GAL4
R-HSA-1369062	ABC transporters in lipid homeostasis	0.581833710957369	-0.541570592080956	18	1	0.00205761316872428	486	10287	26154	ABCA12
R-HSA-196757	Metabolism of folate and pterines	0.581833710957369	-0.541570592080956	18	1	0.00205761316872428	486	10287	441024	MTHFD2L
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.581833710957369	-0.541570592080956	18	1	0.00205761316872428	486	10287	330	BIRC3
R-HSA-209776	Amine-derived hormones	0.581833710957369	-0.541570592080956	18	1	0.00205761316872428	486	10287	1644	DDC
R-HSA-69205	G1/S-Specific Transcription	0.581833710957369	-0.541570592080956	18	1	0.00205761316872428	486	10287	8900	CCNA1
R-HSA-5654743	Signaling by FGFR4	0.583515956039712	-0.538683482231441	41	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-69002	DNA Replication Pre-Initiation	0.584533725829553	-0.536940799427422	86	4	0.00823045267489712	486	10287	23649,5698,5699,5721	POLA2,PSMB9,PSMB10,PSME2
R-HSA-68874	M/G1 Transition	0.584533725829553	-0.536940799427422	86	4	0.00823045267489712	486	10287	23649,5698,5699,5721	POLA2,PSMB9,PSMB10,PSME2
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.588288194798816	-0.530538323947747	64	3	0.00617283950617284	486	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-453276	Regulation of mitotic cell cycle	0.593753136056573	-0.521291641867744	87	4	0.00823045267489712	486	10287	8900,5698,5699,5721	CCNA1,PSMB9,PSMB10,PSME2
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.593753136056573	-0.521291641867744	87	4	0.00823045267489712	486	10287	5721,5699,8900,5698	PSME2,PSMB10,CCNA1,PSMB9
R-HSA-373752	Netrin-1 signaling	0.596748384919808	-0.516259720227174	42	2	0.00411522633744856	486	10287	9353,137970	SLIT2,UNC5D
R-HSA-3928662	EPHB-mediated forward signaling	0.596748384919808	-0.516259720227174	42	2	0.00411522633744856	486	10287	2048,4067	EPHB2,LYN
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.597239185234116	-0.51543760054315	373	17	0.0349794238683128	486	10287	92369,1520,6891,23327,6890,5699,4688,127544,84676,5698,55008,7097,255488,221687,55521,5721,10517	SPSB4,CTSS,TAP2,NEDD4L,TAP1,PSMB10,NCF2,RNF19B,TRIM63,PSMB9,HERC6,TLR2,RNF144B,RNF182,TRIM36,PSME2,FBXW10
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	0.601624227701728	-0.508122235046822	19	1	0.00205761316872428	486	10287	25946	ZNF385A
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.601624227701728	-0.508122235046822	19	1	0.00205761316872428	486	10287	6616	SNAP25
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.601624227701728	-0.508122235046822	19	1	0.00205761316872428	486	10287	2247	FGF2
R-HSA-416700	Other semaphorin interactions	0.601624227701728	-0.508122235046822	19	1	0.00205761316872428	486	10287	80031	SEMA6D
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.601624227701728	-0.508122235046822	19	1	0.00205761316872428	486	10287	2903	GRIN2A
R-HSA-190861	Gap junction assembly	0.601624227701728	-0.508122235046822	19	1	0.00205761316872428	486	10287	2706	GJB2
R-HSA-3928664	Ephrin signaling	0.601624227701728	-0.508122235046822	19	1	0.00205761316872428	486	10287	2048	EPHB2
R-HSA-156584	Cytosolic sulfonation of small molecules	0.601624227701728	-0.508122235046822	19	1	0.00205761316872428	486	10287	27233	SULT1C4
R-HSA-416482	G alpha (12/13) signalling events	0.602850589228135	-0.506085892015074	88	4	0.00823045267489712	486	10287	5880,26230,147,8503	RAC2,TIAM2,ADRA1B,PIK3R3
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.602850589228135	-0.506085892015074	88	4	0.00823045267489712	486	10287	688,85441,4023,4790	KLF5,HELZ2,LPL,NFKB1
R-HSA-446728	Cell junction organization	0.602850589228135	-0.506085892015074	88	4	0.00823045267489712	486	10287	5818,3914,3918,1000	NECTIN1,LAMB3,LAMC2,CDH2
R-HSA-5655253	Signaling by FGFR2 in disease	0.609663175008792	-0.494848646434679	43	2	0.00411522633744856	486	10287	2247,26281	FGF2,FGF20
R-HSA-1236394	Signaling by ERBB4	0.609663175008792	-0.494848646434679	43	2	0.00411522633744856	486	10287	2069,1839	EREG,HBEGF
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.619576693358362	-0.478718786772535	67	3	0.00617283950617284	486	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-5358346	Hedgehog ligand biogenesis	0.619576693358362	-0.478718786772535	67	3	0.00617283950617284	486	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-8848021	Signaling by PTK6	0.619576693358362	-0.478718786772535	67	3	0.00617283950617284	486	10287	2069,595,1839	EREG,CCND1,HBEGF
R-HSA-69186	Lagging Strand Synthesis	0.620479956716431	-0.477261976686055	20	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-8876384	Listeria monocytogenes entry into host cells	0.620479956716431	-0.477261976686055	20	1	0.00205761316872428	486	10287	4233	MET
R-HSA-5687128	MAPK6/MAPK4 signaling	0.620671547180374	-0.476953246503054	90	4	0.00823045267489712	486	10287	5698,5699,5721,3725	PSMB9,PSMB10,PSME2,JUN
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.629640587339524	-0.462606118677953	68	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-381119	Unfolded Protein Response (UPR)	0.637982518397702	-0.449444396643312	92	4	0.00823045267489712	486	10287	3484,3576,6347,467	IGFBP1,CXCL8,CCL2,ATF3
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.638444965088159	-0.448719801291562	21	1	0.00205761316872428	486	10287	4363	ABCC1
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.638444965088159	-0.448719801291562	21	1	0.00205761316872428	486	10287	50515	CHST11
R-HSA-5423646	Aflatoxin activation and detoxification	0.638444965088159	-0.448719801291562	21	1	0.00205761316872428	486	10287	1577	CYP3A5
R-HSA-6807004	Negative regulation of MET activity	0.638444965088159	-0.448719801291562	21	1	0.00205761316872428	486	10287	4233	MET
R-HSA-8849932	SALM protein interactions at the synapses	0.638444965088159	-0.448719801291562	21	1	0.00205761316872428	486	10287	2903	GRIN2A
R-HSA-3000480	Scavenging by Class A Receptors	0.638444965088159	-0.448719801291562	21	1	0.00205761316872428	486	10287	2495	FTH1
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.638444965088159	-0.448719801291562	21	1	0.00205761316872428	486	10287	54567	DLL4
R-HSA-2028269	Signaling by Hippo	0.638444965088159	-0.448719801291562	21	1	0.00205761316872428	486	10287	23286	WWC1
R-HSA-68867	Assembly of the pre-replicative complex	0.639519364633626	-0.447038377524705	69	3	0.00617283950617284	486	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-6806834	Signaling by MET	0.639519364633626	-0.447038377524705	69	3	0.00617283950617284	486	10287	3918,4233,3914	LAMC2,MET,LAMB3
R-HSA-70153	Glucose transport	0.646509172325224	-0.436167893206176	46	2	0.00411522633744856	486	10287	6513,3099	SLC2A1,HK2
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.646509172325224	-0.436167893206176	46	2	0.00411522633744856	486	10287	23327,1030	NEDD4L,CDKN2B
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.649212126455119	-0.431995764441724	70	3	0.00617283950617284	486	10287	1294,1305,169044	COL7A1,COL13A1,COL22A1
R-HSA-5658442	Regulation of RAS by GAPs	0.649212126455119	-0.431995764441724	70	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.655561246684279	-0.42226354507943	22	1	0.00205761316872428	486	10287	8900	CCNA1
R-HSA-1482801	Acyl chain remodelling of PS	0.655561246684279	-0.42226354507943	22	1	0.00205761316872428	486	10287	51365	PLA1A
R-HSA-198753	ERK/MAPK targets	0.655561246684279	-0.42226354507943	22	1	0.00205761316872428	486	10287	1848	DUSP6
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.655561246684279	-0.42226354507943	22	1	0.00205761316872428	486	10287	4363	ABCC1
R-HSA-400253	Circadian Clock	0.658718275452321	-0.417459338992386	71	3	0.00617283950617284	486	10287	10135,56938,85441	NAMPT,ARNTL2,HELZ2
R-HSA-6809371	Formation of the cornified envelope	0.658718275452321	-0.417459338992386	71	3	0.00617283950617284	486	10287	5266,5317,2312	PI3,PKP1,FLG
R-HSA-948021	Transport to the Golgi and subsequent modification	0.662204375317434	-0.412181046646129	164	7	0.01440329218107	486	10287	1604,6484,4121,286,6708,374,1294	CD55,ST3GAL4,MAN1A1,ANK1,SPTA1,AREG,COL7A1
R-HSA-389948	PD-1 signaling	0.671868819424258	-0.397692166704874	23	1	0.00205761316872428	486	10287	29126	CD274
R-HSA-5365859	RA biosynthesis pathway	0.671868819424258	-0.397692166704874	23	1	0.00205761316872428	486	10287	195814	SDR16C5
R-HSA-5627123	RHO GTPases activate PAKs	0.671868819424258	-0.397692166704874	23	1	0.00205761316872428	486	10287	4629	MYH11
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.671868819424258	-0.397692166704874	23	1	0.00205761316872428	486	10287	2847	MCHR1
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.671868819424258	-0.397692166704874	23	1	0.00205761316872428	486	10287	6616	SNAP25
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.671868819424258	-0.397692166704874	23	1	0.00205761316872428	486	10287	23327	NEDD4L
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.677169750921718	-0.389833297585949	73	3	0.00617283950617284	486	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.687405818037304	-0.374830450771403	24	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.687405818037304	-0.374830450771403	24	1	0.00205761316872428	486	10287	330	BIRC3
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.691284476116473	-0.369203852356439	50	2	0.00411522633744856	486	10287	8503,660	PIK3R3,BMX
R-HSA-418555	G alpha (s) signalling events	0.693843429685297	-0.365508949568896	146	6	0.0123456790123457	486	10287	9340,2642,5142,134864,53831,135	GLP2R,GCGR,PDE4B,TAAR1,GPR84,ADORA2A
R-HSA-383280	Nuclear Receptor transcription pathway	0.701721847894191	-0.354218181546362	51	2	0.00411522633744856	486	10287	8013,4929	NR4A3,NR4A2
R-HSA-162588	Budding and maturation of HIV virion	0.702208582578813	-0.353524792908923	25	1	0.00205761316872428	486	10287	23327	NEDD4L
R-HSA-3295583	TRP channels	0.702208582578813	-0.353524792908923	25	1	0.00205761316872428	486	10287	8989	TRPA1
R-HSA-982772	Growth hormone receptor signaling	0.702208582578813	-0.353524792908923	25	1	0.00205761316872428	486	10287	4067	LYN
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.702208582578813	-0.353524792908923	25	1	0.00205761316872428	486	10287	1848	DUSP6
R-HSA-182971	EGFR downregulation	0.702208582578813	-0.353524792908923	25	1	0.00205761316872428	486	10287	10252	SPRY1
R-HSA-1538133	G0 and Early G1	0.702208582578813	-0.353524792908923	25	1	0.00205761316872428	486	10287	8900	CCNA1
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.711836633387267	-0.339906841387057	77	3	0.00617283950617284	486	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-2262749	Cellular response to hypoxia	0.711836633387267	-0.339906841387057	77	3	0.00617283950617284	486	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-445717	Aquaporin-mediated transport	0.711864574976147	-0.339867589346363	52	2	0.00411522633744856	486	10287	4645,366	MYO5B,AQP9
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.716311742666676	-0.333639811992438	26	1	0.00205761316872428	486	10287	6484	ST3GAL4
R-HSA-2029485	Role of phospholipids in phagocytosis	0.716311742666676	-0.333639811992438	26	1	0.00205761316872428	486	10287	3710	ITPR3
R-HSA-1187000	Fertilization	0.716311742666676	-0.333639811992438	26	1	0.00205761316872428	486	10287	7784	ZP3
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.716311742666676	-0.333639811992438	26	1	0.00205761316872428	486	10287	7474	WNT5A
R-HSA-912694	Regulation of IFNA signaling	0.716311742666676	-0.333639811992438	26	1	0.00205761316872428	486	10287	3455	IFNAR2
R-HSA-1474165	Reproduction	0.716311742666676	-0.333639811992438	26	1	0.00205761316872428	486	10287	7784	ZP3
R-HSA-2559580	Oxidative Stress Induced Senescence	0.716618806822294	-0.333211229936695	126	5	0.0102880658436214	486	10287	23135,3725,723790,1030,7295	KDM6B,JUN,HIST2H2AA4,CDKN2B,TXN
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.720041629048388	-0.328446250520679	78	3	0.00617283950617284	486	10287	6482,6484,9945	ST3GAL1,ST3GAL4,GFPT2
R-HSA-6807878	COPI-mediated anterograde transport	0.728064142041504	-0.317366127466794	79	3	0.00617283950617284	486	10287	286,6708,1604	ANK1,SPTA1,CD55
R-HSA-180024	DARPP-32 events	0.729748297883076	-0.315055601716442	27	1	0.00205761316872428	486	10287	5142	PDE4B
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.729748297883076	-0.315055601716442	27	1	0.00205761316872428	486	10287	23327	NEDD4L
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.731284251843155	-0.312953041405644	54	2	0.00411522633744856	486	10287	6385,375790	SDC4,AGRN
R-HSA-2262752	Cellular responses to stress	0.731795729835559	-0.312253861566338	451	19	0.0390946502057613	486	10287	3552,5721,7296,4790,7295,1030,5698,723790,3159,23135,5699,4688,3725,8900,6648,3569,3008,3576,8091	IL1A,PSME2,TXNRD1,NFKB1,TXN,CDKN2B,PSMB9,HIST2H2AA4,HMGA1,KDM6B,PSMB10,NCF2,JUN,CCNA1,SOD2,IL6,HIST1H1E,CXCL8,HMGA2
R-HSA-5689603	UCH proteinases	0.737579220657234	-0.304381778696728	105	4	0.00823045267489712	486	10287	5699,5721,723790,5698	PSMB10,PSME2,HIST2H2AA4,PSMB9
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.740570834587115	-0.300333992067813	55	2	0.00411522633744856	486	10287	3638,85441	INSIG1,HELZ2
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.742549694301005	-0.297665482193362	28	1	0.00205761316872428	486	10287	10125	RASGRP1
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.742549694301005	-0.297665482193362	28	1	0.00205761316872428	486	10287	150	ADRA2A
R-HSA-174800	Chylomicron-mediated lipid transport	0.742549694301005	-0.297665482193362	28	1	0.00205761316872428	486	10287	4023	LPL
R-HSA-5576893	Phase 2 - plateau phase	0.742549694301005	-0.297665482193362	28	1	0.00205761316872428	486	10287	23630	KCNE5
R-HSA-1368082	RORA activates gene expression	0.742549694301005	-0.297665482193362	28	1	0.00205761316872428	486	10287	85441	HELZ2
R-HSA-190828	Gap junction trafficking	0.742549694301005	-0.297665482193362	28	1	0.00205761316872428	486	10287	2706	GJB2
R-HSA-597592	Post-translational protein modification	0.74603143530689	-0.292987541185091	1034	45	0.0925925925925926	486	10287	5277,1294,8975,27076,219333,4586,79931,50614,1080,9507,5698,10318,1540,51301,6482,79623,90865,4121,330,6484,1604,8767,5699,10071,84101,154064,8900,8876,286,723790,5721,7128,6708,64127,10164,9945,8875,124872,23586,374,4792,8313,5329,56999,64135	PIGA,COL7A1,USP13,LYPD3,USP12,MUC5AC,TNIP3,GALNT9,CFTR,ADAMTS4,PSMB9,TNIP1,CYLD,GCNT4,ST3GAL1,GALNT14,IL33,MAN1A1,BIRC3,ST3GAL4,CD55,RIPK2,PSMB10,MUC12,USP44,RAET1L,CCNA1,VNN1,ANK1,HIST2H2AA4,PSME2,TNFAIP3,SPTA1,NOD2,CHST4,GFPT2,VNN2,B4GALNT2,DDX58,AREG,NFKBIA,AXIN2,PLAUR,ADAMTS9,IFIH1
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.752637274775787	-0.284171874045302	156	6	0.0123456790123457	486	10287	23764,4602,9732,10938,3659,55619	MAFF,MYB,DOCK4,EHD1,IRF1,DOCK10
R-HSA-114608	Platelet degranulation	0.75375010117288	-0.282694396714708	132	5	0.0102880658436214	486	10287	5004,7273,5552,5341,5005	ORM1,TTN,SRGN,PLEK,ORM2
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.754745897480186	-0.281374146010908	29	1	0.00205761316872428	486	10287	2903	GRIN2A
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.754745897480186	-0.281374146010908	29	1	0.00205761316872428	486	10287	54514	DDX4
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.754745897480186	-0.281374146010908	29	1	0.00205761316872428	486	10287	857	CAV1
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.754745897480186	-0.281374146010908	29	1	0.00205761316872428	486	10287	10471	PFDN6
R-HSA-525793	Myogenesis	0.754745897480186	-0.281374146010908	29	1	0.00205761316872428	486	10287	1000	CDH2
R-HSA-375170	CDO in myogenesis	0.754745897480186	-0.281374146010908	29	1	0.00205761316872428	486	10287	1000	CDH2
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.754745897480186	-0.281374146010908	29	1	0.00205761316872428	486	10287	85441	HELZ2
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.754745897480186	-0.281374146010908	29	1	0.00205761316872428	486	10287	3055	HCK
R-HSA-3700989	Transcriptional Regulation by TP53	0.756055979397824	-0.279639858721417	367	15	0.0308641975308642	486	10287	8900,1263,25946,7296,7295,6446,639,3725,7832,5366,27113,637,8626,10769,54541	CCNA1,PLK3,ZNF385A,TXNRD1,TXN,SGK1,PRDM1,JUN,BTG2,PMAIP1,BBC3,BID,TP63,PLK2,DDIT4
R-HSA-199977	ER to Golgi Anterograde Transport	0.75957176971065	-0.275000465412553	133	5	0.0102880658436214	486	10287	1604,286,6708,374,1294	CD55,ANK1,SPTA1,AREG,COL7A1
R-HSA-162909	Host Interactions of HIV factors	0.765289628655478	-0.267500917256682	134	5	0.0102880658436214	486	10287	3159,5698,5721,3055,5699	HMGA1,PSMB9,PSME2,HCK,PSMB10
R-HSA-157858	Gap junction trafficking and regulation	0.766365462093792	-0.266096118458653	30	1	0.00205761316872428	486	10287	2706	GJB2
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.766799007767234	-0.265530561803094	58	2	0.00411522633744856	486	10287	10046,54567	MAMLD1,DLL4
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.766799007767234	-0.265530561803094	58	2	0.00411522633744856	486	10287	54567,10046	DLL4,MAMLD1
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.766799007767234	-0.265530561803094	58	2	0.00411522633744856	486	10287	10046,54567	MAMLD1,DLL4
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.766799007767234	-0.265530561803094	58	2	0.00411522633744856	486	10287	10046,54567	MAMLD1,DLL4
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.766799007767234	-0.265530561803094	58	2	0.00411522633744856	486	10287	10046,54567	MAMLD1,DLL4
R-HSA-1483257	Phospholipid metabolism	0.768415113122589	-0.263425179980023	207	8	0.0164609053497942	486	10287	25816,8503,51365,84879,11343,660,80736,9108	TNFAIP8,PIK3R3,PLA1A,MFSD2A,MGLL,BMX,SLC44A4,MTMR7
R-HSA-180786	Extension of Telomeres	0.777435598140152	-0.251754470333586	31	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-983712	Ion channel transport	0.777449899414328	-0.25173607505728	209	8	0.0164609053497942	486	10287	50617,6446,490,245973,6338,23327,266675,8989	ATP6V0A4,SGK1,ATP2B1,ATP6V1C2,SCNN1B,NEDD4L,BEST4,TRPA1
R-HSA-5632684	Hedgehog 'on' state	0.77924843318582	-0.249425371006177	86	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.781825878666999	-0.246123224780742	137	5	0.0102880658436214	486	10287	5552,5341,5005,7273,5004	SRGN,PLEK,ORM2,TTN,ORM1
R-HSA-193648	NRAGE signals death through JNK	0.78297854967672	-0.244649978415474	60	2	0.00411522633744856	486	10287	4803,26230	NGF,TIAM2
R-HSA-5633007	Regulation of TP53 Activity	0.783745317887354	-0.243671161040278	162	6	0.0123456790123457	486	10287	1263,25946,8900,8626,639,6446	PLK3,ZNF385A,CCNA1,TP63,PRDM1,SGK1
R-HSA-2559585	Oncogene Induced Senescence	0.787982234204304	-0.23827973480442	32	1	0.00205761316872428	486	10287	1030	CDKN2B
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.787982234204304	-0.23827973480442	32	1	0.00205761316872428	486	10287	857	CAV1
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.787982234204304	-0.23827973480442	32	1	0.00205761316872428	486	10287	2151	F2RL2
R-HSA-399719	Trafficking of AMPA receptors	0.787982234204304	-0.23827973480442	32	1	0.00205761316872428	486	10287	80852	GRIP2
R-HSA-70171	Glycolysis	0.787982234204304	-0.23827973480442	32	1	0.00205761316872428	486	10287	3099	HK2
R-HSA-68962	Activation of the pre-replicative complex	0.787982234204304	-0.23827973480442	32	1	0.00205761316872428	486	10287	23649	POLA2
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.787982234204304	-0.23827973480442	32	1	0.00205761316872428	486	10287	80852	GRIP2
R-HSA-421270	Cell-cell junction organization	0.790693119869107	-0.234845351259532	61	2	0.00411522633744856	486	10287	5818,1000	NECTIN1,CDH2
R-HSA-202433	Generation of second messenger molecules	0.798030077629556	-0.225608990977519	33	1	0.00205761316872428	486	10287	3937	LCP2
R-HSA-163359	Glucagon signaling in metabolic regulation	0.798030077629556	-0.225608990977519	33	1	0.00205761316872428	486	10287	2642	GCGR
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.798030077629556	-0.225608990977519	33	1	0.00205761316872428	486	10287	3159	HMGA1
R-HSA-190236	Signaling by FGFR	0.798629710345671	-0.224857882007628	89	3	0.00617283950617284	486	10287	26281,2247,23767	FGF20,FGF2,FLRT3
R-HSA-6805567	Keratinization	0.798908880103827	-0.224508382142439	214	8	0.0164609053497942	486	10287	9119,3849,5317,3855,5266,3854,2312,3868	KRT75,KRT2,PKP1,KRT7,PI3,KRT6B,FLG,KRT16
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.804495617799856	-0.21753975967472	311	12	0.0246913580246914	486	10287	5698,23327,55008,255488,84676,92369,127544,10517,221687,55521,5699,5721	PSMB9,NEDD4L,HERC6,RNF144B,TRIM63,SPSB4,RNF19B,FBXW10,RNF182,TRIM36,PSMB10,PSME2
R-HSA-1226099	Signaling by FGFR in disease	0.805399984198206	-0.216416250184592	63	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-390522	Striated Muscle Contraction	0.807602671940882	-0.213685084053531	34	1	0.00205761316872428	486	10287	7273	TTN
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.807602671940882	-0.213685084053531	34	1	0.00205761316872428	486	10287	10471	PFDN6
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.807602671940882	-0.213685084053531	34	1	0.00205761316872428	486	10287	1030	CDKN2B
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.807602671940882	-0.213685084053531	34	1	0.00205761316872428	486	10287	23327	NEDD4L
R-HSA-5656169	Termination of translesion DNA synthesis	0.807602671940882	-0.213685084053531	34	1	0.00205761316872428	486	10287	9636	ISG15
R-HSA-1489509	DAG and IP3 signaling	0.807602671940882	-0.213685084053531	34	1	0.00205761316872428	486	10287	3710	ITPR3
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.810744880451992	-0.209801848397451	91	3	0.00617283950617284	486	10287	8313,51176,723790	AXIN2,LEF1,HIST2H2AA4
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.810744880451992	-0.209801848397451	91	3	0.00617283950617284	486	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-194840	Rho GTPase cycle	0.812183275060751	-0.208029256085828	143	5	0.0102880658436214	486	10287	83478,116984,5880,26230,9938	ARHGAP24,ARAP2,RAC2,TIAM2,ARHGAP25
R-HSA-4791275	Signaling by WNT in cancer	0.816722451661295	-0.202455958287683	35	1	0.00205761316872428	486	10287	27121	DKK4
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.825410794274712	-0.191874084120488	36	1	0.00205761316872428	486	10287	2247	FGF2
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.825410794274712	-0.191874084120488	36	1	0.00205761316872428	486	10287	3710	ITPR3
R-HSA-445355	Smooth Muscle Contraction	0.825410794274712	-0.191874084120488	36	1	0.00205761316872428	486	10287	4629	MYH11
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.825410794274712	-0.191874084120488	36	1	0.00205761316872428	486	10287	644150	WIPF3
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.825410794274712	-0.191874084120488	36	1	0.00205761316872428	486	10287	3159	HMGA1
R-HSA-438064	Post NMDA receptor activation events	0.833688070051867	-0.18189596330947	37	1	0.00205761316872428	486	10287	2903	GRIN2A
R-HSA-5663202	Diseases of signal transduction	0.840044735477633	-0.174300132041864	370	14	0.0288065843621399	486	10287	2247,10046,5698,64220,8503,2069,54567,27121,26281,4233,941,5699,1839,5721	FGF2,MAMLD1,PSMB9,STRA6,PIK3R3,EREG,DLL4,DKK4,FGF20,MET,CD80,PSMB10,HBEGF,PSME2
R-HSA-5689901	Metalloprotease DUBs	0.841573689386016	-0.17248170009905	38	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-156590	Glutathione conjugation	0.841573689386016	-0.17248170009905	38	1	0.00205761316872428	486	10287	2730	GCLM
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.844148786713389	-0.169426512347903	69	2	0.00411522633744856	486	10287	374,1294	AREG,COL7A1
R-HSA-390466	Chaperonin-mediated protein folding	0.853209644570307	-0.158749988451754	99	3	0.00617283950617284	486	10287	10471,9628,10517	PFDN6,RGS6,FBXW10
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.856243069421669	-0.155200983544539	40	1	0.00205761316872428	486	10287	9636	ISG15
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.856243069421669	-0.155200983544539	40	1	0.00205761316872428	486	10287	10517	FBXW10
R-HSA-1296071	Potassium Channels	0.85788774939925	-0.153282016258934	100	3	0.00617283950617284	486	10287	3779,131096,3783	KCNMB1,KCNH8,KCNN4
R-HSA-5610787	Hedgehog 'off' state	0.86243499443397	-0.147995501689199	101	3	0.00617283950617284	486	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.863061247246445	-0.147269620258866	41	1	0.00205761316872428	486	10287	2903	GRIN2A
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.863061247246445	-0.147269620258866	41	1	0.00205761316872428	486	10287	9636	ISG15
R-HSA-1483206	Glycerophospholipid biosynthesis	0.864964161281025	-0.145067204953647	129	4	0.00823045267489712	486	10287	80736,11343,51365,84879	SLC44A4,MGLL,PLA1A,MFSD2A
R-HSA-3214841	PKMTs methylate histone lysines	0.865949116380353	-0.143929129212533	73	2	0.00411522633744856	486	10287	4790,4791	NFKB1,NFKB2
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.869556682920244	-0.139771757065042	42	1	0.00205761316872428	486	10287	85441	HELZ2
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.869556682920244	-0.139771757065042	42	1	0.00205761316872428	486	10287	3710	ITPR3
R-HSA-168253	Host Interactions with Influenza Factors	0.869556682920244	-0.139771757065042	42	1	0.00205761316872428	486	10287	9636	ISG15
R-HSA-1461957	Beta defensins	0.869556682920244	-0.139771757065042	42	1	0.00205761316872428	486	10287	7097	TLR2
R-HSA-446203	Asparagine N-linked glycosylation	0.869657935735297	-0.139655321963725	284	10	0.0205761316872428	486	10287	9945,6482,6708,6484,1604,4121,286,1294,124872,374	GFPT2,ST3GAL1,SPTA1,ST3GAL4,CD55,MAN1A1,ANK1,COL7A1,B4GALNT2,AREG
R-HSA-5362517	Signaling by Retinoic Acid	0.875744623575202	-0.132680756146678	43	1	0.00205761316872428	486	10287	195814	SDR16C5
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	0.875744623575202	-0.132680756146678	43	1	0.00205761316872428	486	10287	9628	RGS6
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.875744623575202	-0.132680756146678	43	1	0.00205761316872428	486	10287	4645	MYO5B
R-HSA-5654738	Signaling by FGFR2	0.875768340154255	-0.132653674898014	75	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-391251	Protein folding	0.879370157059397	-0.128549358381644	105	3	0.00617283950617284	486	10287	10517,9628,10471	FBXW10,RGS6,PFDN6
R-HSA-1500931	Cell-Cell communication	0.880026416077755	-0.127803353690248	133	4	0.00823045267489712	486	10287	3914,5818,1000,3918	LAMB3,NECTIN1,CDH2,LAMC2
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.880425649001776	-0.127349796403703	76	2	0.00411522633744856	486	10287	26230,4803	TIAM2,NGF
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.880425649001776	-0.127349796403703	76	2	0.00411522633744856	486	10287	23586,9636	DDX58,ISG15
R-HSA-1169408	ISG15 antiviral mechanism	0.880425649001776	-0.127349796403703	76	2	0.00411522633744856	486	10287	23586,9636	DDX58,ISG15
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.881639597508021	-0.125971926088504	44	1	0.00205761316872428	486	10287	130367	SGPP2
R-HSA-1296072	Voltage gated Potassium channels	0.881639597508021	-0.125971926088504	44	1	0.00205761316872428	486	10287	131096	KCNH8
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.884921356072023	-0.12225650111823	77	2	0.00411522633744856	486	10287	1030,23327	CDKN2B,NEDD4L
R-HSA-1643685	Disease	0.884954063652091	-0.122219540799207	859	34	0.0699588477366255	486	10287	54567,8503,375790,10046,2247,27121,941,4790,5721,56999,23327,4792,3055,9636,6648,4791,7852,3725,1080,3159,7097,9507,5698,4233,4586,7296,6616,2069,64220,26281,6385,10071,1839,5699	DLL4,PIK3R3,AGRN,MAMLD1,FGF2,DKK4,CD80,NFKB1,PSME2,ADAMTS9,NEDD4L,NFKBIA,HCK,ISG15,SOD2,NFKB2,CXCR4,JUN,CFTR,HMGA1,TLR2,ADAMTS4,PSMB9,MET,MUC5AC,TXNRD1,SNAP25,EREG,STRA6,FGF20,SDC4,MUC12,HBEGF,PSMB10
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.887255447903758	-0.119622347261637	45	1	0.00205761316872428	486	10287	85441	HELZ2
R-HSA-6811438	Intra-Golgi traffic	0.887255447903758	-0.119622347261637	45	1	0.00205761316872428	486	10287	4121	MAN1A1
R-HSA-109704	PI3K Cascade	0.893447209369109	-0.112668029094984	79	2	0.00411522633744856	486	10287	26281,2247	FGF20,FGF2
R-HSA-3214858	RMTs methylate histone arginines	0.893447209369109	-0.112668029094984	79	2	0.00411522633744856	486	10287	595,723790	CCND1,HIST2H2AA4
R-HSA-112043	PLC beta mediated events	0.897701917485977	-0.107917206223138	47	1	0.00205761316872428	486	10287	3710	ITPR3
R-HSA-1483249	Inositol phosphate metabolism	0.897701917485977	-0.107917206223138	47	1	0.00205761316872428	486	10287	117283	IP6K3
R-HSA-70326	Glucose metabolism	0.901383427693931	-0.103824553969003	81	2	0.00411522633744856	486	10287	669,3099	BPGM,HK2
R-HSA-112040	G-protein mediated events	0.902557080387152	-0.102523343808732	48	1	0.00205761316872428	486	10287	3710	ITPR3
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.902557080387152	-0.102523343808732	48	1	0.00205761316872428	486	10287	10046	MAMLD1
R-HSA-112316	Neuronal System	0.904874649075522	-0.0999588541843264	349	12	0.0246913580246914	486	10287	80852,3779,9369,9378,6580,3783,6616,131096,9456,6506,2903,56666	GRIP2,KCNMB1,NRXN3,NRXN1,SLC22A1,KCNN4,SNAP25,KCNH8,HOMER1,SLC1A2,GRIN2A,PANX2
R-HSA-157579	Telomere Maintenance	0.905141722759448	-0.099663747808473	82	2	0.00411522633744856	486	10287	723790,23649	HIST2H2AA4,POLA2
R-HSA-5576891	Cardiac conduction	0.908683636591219	-0.0957582799358536	142	4	0.00823045267489712	486	10287	490,3710,6547,23630	ATP2B1,ITPR3,SLC8A3,KCNE5
R-HSA-73893	DNA Damage Bypass	0.91158834168385	-0.0925667705429234	50	1	0.00205761316872428	486	10287	9636	ISG15
R-HSA-111885	Opioid Signalling	0.915629188972563	-0.0881438118000702	85	2	0.00411522633744856	486	10287	3710,5142	ITPR3,PDE4B
R-HSA-171306	Packaging Of Telomere Ends	0.9157856715681	-0.0879729246905579	51	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-1461973	Defensins	0.9157856715681	-0.0879729246905579	51	1	0.00205761316872428	486	10287	7097	TLR2
R-HSA-3214842	HDMs demethylate histones	0.919784124434534	-0.0836162838268159	52	1	0.00205761316872428	486	10287	23135	KDM6B
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.923593104956014	-0.0794836669302543	53	1	0.00205761316872428	486	10287	2847	MCHR1
R-HSA-397014	Muscle contraction	0.924913393997869	-0.0780551739635094	204	6	0.0123456790123457	486	10287	490,3710,7273,23630,6547,4629	ATP2B1,ITPR3,TTN,KCNE5,SLC8A3,MYH11
R-HSA-1592230	Mitochondrial biogenesis	0.927221573884919	-0.0755627194480376	54	1	0.00205761316872428	486	10287	85441	HELZ2
R-HSA-162906	HIV Infection	0.934215528904507	-0.0680481083756557	236	7	0.01440329218107	486	10287	5699,3055,7852,5721,5698,3159,23327	PSMB10,HCK,CXCR4,PSME2,PSMB9,HMGA1,NEDD4L
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.937107293306466	-0.0649574960350665	57	1	0.00205761316872428	486	10287	2495	FTH1
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	0.938519774936089	-0.063451352387907	93	2	0.00411522633744856	486	10287	8900,1263	CCNA1,PLK3
R-HSA-5625740	RHO GTPases activate PKNs	0.938519774936089	-0.063451352387907	93	2	0.00411522633744856	486	10287	723790,4629	HIST2H2AA4,MYH11
R-HSA-936837	Ion transport by P-type ATPases	0.94009515797118	-0.0617741769574553	58	1	0.00205761316872428	486	10287	490	ATP2B1
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	0.941267846662579	-0.0605275394500902	126	3	0.00617283950617284	486	10287	3725,4211,723790	JUN,MEIS1,HIST2H2AA4
R-HSA-5619507	Activation of HOX genes during differentiation	0.941267846662579	-0.0605275394500902	126	3	0.00617283950617284	486	10287	723790,4211,3725	HIST2H2AA4,MEIS1,JUN
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.948235247184018	-0.0531526564734976	61	1	0.00205761316872428	486	10287	644150	WIPF3
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.951681818231942	-0.0495245246025227	99	2	0.00411522633744856	486	10287	1080,7474	CFTR,WNT5A
R-HSA-73728	RNA Polymerase I Promoter Opening	0.953038889070792	-0.0480995691607366	63	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-977225	Amyloid fiber formation	0.955437619046009	-0.0455858036224651	101	2	0.00411522633744856	486	10287	6288,723790	SAA1,HIST2H2AA4
R-HSA-5334118	DNA methylation	0.957397596567395	-0.0435365124014407	65	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-5663205	Infectious disease	0.959276401180039	-0.041576027502478	388	12	0.0246913580246914	486	10287	5698,23327,3159,3055,4233,7296,9636,6616,5699,1839,7852,5721	PSMB9,NEDD4L,HMGA1,HCK,MET,TXNRD1,ISG15,SNAP25,PSMB10,HBEGF,CXCR4,PSME2
R-HSA-2467813	Separation of Sister Chromatids	0.960382749864911	-0.0404233762031451	168	4	0.00823045267489712	486	10287	5698,9700,5699,5721	PSMB9,ESPL1,PSMB10,PSME2
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.961352504349804	-0.0394141273328021	67	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-5358351	Signaling by Hedgehog	0.961817760739447	-0.0389302841628389	138	3	0.00617283950617284	486	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-156580	Phase II conjugation	0.963644803205995	-0.0370325136747436	106	2	0.00411522633744856	486	10287	27233,2730	SULT1C4,GCLM
R-HSA-69620	Cell Cycle Checkpoints	0.964223753209963	-0.0364319021657845	201	5	0.0102880658436214	486	10287	5721,5699,8900,25946,5698	PSME2,PSMB10,CCNA1,ZNF385A,PSMB9
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.964940951328827	-0.0356883698481782	69	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	0.964940951328827	-0.0356883698481782	69	1	0.00205761316872428	486	10287	3725	JUN
R-HSA-73886	Chromosome Maintenance	0.967850891039345	-0.0326772417531542	109	2	0.00411522633744856	486	10287	723790,23649	HIST2H2AA4,POLA2
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.96970978441355	-0.0307584435776003	72	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-774815	Nucleosome assembly	0.96970978441355	-0.0307584435776003	72	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-195258	RHO GTPase Effectors	0.971079188076039	-0.0293472608996718	294	8	0.0164609053497942	486	10287	1080,723790,91010,23002,4629,644150,4688,5880	CFTR,HIST2H2AA4,FMNL3,DAAM1,MYH11,WIPF3,NCF2,RAC2
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	0.971150904804489	-0.0292734110208697	73	1	0.00205761316872428	486	10287	5452	POU2F2
R-HSA-421837	Clathrin derived vesicle budding	0.971150904804489	-0.0292734110208697	73	1	0.00205761316872428	486	10287	2495	FTH1
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.971150904804489	-0.0292734110208697	73	1	0.00205761316872428	486	10287	2495	FTH1
R-HSA-174824	Lipoprotein metabolism	0.972523595261026	-0.0278609413046606	74	1	0.00205761316872428	486	10287	4023	LPL
R-HSA-212300	PRC2 methylates histones and DNA	0.972523595261026	-0.0278609413046606	74	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-2299718	Condensation of Prophase Chromosomes	0.972523595261026	-0.0278609413046606	74	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-68882	Mitotic Anaphase	0.972668551797962	-0.0277119004631963	179	4	0.00823045267489712	486	10287	5698,9700,5699,5721	PSMB9,ESPL1,PSMB10,PSME2
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.973587936622012	-0.0267671278724232	180	4	0.00823045267489712	486	10287	5698,5721,9700,5699	PSMB9,PSME2,ESPL1,PSMB10
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	0.975076504716116	-0.0252393446871115	76	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-69275	G2/M Transition	0.975340519704321	-0.0249686179794257	182	4	0.00823045267489712	486	10287	5698,8900,5721,5699	PSMB9,CCNA1,PSME2,PSMB10
R-HSA-5663220	RHO GTPases Activate Formins	0.976902507425738	-0.0233684196096362	117	2	0.00411522633744856	486	10287	91010,23002	FMNL3,DAAM1
R-HSA-453274	Mitotic G2-G2/M phases	0.976983621879055	-0.023285390765583	184	4	0.00823045267489712	486	10287	5698,8900,5721,5699	PSMB9,CCNA1,PSME2,PSMB10
R-HSA-162587	HIV Life Cycle	0.977234206936742	-0.0230289351592884	152	3	0.00617283950617284	486	10287	7852,23327,3159	CXCR4,NEDD4L,HMGA1
R-HSA-1221632	Meiotic synapsis	0.978468882467363	-0.0217662939113982	79	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-112315	Transmission across Chemical Synapses	0.978536768934804	-0.0216969160152025	217	5	0.0102880658436214	486	10287	6616,2903,6580,6506,80852	SNAP25,GRIN2A,SLC22A1,SLC1A2,GRIP2
R-HSA-194315	Signaling by Rho GTPases	0.984161931399037	-0.0159648310392083	427	12	0.0246913580246914	486	10287	5880,4688,644150,4629,9938,26230,116984,23002,91010,83478,723790,1080	RAC2,NCF2,WIPF3,MYH11,ARHGAP25,TIAM2,ARAP2,DAAM1,FMNL3,ARHGAP24,HIST2H2AA4,CFTR
R-HSA-912446	Meiotic recombination	0.986122074157028	-0.0139751245815238	88	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	0.986783381344507	-0.0133047354248591	89	1	0.00205761316872428	486	10287	23258	DENND5A
R-HSA-392499	Metabolism of proteins	0.986894702462841	-0.0131919296746559	1619	60	0.123456790123457	486	10287	723790,6288,6347,286,8876,8875,7295,64127,10164,9945,10517,6708,5721,7128,56999,8313,5329,135,23586,374,124872,4792,3624,64135,467,150,5069,9628,9507,5698,1080,4586,79931,50614,4312,5277,1294,219333,8975,27076,10471,90865,79623,6482,3484,10318,51301,1540,1604,6484,60676,330,4121,3576,154064,8900,10071,84101,8767,5699	HIST2H2AA4,SAA1,CCL2,ANK1,VNN1,VNN2,TXN,NOD2,CHST4,GFPT2,FBXW10,SPTA1,PSME2,TNFAIP3,ADAMTS9,AXIN2,PLAUR,ADORA2A,DDX58,AREG,B4GALNT2,NFKBIA,INHBA,IFIH1,ATF3,ADRA2A,PAPPA,RGS6,ADAMTS4,PSMB9,CFTR,MUC5AC,TNIP3,GALNT9,MMP1,PIGA,COL7A1,USP12,USP13,LYPD3,PFDN6,IL33,GALNT14,ST3GAL1,IGFBP1,TNIP1,GCNT4,CYLD,CD55,ST3GAL4,PAPPA2,BIRC3,MAN1A1,CXCL8,RAET1L,CCNA1,MUC12,USP44,RIPK2,PSMB10
R-HSA-428157	Sphingolipid metabolism	0.987413237857382	-0.012666646464399	90	1	0.00205761316872428	486	10287	130367	SGPP2
R-HSA-2980736	Peptide hormone metabolism	0.988013136499357	-0.0120592852706802	91	1	0.00205761316872428	486	10287	3624	INHBA
R-HSA-73777	RNA Polymerase I Chain Elongation	0.988013136499357	-0.0120592852706802	91	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-69481	G2/M Checkpoints	0.988070056389384	-0.0120016764713672	169	3	0.00617283950617284	486	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	0.989128681140838	-0.0109308434463213	93	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-3214815	HDACs deacetylate histones	0.989646972386992	-0.0104069929965929	94	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-8856828	Clathrin-mediated endocytosis	0.990049939680611	-0.00999989300393463	137	2	0.00411522633744856	486	10287	7474,1080	WNT5A,CFTR
R-HSA-211000	Gene Silencing by RNA	0.990049939680611	-0.00999989300393463	137	2	0.00411522633744856	486	10287	54514,723790	DDX4,HIST2H2AA4
R-HSA-5693607	Processing of DNA double-strand break ends	0.991484961972109	-0.00855149808424546	98	1	0.00205761316872428	486	10287	8900	CCNA1
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.993230639350608	-0.00679237669929413	146	2	0.00411522633744856	486	10287	80852,2903	GRIP2,GRIN2A
R-HSA-2132295	MHC class II antigen presentation	0.993331355261748	-0.00669097950001277	103	1	0.00205761316872428	486	10287	1520	CTSS
R-HSA-5578749	Transcriptional regulation by small RNAs	0.994241325437209	-0.0057753196623857	106	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-427413	NoRC negatively regulates rRNA expression	0.994516221398556	-0.00549886971147549	107	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	0.994778020669341	-0.00523566151757436	108	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.995264790407296	-0.00474645621510194	110	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.995264790407296	-0.00474645621510194	110	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-73864	RNA Polymerase I Transcription	0.99570627027043	-0.00430297425889602	112	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-1500620	Meiosis	0.997236506621269	-0.00276731887600803	121	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-2408522	Selenoamino acid metabolism	0.997236506621269	-0.00276731887600803	121	1	0.00205761316872428	486	10287	7296	TXNRD1
R-HSA-3247509	Chromatin modifying enzymes	0.99746464704684	-0.00253857240323778	279	5	0.0102880658436214	486	10287	4790,723790,4791,23135,595	NFKB1,HIST2H2AA4,NFKB2,KDM6B,CCND1
R-HSA-4839726	Chromatin organization	0.99746464704684	-0.00253857240323778	279	5	0.0102880658436214	486	10287	595,23135,723790,4790,4791	CCND1,KDM6B,HIST2H2AA4,NFKB1,NFKB2
R-HSA-212436	Generic Transcription Pathway	0.998197660227792	-0.00180396594076832	865	25	0.051440329218107	486	10287	27113,5366,23327,8626,90874,54541,1263,85441,8900,10308,639,7832,3725,10046,4929,10769,637,4435,163732,25946,7296,1030,7295,6446,8013	BBC3,PMAIP1,NEDD4L,TP63,ZNF697,DDIT4,PLK3,HELZ2,CCNA1,ZNF267,PRDM1,BTG2,JUN,MAMLD1,NR4A2,PLK2,BID,CITED1,CITED4,ZNF385A,TXNRD1,CDKN2B,TXN,SGK1,NR4A3
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.998388174048343	-0.00161312634062741	132	1	0.00205761316872428	486	10287	8900	CCNA1
R-HSA-5693538	Homology Directed Repair	0.998799130855753	-0.00120159076537019	138	1	0.00205761316872428	486	10287	8900	CCNA1
R-HSA-162599	Late Phase of HIV Life Cycle	0.998856636266565	-0.00114401787240873	139	1	0.00205761316872428	486	10287	23327	NEDD4L
R-HSA-68875	Mitotic Prophase	0.998963533163163	-0.00103700434002401	141	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-3214847	HATs acetylate histones	0.99906045455858	-0.00093998709089293	143	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-68886	M Phase	0.999127903886793	-0.000872476610257984	308	5	0.0102880658436214	486	10287	723790,5698,9700,5699,5721	HIST2H2AA4,PSMB9,ESPL1,PSMB10,PSME2
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.99930023338191	-0.000700011569028684	149	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-212165	Epigenetic regulation of gene expression	0.999365719858937	-0.00063448138181147	151	1	0.00205761316872428	486	10287	723790	HIST2H2AA4
R-HSA-168254	Influenza Infection	0.999527705373266	-0.000472406192971045	157	1	0.00205761316872428	486	10287	9636	ISG15
R-HSA-5693532	DNA Double-Strand Break Repair	0.99971120260523	-0.000288839104767904	167	1	0.00205761316872428	486	10287	8900	CCNA1
R-HSA-69278	Cell Cycle, Mitotic	0.999788132291677	-0.000211890155457027	514	10	0.0205761316872428	486	10287	9700,723790,5698,5721,595,5699,1030,64785,8900,23649	ESPL1,HIST2H2AA4,PSMB9,PSME2,CCND1,PSMB10,CDKN2B,GINS3,CCNA1,POLA2
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	0.999840057533311	-0.000159955258849395	179	1	0.00205761316872428	486	10287	4121	MAN1A1
R-HSA-5617833	Cilium Assembly	0.999915744964849	-8.42585848062005e-05	192	1	0.00205761316872428	486	10287	2847	MCHR1
R-HSA-5653656	Vesicle-mediated transport	0.99994623997213	-5.37614729922439e-05	650	13	0.0267489711934156	486	10287	2706,23258,8578,6708,2495,6288,1080,1604,4121,286,374,7474,1294	GJB2,DENND5A,SCARF1,SPTA1,FTH1,SAA1,CFTR,CD55,MAN1A1,ANK1,AREG,WNT5A,COL7A1
R-HSA-199991	Membrane Trafficking	0.999975801350481	-2.41989423110146e-05	610	11	0.0226337448559671	486	10287	2706,23258,6708,2495,1080,1604,374,1294,7474,4121,286	GJB2,DENND5A,SPTA1,FTH1,CFTR,CD55,AREG,COL7A1,WNT5A,MAN1A1,ANK1
R-HSA-1640170	Cell Cycle	0.999983502161642	-1.64979744485371e-05	621	11	0.0226337448559671	486	10287	595,5699,5721,8900,23649,64785,25946,1030,9700,723790,5698	CCND1,PSMB10,PSME2,CCNA1,POLA2,GINS3,ZNF385A,CDKN2B,ESPL1,HIST2H2AA4,PSMB9
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.99999445622685	-5.5437885171499e-06	247	1	0.00205761316872428	486	10287	9589	WTAP
R-HSA-73894	DNA Repair	0.999996930681017	-3.0693236932602e-06	316	2	0.00411522633744856	486	10287	9636,8900	ISG15,CCNA1
R-HSA-1852241	Organelle biogenesis and maintenance	0.999999007715608	-9.9228488469429e-07	340	2	0.00411522633744856	486	10287	2847,85441	MCHR1,HELZ2
R-HSA-381753	Olfactory Signaling Pathway	0.999999912077348	-8.79226562254094e-08	391	2	0.00411522633744856	486	10287	64108,283365	RTP4,OR6C6
R-HSA-74160	Gene Expression	0.999999999909224	-9.07756612324374e-11	1821	32	0.065843621399177	486	10287	9589,6446,7296,163732,5698,639,5699,10308,8900,1263,85441,54514,54541,5452,5366,8013,5721,7295,1030,25946,4435,637,10769,4929,723790,10046,3725,7832,90874,8626,23327,27113	WTAP,SGK1,TXNRD1,CITED4,PSMB9,PRDM1,PSMB10,ZNF267,CCNA1,PLK3,HELZ2,DDX4,DDIT4,POU2F2,PMAIP1,NR4A3,PSME2,TXN,CDKN2B,ZNF385A,CITED1,BID,PLK2,NR4A2,HIST2H2AA4,MAMLD1,JUN,BTG2,ZNF697,TP63,NEDD4L,BBC3
R-HSA-72731	Recycling of eIF2:GDP	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-73928	Depyrimidination	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-77111	Synthesis of Ketone Bodies	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-8937144	Aryl hydrocarbon receptor signalling	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-1483148	Synthesis of PG	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-70921	Histidine catabolism	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-977347	Serine biosynthesis	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-444821	Relaxin receptors	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-196783	Coenzyme A biosynthesis	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-2142789	Ubiquinol biosynthesis	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-1483115	Hydrolysis of LPC	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-400451	Free fatty acids regulate insulin secretion	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-804914	Transport of fatty acids	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-73942	DNA Damage Reversal	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-6787450	tRNA modification in the mitochondrion	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-5632681	Ligand-receptor interactions	0.999999999958733	-4.12665374075511e-11	8	0	0	486	10287
R-HSA-375281	Hormone ligand-binding receptors	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-2995410	Nuclear Envelope Reassembly	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-2408517	SeMet incorporation into proteins	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-2168880	Scavenging of heme from plasma	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-1663150	The activation of arylsulfatases	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-175474	Assembly Of The HIV Virion	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-5626467	RHO GTPases activate IQGAPs	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-5210891	Uptake and function of anthrax toxins	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-977441	GABA A receptor activation	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-171007	p38MAPK events	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.999999999971852	-2.81484766575402e-11	13	0	0	486	10287
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-1296067	Potassium transport channels	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-191650	Regulation of gap junction activity	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-5357572	Lysosomal glycogen catabolism	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-217271	FMO oxidises nucleophiles	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-110331	Cleavage of the damaged purine	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-844455	The NLRP1 inflammasome	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-111458	Formation of apoptosome	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-77108	Utilization of Ketone Bodies	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-73927	Depurination	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-6806664	Metabolism of vitamin K	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-163282	Mitochondrial transcription initiation	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-977442	GABA A (rho) receptor activation	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-8849472	PTK6 Down-Regulation	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-265473	Trafficking of dietary sterols	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-844615	The AIM2 inflammasome	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999972223	-2.77766353619152e-11	3	0	0	486	10287
R-HSA-420029	Tight junction interactions	0.999999999975254	-2.47457785672926e-11	30	0	0	486	10287
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.999999999975254	-2.47457785672926e-11	30	0	0	486	10287
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	0.999999999975254	-2.47457785672926e-11	30	0	0	486	10287
R-HSA-111996	Ca-dependent events	0.999999999975254	-2.47457785672926e-11	30	0	0	486	10287
R-HSA-72086	mRNA Capping	0.999999999976061	-2.39390270645242e-11	29	0	0	486	10287
R-HSA-202040	G-protein activation	0.999999999976061	-2.39390270645242e-11	29	0	0	486	10287
R-HSA-1482839	Acyl chain remodelling of PE	0.999999999976061	-2.39390270645242e-11	29	0	0	486	10287
R-HSA-390918	Peroxisomal lipid metabolism	0.999999999976061	-2.39390270645242e-11	29	0	0	486	10287
R-HSA-5620916	VxPx cargo-targeting to cilium	0.999999999976643	-2.33566600741851e-11	22	0	0	486	10287
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999976643	-2.33566600741851e-11	22	0	0	486	10287
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.999999999976643	-2.33566600741851e-11	22	0	0	486	10287
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999976643	-2.33566600741851e-11	22	0	0	486	10287
R-HSA-166208	mTORC1-mediated signalling	0.999999999976643	-2.33566600741851e-11	22	0	0	486	10287
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.999999999976643	-2.33566600741851e-11	22	0	0	486	10287
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.999999999976643	-2.33566600741851e-11	22	0	0	486	10287
R-HSA-373753	Nephrin interactions	0.999999999976643	-2.33566600741851e-11	22	0	0	486	10287
R-HSA-8849175	Threonine catabolism	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-70688	Proline catabolism	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-198765	Signalling to ERK5	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-1483101	Synthesis of PS	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-888568	GABA synthesis	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-71737	Pyrophosphate hydrolysis	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-75102	C6 deamination of adenosine	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-168268	Virus Assembly and Release	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-351143	Agmatine biosynthesis	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-165160	PDE3B signalling	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-8854521	Interaction between PHLDA1 and AURKA	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-192905	vRNP Assembly	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-8942233	Intestinal infectious diseases	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-380612	Metabolism of serotonin	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-844623	The IPAF inflammasome	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-916853	Degradation of GABA	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-156582	Acetylation	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-75896	Plasmalogen biosynthesis	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-1483152	Hydrolysis of LPE	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-111995	phospho-PLA2 pathway	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999977753	-2.22473489283614e-11	2	0	0	486	10287
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-418885	DCC mediated attractive signaling	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-2024101	CS/DS degradation	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-1483213	Synthesis of PE	0.999999999980844	-1.91555692135966e-11	14	0	0	486	10287
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	0.999999999982862	-1.71375069760907e-11	82	0	0	486	10287
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.999999999982862	-1.71375069760907e-11	82	0	0	486	10287
R-HSA-380287	Centrosome maturation	0.999999999982862	-1.71375069760907e-11	82	0	0	486	10287
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-399956	CRMPs in Sema3A signaling	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-110312	Translesion synthesis by REV1	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-446353	Cell-extracellular matrix interactions	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-1834941	STING mediated induction of host immune responses	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-163615	PKA activation	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-1170546	Prolactin receptor signaling	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999983152	-1.68477900679847e-11	16	0	0	486	10287
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-176412	Phosphorylation of the APC/C	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-110320	Translesion Synthesis by POLH	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-5576886	Phase 4 - resting membrane potential	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-8876725	Protein methylation	0.999999999983617	-1.63828262162767e-11	19	0	0	486	10287
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-3248023	Regulation by TREX1	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-164516	Minus-strand DNA synthesis	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-2408552	Methylation of MeSeH for excretion	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-389542	NADPH regeneration	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-140180	COX reactions	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-162585	Uncoating of the HIV Virion	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1483076	Synthesis of CL	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-164525	Plus-strand DNA synthesis	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-6809583	Retinoid metabolism disease events	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-163316	Mitochondrial transcription termination	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-8853333	Signaling by FGFR2 fusions	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1300645	Acrosome Reaction	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-169131	Inhibition of PKR	0.999999999984009	-1.59913679520507e-11	1	0	0	486	10287
R-HSA-1296065	Inwardly rectifying K+ channels	0.999999999984588	-1.54116983268565e-11	31	0	0	486	10287
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	0.999999999984588	-1.54116983268565e-11	31	0	0	486	10287
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.999999999984588	-1.54116983268565e-11	31	0	0	486	10287
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.999999999984588	-1.54116983268565e-11	31	0	0	486	10287
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.999999999984588	-1.54116983268565e-11	31	0	0	486	10287
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.999999999984588	-1.54116983268565e-11	31	0	0	486	10287
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.999999999984588	-1.54116983268565e-11	31	0	0	486	10287
R-HSA-73772	RNA Polymerase I Promoter Escape	0.999999999984588	-1.54116983268565e-11	31	0	0	486	10287
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	0.999999999986152	-1.38479848357444e-11	18	0	0	486	10287
R-HSA-5635838	Activation of SMO	0.999999999986152	-1.38479848357444e-11	18	0	0	486	10287
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.999999999986152	-1.38479848357444e-11	18	0	0	486	10287
R-HSA-1482925	Acyl chain remodelling of PG	0.999999999986152	-1.38479848357444e-11	18	0	0	486	10287
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999986152	-1.38479848357444e-11	18	0	0	486	10287
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.999999999986152	-1.38479848357444e-11	18	0	0	486	10287
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.999999999986152	-1.38479848357444e-11	18	0	0	486	10287
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999986152	-1.38479848357444e-11	18	0	0	486	10287
R-HSA-3371511	HSF1 activation	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-5689877	Josephin domain DUBs	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-211958	Miscellaneous substrates	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-1296346	Tandem pore domain potassium channels	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-390666	Serotonin receptors	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-71064	Lysine catabolism	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-211979	Eicosanoids	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-71384	Ethanol oxidation	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-166786	Creation of C4 and C2 activators	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-8866427	VLDLR internalisation and degradation	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-417957	P2Y receptors	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-2022857	Keratan sulfate degradation	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-5578768	Physiological factors	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999987491	-1.25090646909745e-11	12	0	0	486	10287
R-HSA-8868773	rRNA processing in the nucleus and cytosol	0.999999999988563	-1.14367569165756e-11	191	0	0	486	10287
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.999999999989062	-1.09380282869075e-11	34	0	0	486	10287
R-HSA-1483166	Synthesis of PA	0.999999999989062	-1.09380282869075e-11	34	0	0	486	10287
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.999999999989062	-1.09380282869075e-11	34	0	0	486	10287
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.999999999989062	-1.09380282869075e-11	34	0	0	486	10287
R-HSA-390650	Histamine receptors	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-428776	Class II GLUTs	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-1296053	Classical Kir channels	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-8848584	Wax biosynthesis	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-8847453	Synthesis of PIPs in the nucleus	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-5083630	Defective LFNG causes SCDO3	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-8935690	Miscellaneous digestion events	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-4551638	SUMOylation of chromatin organization proteins	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-399710	Activation of AMPA receptors	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-8849474	PTK6 Activates STAT3	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-6783984	Glycine degradation	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-442745	Activation of CaMK IV	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-1296061	HCN channels	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-888593	Reuptake of GABA	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-165158	Activation of AKT2	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	0.999999999990377	-9.62320076106944e-12	4	0	0	486	10287
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.999999999990559	-9.44118303426727e-12	26	0	0	486	10287
R-HSA-975298	Ligand-gated ion channel transport	0.999999999990559	-9.44118303426727e-12	26	0	0	486	10287
R-HSA-379716	Cytosolic tRNA aminoacylation	0.999999999990559	-9.44118303426727e-12	26	0	0	486	10287
R-HSA-3371378	Regulation by c-FLIP	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-5655291	Signaling by FGFR4 in disease	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-5625970	RHO GTPases activate KTN1	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-69416	Dimerization of procaspase-8	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-5218900	CASP8 activity is inhibited	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-211999	CYP2E1 reactions	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-418889	Ligand-independent caspase activation via DCC	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-75072	mRNA Editing	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-189451	Heme biosynthesis	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-376172	DSCAM interactions	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-2022923	Dermatan sulfate biosynthesis	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-196780	Biotin transport and metabolism	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.999999999991906	-8.09349770759977e-12	11	0	0	486	10287
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-1566977	Fibronectin matrix formation	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-6787639	GDP-fucose biosynthesis	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-444257	RSK activation	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-1237112	Methionine salvage pathway	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-111957	Cam-PDE 1 activation	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-3065679	SUMO is proteolytically processed	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-176417	Phosphorylation of Emi1	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-6798163	Choline catabolism	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-500753	Pyrimidine biosynthesis	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-166662	Lectin pathway of complement activation	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-6793080	rRNA modification in the mitochondrion	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999992366	-7.6337765927473e-12	6	0	0	486	10287
R-HSA-6784531	tRNA processing in the nucleus	0.999999999992473	-7.52717363732057e-12	60	0	0	486	10287
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.999999999993042	-6.95824498322934e-12	21	0	0	486	10287
R-HSA-1181150	Signaling by NODAL	0.999999999993042	-6.95824498322934e-12	21	0	0	486	10287
R-HSA-69618	Mitotic Spindle Checkpoint	0.999999999993042	-6.95824498322934e-12	21	0	0	486	10287
R-HSA-445144	Signal transduction by L1	0.999999999993042	-6.95824498322934e-12	21	0	0	486	10287
R-HSA-500657	Presynaptic function of Kainate receptors	0.999999999993042	-6.95824498322934e-12	21	0	0	486	10287
R-HSA-210745	Regulation of gene expression in beta cells	0.999999999993042	-6.95824498322934e-12	21	0	0	486	10287
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-156581	Methylation	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-391903	Eicosanoid ligand-binding receptors	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-3371568	Attenuation phase	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-5358508	Mismatch Repair	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-211935	Fatty acids	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-3322077	Glycogen synthesis	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.999999999993172	-6.82795979811295e-12	15	0	0	486	10287
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.999999999993591	-6.40935063025641e-12	24	0	0	486	10287
R-HSA-70895	Branched-chain amino acid catabolism	0.999999999993591	-6.40935063025641e-12	24	0	0	486	10287
R-HSA-156588	Glucuronidation	0.999999999993591	-6.40935063025641e-12	24	0	0	486	10287
R-HSA-171052	LDL-mediated lipid transport	0.999999999993591	-6.40935063025641e-12	24	0	0	486	10287
R-HSA-191273	Cholesterol biosynthesis	0.999999999993591	-6.40935063025641e-12	24	0	0	486	10287
R-HSA-3371571	HSF1-dependent transactivation	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-73980	RNA Polymerase III Transcription Termination	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-8855121	VLDL interactions	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-428930	Thromboxane signalling through TP receptor	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-5205647	Mitophagy	0.999999999993638	-6.36220620321534e-12	23	0	0	486	10287
R-HSA-264876	Insulin processing	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-111997	CaM pathway	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-70268	Pyruvate metabolism	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-437239	Recycling pathway of L1	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-111933	Calmodulin induced events	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-6803529	FGFR2 alternative splicing	0.999999999994002	-5.99783402642594e-12	28	0	0	486	10287
R-HSA-156587	Amino Acid conjugation	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-1300642	Sperm Motility And Taxes	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-74182	Ketone body metabolism	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-166665	Terminal pathway of complement	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-196025	Formation of annular gap junctions	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-159424	Conjugation of carboxylic acids	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-419771	Opsins	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-391908	Prostanoid ligand receptors	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-75094	Formation of the Editosome	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-1462054	Alpha-defensins	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-425986	Sodium/Proton exchangers	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-2428933	SHC-related events triggered by IGF1R	0.999999999995289	-4.71053566272062e-12	9	0	0	486	10287
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-1296041	Activation of G protein gated Potassium channels	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-5673000	RAF activation	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-429947	Deadenylation of mRNA	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-1296059	G protein gated Potassium channels	0.999999999995396	-4.60363673524216e-12	25	0	0	486	10287
R-HSA-156842	Eukaryotic Translation Elongation	0.999999999995648	-4.35155164375293e-12	96	0	0	486	10287
R-HSA-72764	Eukaryotic Translation Termination	0.999999999995648	-4.35155164375293e-12	96	0	0	486	10287
R-HSA-167169	HIV Transcription Elongation	0.999999999995877	-4.12330075612935e-12	50	0	0	486	10287
R-HSA-6802949	Signaling by RAS mutants	0.999999999995877	-4.12330075612935e-12	50	0	0	486	10287
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.999999999995877	-4.12330075612935e-12	50	0	0	486	10287
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.999999999995877	-4.12330075612935e-12	50	0	0	486	10287
R-HSA-164378	PKA activation in glucagon signalling	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-156711	Polo-like kinase mediated events	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-5656121	Translesion synthesis by POLI	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-196299	Beta-catenin phosphorylation cascade	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-140534	Ligand-dependent caspase activation	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-1482922	Acyl chain remodelling of PI	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-5655862	Translesion synthesis by POLK	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-3232118	SUMOylation of transcription factors	0.999999999995949	-4.05145824402412e-12	17	0	0	486	10287
R-HSA-170660	Adenylate cyclase activating pathway	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-74749	Signal attenuation	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-8868766	rRNA processing in the mitochondrion	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-2046105	Linoleic acid (LA) metabolism	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-430116	GP1b-IX-V activation signalling	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-190873	Gap junction degradation	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-419812	Calcitonin-like ligand receptors	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-390450	Folding of actin by CCT/TriC	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-201688	WNT mediated activation of DVL	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-5687613	Diseases associated with surfactant metabolism	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-2562578	TRIF-mediated programmed cell death	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-3215018	Processing and activation of SUMO	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-209968	Thyroxine biosynthesis	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-428643	Organic anion transporters	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-159740	Gamma-carboxylation of protein precursors	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-3229121	Glycogen storage diseases	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-70635	Urea cycle	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-5663084	Diseases of carbohydrate metabolism	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-727802	Transport of nucleotide sugars	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-6811555	PI5P Regulates TP53 Acetylation	0.99999999999595	-4.04989533613322e-12	10	0	0	486	10287
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	0.999999999996251	-3.74884252518927e-12	35	0	0	486	10287
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.999999999996251	-3.74884252518927e-12	35	0	0	486	10287
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.999999999996251	-3.74884252518927e-12	35	0	0	486	10287
R-HSA-113418	Formation of the Early Elongation Complex	0.999999999996251	-3.74884252518927e-12	35	0	0	486	10287
R-HSA-5693537	Resolution of D-Loop Structures	0.999999999996251	-3.74884252518927e-12	35	0	0	486	10287
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.999999999996251	-3.74884252518927e-12	35	0	0	486	10287
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.999999999996825	-3.1747312250388e-12	78	0	0	486	10287
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.999999999997211	-2.78943842683945e-12	137	0	0	486	10287
R-HSA-176187	Activation of ATR in response to replication stress	0.999999999997496	-2.50368527436519e-12	37	0	0	486	10287
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.999999999997496	-2.50368527436519e-12	37	0	0	486	10287
R-HSA-73884	Base Excision Repair	0.999999999997496	-2.50368527436519e-12	37	0	0	486	10287
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-114516	Disinhibition of SNARE formation	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-71032	Propionyl-CoA catabolism	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-6785470	tRNA processing in the mitochondrion	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-1483226	Synthesis of PI	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-2161541	Abacavir metabolism	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-446205	Synthesis of GDP-mannose	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-444209	Free fatty acid receptors	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-74713	IRS activation	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-157881	Cyclin B2 mediated events	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-8852405	Signaling by MST1	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-70350	Fructose catabolism	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-167827	The proton buffering model	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-8866376	Reelin signalling pathway	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-390651	Dopamine receptors	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-71262	Carnitine synthesis	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-75157	FasL/ CD95L signaling	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-561048	Organic anion transport	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-111469	SMAC-mediated apoptotic response	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-390648	Muscarinic acetylcholine receptors	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-70370	Galactose catabolism	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-167826	The fatty acid cycling model	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-8853383	Lysosomal oligosaccharide catabolism	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-8849473	PTK6 Expression	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-391906	Leukotriene receptors	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-5662702	Melanin biosynthesis	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-111463	SMAC binds to IAPs	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-8866423	VLDL biosynthesis	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-69478	G2/M DNA replication checkpoint	0.999999999998045	-1.95541054180608e-12	5	0	0	486	10287
R-HSA-5389840	Mitochondrial translation elongation	0.999999999998136	-1.86355888758767e-12	88	0	0	486	10287
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.999999999998136	-1.86355888758767e-12	88	0	0	486	10287
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.999999999998523	-1.47700796880596e-12	100	0	0	486	10287
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.999999999998891	-1.10891916006578e-12	52	0	0	486	10287
R-HSA-2980766	Nuclear Envelope Breakdown	0.999999999998891	-1.10891916006578e-12	52	0	0	486	10287
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.999999999998923	-1.07751023079464e-12	36	0	0	486	10287
R-HSA-177243	Interactions of Rev with host cellular proteins	0.999999999998923	-1.07751023079464e-12	36	0	0	486	10287
R-HSA-432720	Lysosome Vesicle Biogenesis	0.999999999998923	-1.07751023079464e-12	36	0	0	486	10287
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.999999999998923	-1.07751023079464e-12	36	0	0	486	10287
R-HSA-1660662	Glycosphingolipid metabolism	0.99999999999975	-2.49576158360261e-13	46	0	0	486	10287
R-HSA-4615885	SUMOylation of DNA replication proteins	0.99999999999975	-2.49576158360261e-13	46	0	0	486	10287
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.99999999999997	-3.03767034045373e-14	32	0	0	486	10287
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.99999999999997	-3.03767034045373e-14	32	0	0	486	10287
R-HSA-73863	RNA Polymerase I Transcription Termination	0.99999999999997	-3.03767034045373e-14	32	0	0	486	10287
R-HSA-70263	Gluconeogenesis	0.99999999999997	-3.03767034045373e-14	32	0	0	486	10287
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	1.00000000000029	2.90545962906361e-13	27	0	0	486	10287
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	1.00000000000029	2.90545962906361e-13	27	0	0	486	10287
R-HSA-901042	Calnexin/calreticulin cycle	1.00000000000029	2.90545962906361e-13	27	0	0	486	10287
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	1.00000000000029	2.90545962906361e-13	27	0	0	486	10287
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	1.00000000000029	2.90545962906361e-13	27	0	0	486	10287
R-HSA-1482788	Acyl chain remodelling of PC	1.00000000000029	2.90545962906361e-13	27	0	0	486	10287
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.00000000000029	2.90545962906361e-13	27	0	0	486	10287
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-5619102	SLC transporter disorders	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-174362	Transport and synthesis of PAPS	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-6814848	Glycerophospholipid catabolism	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-199920	CREB phosphorylation	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-171319	Telomere Extension By Telomerase	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-75158	TRAIL  signaling	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-433692	Proton-coupled monocarboxylate transport	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-111471	Apoptotic factor-mediated response	1.00000000000078	7.83664522578504e-13	7	0	0	486	10287
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	1.00000000000146	1.45639901212186e-12	69	0	0	486	10287
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1.00000000000187	1.86940282904157e-12	99	0	0	486	10287
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	1.00000000000259	2.59477886981951e-12	104	0	0	486	10287
R-HSA-1632852	Macroautophagy	1.00000000000293	2.92904176092865e-12	67	0	0	486	10287
R-HSA-3371556	Cellular response to heat stress	1.00000000000297	2.96988574907269e-12	89	0	0	486	10287
R-HSA-5696395	Formation of Incision Complex in GG-NER	1.00000000000304	3.03887456289268e-12	43	0	0	486	10287
R-HSA-168325	Viral Messenger RNA Synthesis	1.00000000000304	3.03887456289268e-12	43	0	0	486	10287
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	1.00000000000304	3.03887456289268e-12	43	0	0	486	10287
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	1.00000000000305	3.04608250772996e-12	20	0	0	486	10287
R-HSA-194223	HDL-mediated lipid transport	1.00000000000305	3.04608250772996e-12	20	0	0	486	10287
R-HSA-418217	G beta:gamma signalling through PLC beta	1.00000000000305	3.04608250772996e-12	20	0	0	486	10287
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	1.00000000000305	3.04608250772996e-12	20	0	0	486	10287
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	1.00000000000305	3.04608250772996e-12	20	0	0	486	10287
R-HSA-6804760	Regulation of TP53 Activity through Methylation	1.00000000000305	3.04608250772996e-12	20	0	0	486	10287
R-HSA-1643713	Signaling by EGFR in Cancer	1.00000000000305	3.04608250772996e-12	20	0	0	486	10287
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	1.00000000000305	3.04608250772996e-12	20	0	0	486	10287
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	1.00000000000305	3.04608250772996e-12	20	0	0	486	10287
R-HSA-8873719	RAB geranylgeranylation	1.0000000000034	3.395477357704e-12	64	0	0	486	10287
R-HSA-74158	RNA Polymerase III Transcription	1.00000000000359	3.58804439258714e-12	41	0	0	486	10287
R-HSA-5620924	Intraflagellar transport	1.00000000000359	3.58804439258714e-12	41	0	0	486	10287
R-HSA-5696400	Dual Incision in GG-NER	1.00000000000359	3.58804439258714e-12	41	0	0	486	10287
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	1.00000000000359	3.58804439258714e-12	41	0	0	486	10287
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	1.00000000000385	3.84882007370448e-12	87	0	0	486	10287
R-HSA-5419276	Mitochondrial translation termination	1.00000000000385	3.84882007370448e-12	87	0	0	486	10287
R-HSA-5368286	Mitochondrial translation initiation	1.00000000000385	3.84882007370448e-12	87	0	0	486	10287
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1.00000000000416	4.16272932425348e-12	63	0	0	486	10287
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	1.00000000000426	4.26483826196199e-12	158	0	0	486	10287
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	1.00000000000445	4.44859939482016e-12	70	0	0	486	10287
R-HSA-380259	Loss of Nlp from mitotic centrosomes	1.00000000000494	4.935493944764e-12	72	0	0	486	10287
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	1.00000000000494	4.935493944764e-12	72	0	0	486	10287
R-HSA-6799198	Complex I biogenesis	1.00000000000543	5.42522034953819e-12	51	0	0	486	10287
R-HSA-5668914	Diseases of metabolism	1.0000000000055	5.4956134437415e-12	44	0	0	486	10287
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	1.0000000000055	5.4956134437415e-12	44	0	0	486	10287
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	1.00000000000552	5.51704671796346e-12	45	0	0	486	10287
R-HSA-379724	tRNA Aminoacylation	1.00000000000552	5.51704671796346e-12	45	0	0	486	10287
R-HSA-8854214	TBC/RABGAPs	1.00000000000552	5.51704671796346e-12	45	0	0	486	10287
R-HSA-6802952	Signaling by BRAF and RAF fusions	1.00000000000643	6.42567674096562e-12	61	0	0	486	10287
R-HSA-72702	Ribosomal scanning and start codon recognition	1.00000000000643	6.42567674096562e-12	61	0	0	486	10287
R-HSA-4570464	SUMOylation of RNA binding proteins	1.00000000000695	6.9512212774399e-12	48	0	0	486	10287
R-HSA-73762	RNA Polymerase I Transcription Initiation	1.00000000000695	6.9512212774399e-12	48	0	0	486	10287
R-HSA-73857	RNA Polymerase II Transcription	1.0000000000071	7.09965151580519e-12	159	0	0	486	10287
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	1.00000000000726	7.25938277678076e-12	47	0	0	486	10287
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	1.00000000000726	7.25938277678076e-12	47	0	0	486	10287
R-HSA-5576892	Phase 0 - rapid depolarisation	1.00000000000726	7.25938277678076e-12	47	0	0	486	10287
R-HSA-75953	RNA Polymerase II Transcription Initiation	1.00000000000726	7.25938277678076e-12	47	0	0	486	10287
R-HSA-73776	RNA Polymerase II Promoter Escape	1.00000000000726	7.25938277678076e-12	47	0	0	486	10287
R-HSA-167161	HIV Transcription Initiation	1.00000000000726	7.25938277678076e-12	47	0	0	486	10287
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	1.00000000000726	7.25938277678076e-12	47	0	0	486	10287
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	1.00000000000779	7.79069913032361e-12	90	0	0	486	10287
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	1.00000000000785	7.85322374826185e-12	103	0	0	486	10287
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	1.00000000000791	7.91105806076524e-12	39	0	0	486	10287
R-HSA-165159	mTOR signalling	1.00000000000791	7.91105806076524e-12	39	0	0	486	10287
R-HSA-5674135	MAP2K and MAPK activation	1.00000000000791	7.91105806076524e-12	39	0	0	486	10287
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	1.00000000000791	7.91105806076524e-12	39	0	0	486	10287
R-HSA-5696394	DNA Damage Recognition in GG-NER	1.00000000000791	7.91105806076524e-12	39	0	0	486	10287
R-HSA-6783310	Fanconi Anemia Pathway	1.00000000000791	7.91105806076524e-12	39	0	0	486	10287
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	1.00000000000791	7.91105806076524e-12	39	0	0	486	10287
R-HSA-381038	XBP1(S) activates chaperone genes	1.00000000000804	8.04324518359813e-12	56	0	0	486	10287
R-HSA-977443	GABA receptor activation	1.00000000000804	8.04324518359813e-12	56	0	0	486	10287
R-HSA-72172	mRNA Splicing	1.00000000000826	8.25703766835095e-12	195	0	0	486	10287
R-HSA-167172	Transcription of the HIV genome	1.00000000000893	8.93093618967574e-12	77	0	0	486	10287
R-HSA-194441	Metabolism of non-coding RNA	1.00000000000903	9.02776457195031e-12	53	0	0	486	10287
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000000903	9.02776457195031e-12	53	0	0	486	10287
R-HSA-72165	mRNA Splicing - Minor Pathway	1.00000000000903	9.02776457195031e-12	53	0	0	486	10287
R-HSA-191859	snRNP Assembly	1.00000000000903	9.02776457195031e-12	53	0	0	486	10287
R-HSA-168255	Influenza Life Cycle	1.00000000000908	9.08120072166205e-12	146	0	0	486	10287
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	1.00000000000925	9.24539225363891e-12	85	0	0	486	10287
R-HSA-72689	Formation of a pool of free 40S subunits	1.00000000000937	9.37069541182233e-12	105	0	0	486	10287
R-HSA-72312	rRNA processing	1.00000000000977	9.76667720350087e-12	201	0	0	486	10287
R-HSA-73856	RNA Polymerase II Transcription Termination	1.00000000001005	1.00492110715609e-11	71	0	0	486	10287
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	1.00000000001005	1.00492110715609e-11	71	0	0	486	10287
R-HSA-429914	Deadenylation-dependent mRNA decay	1.00000000001066	1.06583360631912e-11	57	0	0	486	10287
R-HSA-5368287	Mitochondrial translation	1.00000000001125	1.12541566474934e-11	94	0	0	486	10287
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	1.00000000001158	1.15822217008956e-11	54	0	0	486	10287
R-HSA-6782315	tRNA modification in the nucleus and cytosol	1.00000000001177	1.17688998529053e-11	42	0	0	486	10287
R-HSA-983189	Kinesins	1.00000000001177	1.17688998529053e-11	42	0	0	486	10287
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	1.00000000001177	1.17688998529053e-11	42	0	0	486	10287
R-HSA-192823	Viral mRNA Translation	1.00000000001182	1.18185905162075e-11	92	0	0	486	10287
R-HSA-611105	Respiratory electron transport	1.00000000001182	1.18185905162075e-11	92	0	0	486	10287
R-HSA-156902	Peptide chain elongation	1.00000000001182	1.18185905162075e-11	92	0	0	486	10287
R-HSA-8856688	Golgi-to-ER retrograde transport	1.00000000001269	1.26870326608359e-11	110	0	0	486	10287
R-HSA-2990846	SUMOylation	1.00000000001269	1.26870326608359e-11	110	0	0	486	10287
R-HSA-72766	Translation	1.00000000001412	1.41235371108313e-11	162	0	0	486	10287
R-HSA-75955	RNA Polymerase II Transcription Elongation	1.00000000001456	1.45550730938939e-11	65	0	0	486	10287
R-HSA-112382	Formation of RNA Pol II elongation complex	1.00000000001456	1.45550730938939e-11	65	0	0	486	10287
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	1.00000000001456	1.45550730938939e-11	65	0	0	486	10287
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	1.0000000000153	1.52994481001832e-11	113	0	0	486	10287
R-HSA-5696398	Nucleotide Excision Repair	1.00000000001584	1.58425127539708e-11	112	0	0	486	10287
R-HSA-2408557	Selenocysteine synthesis	1.00000000001588	1.58754138923803e-11	95	0	0	486	10287
R-HSA-69473	G2/M DNA damage checkpoint	1.00000000001588	1.58754138923803e-11	95	0	0	486	10287
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	1.00000000001615	1.61502306833112e-11	49	0	0	486	10287
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	1.00000000001615	1.61502306833112e-11	49	0	0	486	10287
R-HSA-109703	PKB-mediated events	1.00000000001625	1.62486310049221e-11	40	0	0	486	10287
R-HSA-167290	Pausing and recovery of HIV elongation	1.00000000001625	1.62486310049221e-11	40	0	0	486	10287
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	1.00000000001625	1.62486310049221e-11	40	0	0	486	10287
R-HSA-167287	HIV elongation arrest and recovery	1.00000000001625	1.62486310049221e-11	40	0	0	486	10287
R-HSA-977444	GABA B receptor activation	1.00000000001625	1.62486310049221e-11	40	0	0	486	10287
R-HSA-991365	Activation of GABAB receptors	1.00000000001625	1.62486310049221e-11	40	0	0	486	10287
R-HSA-381070	IRE1alpha activates chaperones	1.00000000001639	1.6387883475453e-11	58	0	0	486	10287
R-HSA-72187	mRNA 3'-end processing	1.0000000000167	1.66987785988238e-11	62	0	0	486	10287
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1.0000000000167	1.66987785988238e-11	62	0	0	486	10287
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	1.0000000000167	1.66987785988238e-11	62	0	0	486	10287
R-HSA-1268020	Mitochondrial protein import	1.0000000000167	1.66987785988238e-11	62	0	0	486	10287
R-HSA-8852135	Protein ubiquitination	1.0000000000167	1.66987785988238e-11	62	0	0	486	10287
R-HSA-72649	Translation initiation complex formation	1.0000000000167	1.66987785988238e-11	62	0	0	486	10287
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	1.00000000001672	1.67168101365352e-11	75	0	0	486	10287
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1.00000000001672	1.67168101365352e-11	75	0	0	486	10287
R-HSA-6802957	Oncogenic MAPK signaling	1.00000000001672	1.67168101365352e-11	75	0	0	486	10287
R-HSA-8854518	AURKA Activation by TPX2	1.00000000001672	1.67168101365352e-11	75	0	0	486	10287
R-HSA-6782135	Dual incision in TC-NER	1.00000000001706	1.70648847502496e-11	66	0	0	486	10287
R-HSA-392518	Signal amplification	1.00000000001745	1.74499787381296e-11	33	0	0	486	10287
R-HSA-180746	Nuclear import of Rev protein	1.00000000001745	1.74499787381296e-11	33	0	0	486	10287
R-HSA-186712	Regulation of beta-cell development	1.00000000001745	1.74499787381296e-11	33	0	0	486	10287
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	1.00000000001759	1.75937400516254e-11	120	0	0	486	10287
R-HSA-927802	Nonsense-Mediated Decay (NMD)	1.00000000001759	1.75937400516254e-11	120	0	0	486	10287
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	1.00000000001812	1.81157930428722e-11	115	0	0	486	10287
R-HSA-72306	tRNA processing	1.00000000002192	2.19247503569029e-11	109	0	0	486	10287
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	1.00000000002221	2.22076816097739e-11	117	0	0	486	10287
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	1.00000000002221	2.22076816097739e-11	117	0	0	486	10287
R-HSA-5693606	DNA Double Strand Break Response	1.00000000002348	2.34817787156165e-11	76	0	0	486	10287
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000002374	2.37392011745242e-11	38	0	0	486	10287
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	1.00000000002374	2.37392011745242e-11	38	0	0	486	10287
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000002374	2.37392011745242e-11	38	0	0	486	10287
R-HSA-72613	Eukaryotic Translation Initiation	1.00000000002397	2.3968216780487e-11	125	0	0	486	10287
R-HSA-72737	Cap-dependent Translation Initiation	1.00000000002397	2.3968216780487e-11	125	0	0	486	10287
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	1.00000000002426	2.42604652504024e-11	179	0	0	486	10287
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1.00000000002576	2.57589186308149e-11	79	0	0	486	10287
R-HSA-68877	Mitotic Prometaphase	1.00000000002641	2.64132672579574e-11	111	0	0	486	10287
R-HSA-72163	mRNA Splicing - Major Pathway	1.00000000002769	2.76887759464213e-11	187	0	0	486	10287
R-HSA-5685942	HDR through Homologous Recombination (HRR)	1.00000000002795	2.79468187672997e-11	68	0	0	486	10287
